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Cells of the immune system have many unique functions, but underlying 
similarities in signaling mechanisms and pathways make a well-defined model system 
useful. We utilize RBL mast cells to probe a variety of questions pertinent to immune 
cell function and infection.  Mast cells serve as innate immune responders as well as the 
mediators of allergic disease.  A major signaling cascade in mast cells is initiated by 
multivalent antigen crosslinking of immunoglobulin E (IgE)-FcεRI receptor complexes.  
Membrane reorganization and signal transduction involving multiple players leads to 
Ca2+ mobilization and protein kinase C activation that ultimately triggers the release of 
preformed mediators from secretory lysosomes and, additionally, to outward trafficking 
of recycling endosomes (RE).  The first study investigates the dynamic lipid environment 
surrounding crosslinked IgE-FcεRI complexes.  By isolating detergent-resistant 
membranes and performing detailed mass spectrometry analysis, cytoskeletal 
interactions are found to be important for regulating membrane lipid reorganization 
resulting from antigen stimulation. Next, we characterized the molecular basis of 
sphingosine inhibition of cell function.  We find that sphingosine derivatives 
electrostatically interfere with phosphoinositide-dependent membrane processes, 
including both Ca2+ mobilization and exocytic processes such as degranulation and RE 
outward trafficking. The function and regulation of RE trafficking in immune cells, 
especially as it pertains to cytokine secretion, is of great interest.  We provide evidence, 
by immunofluorescence microscopy and cytokine secretion assays, that mast cells 
secrete both IL-4 and TNFα in a manner that is consistent with a role for RE in their 
secretion.  The dynamic trafficking of RE in RBL mast cells makes them likely 
candidates in many processes, including interactions with pathogens.  We provide 
strong evidence for a role for RE in the formation of the parasitophorous vacuole (PV) of 
the obligate intracellular parasite, Toxoplasma gondii. In addition, we find that 
Toxoplasma gondii infection of mast cells results in suppression of IgE-FcεRI signaling 
by interfering with the activation of phospholipase Cγ. Colllectively, these studies show 
RBL mast cells as a versatile model of cellular immune function in both health and 
disease.  
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CHAPTER ONE 
Introduction 
1. The Immune System 
Living organisms do not live in a sterile environment. Interacting with the world 
around them results in constant exposure to agents that range from innocuous to life 
threatening.  As a result, all organisms have evolved mechanisms to mitigate 
detrimental effects due to contact with harmful agents.  At the same time, these systems 
must also be tolerant to self-antigens or benign foreign materials. Higher eukaryotes, 
such as mice and man, have complex and finely regulated immune systems comprised 
of multiple components working in concert to keep the host healthy. These factors make 
for a robust system capable of fighting a large spectrum of insults, but they also 
increase the likelihood of aberrant or harmful responses. 
An exhaustive review of immunology is well beyond the scope of this thesis, but a 
brief introduction is worthwhile. I will discuss some of the cell types of hematopoietic 
origin, and while most of these cells some have unique roles in generating effective 
immune responses, it is also important to appreciate the level of redundancy existing in 
the system. Multiple cell types can perform analogous functions, and signal transduction 
within immune cells share important common signaling modules. This dissertation 
reports on the use of mast cells to probe an assortment of questions that are not only 
important to their function, but also generally informative to important topics in immune 
signaling and biological function. 
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Medically, immunity is defined as an organismʼs resistance to pathogens or 
disease. Without pathogens, an immune system has limited utility. It is difficult to think 
about immunity without also thinking about pathogens or disease; after all, the two co-
evolved. As a result much of what we know of the immune system is derived from the 
study of specific diseases. 
Cells that Contribute to Immunity 
 To some extent, every cell in the body of an organism contributes to immune 
function. Skin and mucosal membranes serve as important physical barriers and play 
important roles in innate immunity. In a non-specific manner, these tissues serve as a 
first line of defense and block the vast majority of harmful agents. Similarly, nearly every 
nucleated cell expresses major histocompatibility complex I (MHC I) on its surface. This 
MHC I presents endogenous antigen to effector cells which, in turn, make important 
contributions to the type of adaptive response generated.  
That being said, many of key players in both innate and adaptive immune 
functions are derived from hematopoietic stem cells.  Hematopoietic stem cells 
differentiate into either myeloid or lymphoid progenitors.  B and T lymphocytes are the 
primary cells derived from the lymphoid lineage. They both recognize antigen in a clonal 
manner and are critical for the generation of adaptive immunity.  B cells are responsible 
for the production of antibodies, or immunoglobulins, the major component of humoral 
immunity. B cells also play a major role in antigen presentation. T cells further 
differentiate into helper CD4+ (Th1 and Th2) and cytotoxic CD8+ T cells.  Helper T cells 
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are important in directing the quality of an immune response: Th1 cells induce an 
environment favoring cell-mediated immunity by cytotoxic T cells, whereas Th2 cells 
contribute primarily to humoral immunity.  These effects are largely mediated by specific 
cytokine secretion profiles.  
Cells of myeloid lineage are major contributors to innate immunity, and they 
include macrophages and monocytes, dendritic cells (DC), neutrophils, eosinophils, 
basophils and mast cells.  Most cells of myeloid lineage express toll-like receptors 
(TLRs) that use pathogen-associated molecular patterns (PAMPs) to recognize potential 
threats. Cell signaling through TLRs is a major trigger for the innate immune response, 
as it generates chemokines and cytokines that recruit additional effector cells. 
Macrophages and dendritic cells both act as professional antigen presenting cells 
(APCs), presenting peptide antigen to T cells. Neutrophils, eosinophils, basophils and 
mast cells are all granulocytes that have preformed mediators stored in granules that 
can be rapidly released in response to activation.  Many of these cells have phagocytic 
capabilities and can ingest whole organisms or large pieces of cellular debris. Ingested 
material is then degraded by the phago-lysosomal system.  Additionally, activation of 
these cells can upregulate the secretion of cytokines important for additional effector 
cells of both the innate and adaptive systems. 
Cytokine Secretion 
 Cytokines are essential for directing the traffic of immune effector cells to sites of 
infection, inflammation or damage.  They also play important roles in determining what 
3
type of immune response is generated in response to various insults. Secretion of IFN! 
and IL-12 induce pro-inflammatory responses that are a hallmark of Th1 mediated 
responses.  In contrast, IL-4, IL-5 and IL-13 are linked to Th2 mediated immunity.  In 
response to ligand binding, immuno-receptors such as TLRs and cytokine receptors 
trigger transcription and translation of cytokines. The mechanisms of cytokine secretion 
have lately generated interest, and it is suggested that various cells may have different 
means of regulating cytokine release [1].    
Mast Cells  
Paul Ehrlich first identified mast cells in 1878. Mast cells were seen to be 
uniquely stained granule rich cells that were mistakenly thought to provide nourishment 
to surrounding tissues [2].  They were later correctly identified as cells of the immune 
system, being derived of myeloid lineage. Basophils and mast cells have similar 
function, but basophils circulate while mast cells are tissue-resident cells [3]. Mast cells 
circulate as an immature phenotype, and they mature at their destination, developing 
either a mucosal or  a connective tissue phenotype [4].  Our studies primarily use RBL 
mast cells, which have a mucosal phenotype [5].  
Mast cells are most commonly associated with type I hypersensitivity allergic 
responses. Mast cell-mediated allergic diseases are an important health concern, 
particularly in developed countries.  In the United States, more than 50 million people 
annually are afflicted with allergic symptoms [6], ranging from a runny nose and watery 
eyes to life-threatening anaphylaxis.  In allergic responses, immunoglobulin E (IgE)-
4
mediated reactions to antigen (allergen) result in the secretion of cell products, such as 
histamine, that contribute to disease manifestation. 
Mast cells are not only mediators of allergic disease, but show diversity of 
function (Figure 1.1). As such, they play important protective roles in host defense 
through multiple immune mechanisms [7].  Increased serum levels of IgE and mast cell 
activity are also associated with combating parasitic helminth infections [8]. Helminth 
infection is a major concern in developing nations [9] and the agricultural industry [10]. 
As tissue resident cells, mast cells can act as primary mediators in responses to 
infection [4]. They can express MHC II and serve as APCs to T cells [11], and also act 
as phagocytes [12]. In addition to Fc"RI expression, mast cells express other immune 
recognition receptors including Toll-like receptors (TLRs) and IgG receptors, Fc!RIIb 
and Fc!RI [7]. For example, in mast cells, recognition of LPS (lipopolysaccharide) is 
TLR4 dependent [13]. Mast cells can secrete multiple cytokines including IL-3, IL-4, IL-6 
tumor necrosis factor # (TNF#), and IL-10. In human peripheral mast cells, preformed 
TNF# is secreted during degranulation [14, 15]; however, in RBL mast cells TNF# is not 
a preformed mediator in granules [16]. Rat peritoneal mast cells produce cytokines in 
response to LPS in a degranulation-independent manner [17]. Recent research shows 
that mast cell-derived IL-10 is important for limiting inflammation in contact 
hypersensitivity reactions [18].   
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Figure 1.1. Mast Cells have multiple immune effector functions. 
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2. Signaling in Mast Cells  
 Fc!RI 
 IgE-mediated signaling in mast cells occurs through activation of the high affinity 
receptor for IgE, Fc"RI. Fc"RI is a member of the multi-chain immune recognition 
receptor (MIRR) family, which includes T-cell receptors (TCR), B-cell receptors (BCR) 
and Fc!Rs [19]. For MIRR family members, antigen recognition (or antibody binding) 
and signal transduction are mediated by separate subunits. Fc"RI on mast cells, and 
basophils, is a tetramer composed of an #, a $ and two ! chains (#$!2).  The # subunit 
has an extracellular domain that binds IgE with high affinity and serves as the immune 
recognition site [20]. The two ! chains each have an immune tyrosine activation motif 
(ITAM) that act as signaling moieties. The $ subunit also contains an ITAM that acts as 
a signal amplifier by binding Lyn kinase. In human antigen presenting cells, such as 
monocytes and dendritic cells, Fc"RI is a trimer composed of #!2 [21]. 
IgE/Fc!RI-Mediated Signal Transduction 
IgE is one of the five classes of antibodies secreted by B cells.  In a primary 
response, mature B cells bind antigen in an epitope specific, clonal manner via the 
BCR. In the context of Th2 cytokines such as IL-4 and IL-13, these B cells differentiate 
into plasma cells that class switch to secrete large amounts of IgE with the specificity of 
the BCR [22]. This secreted antibody enters circulation where it can be bound by any 
cell expressing Fc"RI, including mast cells. Upon secondary exposure to the antigen, 
IgE/Fc"RI are crosslinked, and this event results in the redistribution of aggregated 
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receptor into ordered-lipid microdomains, often termed lipid rafts [23]. This redistribution 
allows for the phosphorylation of tyrosine residues within the ITAMs of Fc"RI by Lyn 
kinase. The tyrosine kinase Syk is in turn recruited to the phosphorylated ! chains by its 
tandem SH2 domains. Activated Syk phosphorylates important downstream signaling 
molecules including the adaptor protein linker for the activation of T cells (LAT) and 
phospholipase C! (PLC!). The recruitment of PLC! results in the hydrolysis of 
phosphotidylinositol-4,5-bisphosphate (PI(4,5)P2) at the plasma membrane to yield 
inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds to IP3 receptors on 
the ER membrane, and this results in release of Ca2+ from these stores. Ca2+ release 
promotes interactions between the calcium sensor Stim1 in the ER membrane and the 
store-operated calcium (SOC) channel at the PM, Orai1, triggering additional Ca2+ influx 
[24, 25].  Concurrent with Ca2+ mobilization, DAG activates protein kinase C (PKC).  
Together, these events trigger the degranulation of secretory lysosomes containing 
preformed mediators such as histamine, serine proteases, and serotonin. The signaling 
described above is depicted in Figure 1.2. In addition to degranulation, Fc"RI signaling 
also triggers the production secondary lipid mediators, including prostaglandins and 
leukotrienes.  Cytokines are also produced and contribute to the recruitment of many 
immune effector cells that carry out late-phase allergic responses. These include long-
term inflammation and extensive tissue remodeling at the site of the allergic response.   
Membrane Heterogeneity 
 In 1972, Singer and Nicholson developed the well-known fluid mosaic model that 
postulated that membrane lipids mainly acted as a support structure for the various 
8
 
 
Figure 1.2. Schematic of the signal transduction that occurs through Fc"RI. Crosslinking 
of Fc"RI-IgE complexes by multivalent antigen leads to phosphorylation of receptor by 
Lyn kinase and the subsequent recruitment and activation of Syk which can then 
phosphorylate the adaptor protein LAT and other substrates. Consequent activation of 
PLC! produces DAG and IP3, and IP3 activates IP3 receptors on the endoplasmic 
reticulum (ER), causing calcium release from ER stores. Calcium mobilization and 
activation of PKC by DAG are necessary for maximal degranulation of secretory 
lysosomes. 
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signaling proteins that freely diffuse in the plasma membrane [26]. Work in model 
membranes demonstrated that two lipid phases, liquid ordered (LO) and a liquid 
disordered (LD), could coexist under physiologic conditions [27]. It wasnʼt until the 1990s 
that it was proposed that lipid micro-domains could affect signaling events at the plasma 
membrane [23, 28, 29]. From these early works, the concept of lipid rafts was born. 
Lipid rafts were shown to be enriched in phospholipids with saturated acyl chains, 
cholesterol and sphingolipids. Insolubility in cold non-ionic detergents (e.g. Triton-X 100) 
was a defining feature of lipid rafts for many years [30]. While the term lipid raft invokes 
a long-lived stable structure, it is now appreciated that membrane heterogeneity in living 
cells is highly dynamic and exists on submicron length scales [31].  
In resting RBL cells, IgE/Fc"RI is localized primarily in an LD environment.  It is 
only after crosslinking with multivalent antigen that it clusters in lipid rafts [32].  This 
regulated translocation is an important step, as it exposes ligated receptors to active 
Lyn kinase that is protected from inactivation due to its localization in lipid rafts [33, 34].  
Reducing cholesterol by treatment with methyl $%cyclodextrin perturbs membrane 
heterogeneity such that normal receptor signaling is disrupted [35]. 
3. Recycling Endosomes 
 Many cellular functions rely on intracellular membrane trafficking.  Recycling 
endosomes (RE) are now appreciated to be important participants in these processes.  
They were first identified by Hopkins and Trowbridge in 1983 as being involved in 
transferrin (TfR) receptor trafficking [36]. Yamishiro et al. further described RE as a 
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mildly acidic tubulovesicular organelle, distinct from the phagolysosomal system, and 
involved in the recycling of membrane proteins [37] (Figure 1.3).  RE serve as a large 
internal reservoir of membrane lipids and other plasma membrane components. Our 
laboratory established that the ganglioside GM1, as labeled by Cholera Toxin B (CTxB), 
populates the recycling endosome with a perinuclear localization in RBL mast cells [38]. 
More recently, there is accumulating evidence that RE are a heterogeneous population, 
such that CTxB-labeled RE are distinct from TfR-containing RE [39].  
Biological Function of Recycling Endosomes 
Though initially described as an organelle whose major function is recycling of 
internalized transmembrane proteins, it is now appreciated that RE are a highly dynamic 
organelle that can serve diverse functions in many cells types. In addition to their role as 
plasma membrane recycling compartments, RE have established roles in membrane 
intensive processes that require directed trafficking, such as in cytokinesis [40], 
phagocytosis in macrophages [41], and migration [42].  RE trafficking also actively 
participates in the maintainence of epithelial cell polarity via directed trafficking of 
basolateral proteins [43, 44], and export and secretion of cytokines in macrophages [41, 
45] and NK cells [46]. In plasmacytoid dendritic cells (pDCs), storage of MHC I in RE 
may play important roles in cross-presentation of antigen [47]. In our laboratory, we 
established that IgE/Fc"RI-mediated signaling triggers an outward trafficking response 
of CTxB-labeled RE [38], and that these RE are trafficked to sites of receptor ligation by 
immobilized antigen-patterned surfaces [48].  
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Figure 1.3. Recycling endosomes and the endo-lysosomal system.  RE are a mildly 
acidic tubulovesicular organelle that is spatially and functionally separate from canonical 
lysosomal maturation. Figure adapted from Mukherjee et al. [87].!
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RE not only participate in normal cellular function, they also have important roles 
in host-pathogen interactions and disease states.  RE contribute to enhancement of HIV 
particle release [49]. RE interactions with Salmonella vacuoles are important for 
vacuolar maturation [50]. Furthermore, reduction or absence of presenillin/!-secretase 
activity, associated with the neurodegeneration seen in Alzheimerʼs disease, impairs RE 
trafficking [51]. RE-associated Rab11-overexpression can rescue neurodegenerative 
defects caused by Huntingtonʼs disease [52]. 
Regulators of RE Trafficking   
 Regulation of organelle function is intrinsically linked to membrane identity. Rabs 
and Arfs are large families of small GTPases whose members have differing organelle 
specificity and, due to this distribution, function to mediate and regulate membrane 
traffic between organelles. Rab11 and Rab4 show RE localization [53], and over-
expression of dominant negative Rab11 results in delayed RE trafficking in multiple 
contexts [54]. Arf6 is also directly linked to RE to plasma membrane trafficking [55]. 
Furthermore, Balasubramanian and colleagues demonstrated that Arf6 selectively 
controls exocytosis and GM1-CTxB labeled RE membranes [39], lending credence to 
the concept of RE as a heterogeneous pool that can be differentially regulated.  
Rab11-family interacting proteins (Rab11-FIPs) are genetically diverse but share 
a common Rab11 binding domain (RBD) [56].  They are further broken down into two 
subclasses: Class I Rab11-FIPs are implicated in the recycling functions of RE [57] and 
Rab11-FIP2 interacts directly with the molecular motor protein myosin Vb [58]. Class II 
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Rab11-FIPs are important for RE function in cytokinesis [59, 60]. Moreover, Rab11-FIP3 
also contributes to the structural identity of RE [61]. 
Vesicular fusion is a process regulated by soluble NSF attachment protein 
receptor (SNARE) proteins.  Like the small GTPases, SNAREs also display specific 
subcellular localization.  This ensures that vesicular fusion occurs at the appropriate 
place. VAMP3 is the SNARE primarily associated with RE trafficking.  Murray et al, 
determined that VAMP3 co-localizes with TfR and TNF# in the RE of macrophages [41].  
4. Toxoplasma gondii  
 T. gondii is an obligate intracellular, apicomplexan parasite. It can infect virtually 
any warm-blooded animal. In humans, infection rates vary widely according to 
geographic locations. In United States and the United Kingdom, somewhere between 
16-40% of the populations are infected [62]. There are three main clonal lineages of T. 
gondii, types I, II and III [63], however recently a fourth lineage has been described [64]. 
Infection by type I parasites results in a lethal infection in mice while types II and III are 
less virulent [65]. The molecular bases for virulence differences between lineages are 
an active area of study. 
Toxoplasma is an incredibly successful parasite, and infections generally result in 
latent infection that persists for the life of the host.  For most immunocompetent 
individuals, infection is asymptomatic. However, in immunocompromised individuals, 
such as those with Acquired Immune Deficiency Syndrome (AIDS), severe encephalitis 
can occur as a result of parasite reactivation [66].  Acute toxoplasmosis in pregnant 
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women may be detrimental to fetal development, leading to auditory or visual 
impairment or mental retardation [67]. 
Life Cycle and Invasion 
 As is true of many parasites, Toxoplasma has a complex life cycle. There are 
three infective stages of the parasite: sporozoites, bradyzoites and tachyzoites. The 
sexual reproduction of T. gondii occurs in the gut of the definitive host, members of the 
family Felidae, most notably the domestic cat (Felis catus) [68, 69].  Oocysts containing 
sporozoites are shed in cat feces.  Oocysts are incredibly durable structures that can 
withstand harsh environmental conditions [70], such that contamination of food or water 
is a general mechanism of parasite transmission. Another major mechanism of 
transmission is the consumption of tissues containing encysted bradyzoites.  In 
intermediate hosts, it is generally the ingestion of either oocyts or tissue cysts that 
triggers disease.  Sporozoites and bradyziotes convert to tachyziotes that can invade 
nearly any nucleated cell and divide rapidly to disseminate throughout the host.   
 Tachyziotes infect through a process of active invasion that is parasite-mediated, 
as depicted in Figure 1.4. This is in contrast to a host-mediated phagocytic process [71]. 
Upon initiation of invasion, the parasite secretes proteins from two specialized 
organelles, micronemes and rhoptries (Figure 1.4). These proteins facilitate the 
formation of a structure termed the moving junction [72] that aids in the invasion process 
(reviewed in [73]).  The parasite acquires a vacuolar membrane during the invasion 
process.  This parasitophorous vacuole (PV) is composed of host membrane that is 
15
  
 
 
 
 
 
 
 
 
 
Figure 1.4. T. gondii infects cells via a rapid, active invasion process. Initial attachment 
(1) is followed by apical attachment (2) and release of microneme proteins. 
Subsequently, a moving junction is set up that involves both microneme and rhoptry 
proteins (RONs) (3). Additional rhoptry proteins (ROPs) are secreted into the target cell. 
As invasion progresses the moving junction moves towards the posterior of the parasite 
(4). This process forms the nascent PV. Following invasion the PV closes (5) and 
undergoes fission completing the invasion process. Figure adapted from Carruthers and 
Boothroyd [73].  !
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largely devoid of plasma membrane proteins [74, 75]. Throughout replication, 
tachyzoites remain in the PV, but retain access to necessary host metabolites [76] and 
cholesterol [77].  After initial infection and replication, tachyziotes convert to the slower 
growing bradyziote that establish cysts, particularly in muscle and brain tissue. These 
long-lived cysts represent an avenue for parasite dissemination as many intermediate 
hosts serve as food sources.  
Immune Modulation by T. gondii 
 The long-term survival and successful transmission associated with cyst 
formation requires that T. gondii spread throughout the body of the host while limiting 
immunopathology associated with large scale infections. To this end, Toxoplasma has 
developed multiple mechanisms to subvert the normal immune response to suit its 
needs [78, 79]. Parasites preferentially infect cells of the immune system, such as 
macrophages and dendritic cells [80, 81], possibly because these cells can efficiently 
move the tachyziotes around the body [82]. Infecting immune cells may seem 
counterproductive, but in infected cells apoptotic death signals are actively 
dowregulated [83], and production of the anti-inflammatory cytokine IL-10 is upregulated 
[84]. Furthermore, while parasite infection results in the generation of IL-12 that 
promotes the induction of IFN!-secreting Th1 T lymphocytes, infected cells are not 
responsive to signaling mediated by IFN! [79]. Dissecting the molecular mechanisms 
that T. gondii utilizes is an area of active study.  New evidence suggests that parasite-
secreted proteins, particularly those secreted by parasite rhoptries, modulate signaling 
by interference with kinase-mediated signaling pathways within the host [85, 86]. 
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6. Current Studies 
Mast cells are the common denominator of this dissertation. Mast cells play 
central roles in both host defense and detrimental allergic responses. To this end, fully 
understanding how signaling is regulated or can be exogenously modulated is vital to 
the control of both helminth infections and allergic disease. Furthermore, the work 
presented here demonstrates that mast cells are useful tools that provide information to 
expand our knowledge in areas as diverse as membrane heterogeneity and host-
pathogen interactions. 
Chapter 2 investigates how mast cell signaling by antigen alters the lipid 
composition of membrane domains that contain the IgE/Fc"RI signaling platform, 
allowing for the retention of more polyunsaturated phospholipid species.  We show 
similar lipid changes can be induced by destablilizing the actin cytoskeleton, whereas its 
stabilization prevents the antigen-stimulated changes.  These insights provide evidence 
that cytoskeletal components play crucial roles in regulating membrane heterogeneity at 
the plasma membrane. Chapter 3 characterizes the molecular basis of sphingosine-
mediated inhibition of mast cell signaling, highlighting the contribution that plasma 
membrane polyphosphoinositides play in both granule and recycling endosomal 
exocytic events.  Chapter 4 documents our further investigations of RE, most notably 
the possible role they play in the secretion of cytokines in mast cells.   Our interest in the 
diverse functions of recycling endosomes, aided by the discrete morphological 
distribution of RE in RBL cells, led us to investigate their possible contribution to the 
establishment of the PVM of Toxoplasma gondii in newly invaded cells.  Chapter 5 
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shows compelling evidence that RE does, in fact, contribute to the PVM. Finally, in 
Chapter 6, we establish that T. gondii rapidly modulates IgE/Fc"RI-mediated signaling 
that results in reduced degranulation responses. Further, we provide evidence that this 
inhibition is mediated by imparing PLC!1 activation. We postulate that this inhibitory 
function may be relevant to infection of other immune cells. 
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 CHAPTER TWO 
IgE Receptor-Mediated Alteration of Membrane-Cytoskeletal Interactions 
Revealed by Mass Spectrometric Analysis of Detergent-Resistant Membranes1 
 
SUMMARY 
 
We use electrospray ionization mass spectrometry to quantify >100 phospholipid 
(PL) components in detergent-resistant membrane (DRM) domains that are related to 
ordered membrane compartments commonly known as lipid rafts. We previously 
compared PL compositions of DRMs with plasma membrane vesicles and whole cell 
lipid extracts from RBL mast cells, and we made the initial observation that antigen 
stimulation of IgE receptors (Fc!RI) causes a significant change in the PL composition 
of DRMs [Fridriksson, E. K., et al. (1999) Biochemistry 38, 8056-8063]. We now 
characterize the signaling requirements and time course for this change, which is 
manifested as an increase in the recovery of polyunsaturated PL in DRM, particularly in 
phosphatidylinositol species. We find that this change is largely independent of tyrosine 
phosphorylation, stimulated by engagement of Fc!RI, and can be activated by Ca2+ 
ionophore independent of antigen stimulation. Unexpectedly, we found that inhibitors of 
actin polymerization (cytochalasin D, latrunculin A) cause a similar, but more rapid, 
change in the PL composition of DRMs in the absence of Fc!RI activation, indicating 
that perturbations in the actin cytoskeleton affect the organization of plasma membrane !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Published as X. Han*, N. L. Smith*, D. Sil, D. A. Holowka, F. W. McLafferty and B. A. Baird. 
IgE Receptor-Mediated Alteration of Membrane-Cytoskeletal Interactions Revealed by Mass 
Spectrometric Analysis of Detergent-Resistant Membranes. Biochemistry, 2009. 48(27): p6540-
50. Reprinted with permission.  
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 domains. Consistent with this interpretation, a membrane-permeable stabilizer of F-
actin, jasplakinolide, prevents antigen-stimulated changes in DRM PL composition. 
These results are confirmed by a detailed analysis of multiple experiments, showing that 
receptor and cytochalasin D-stimulated changes in DRM lipid composition follow first-
order kinetics. Analysis in terms of the number of double bonds in the fatty acid chains 
is valid for total PL of the major head groups and for head groups individually. In this 
manner we show that, on average, concentrations of saturated or monounsaturated PL 
decrease in the DRM, whereas concentrations of PL with two or more double bonds 
(polyunsaturated PL) increase due to cytoskeletal perturbation. We find that these 
changes are independent of fatty acid chain length. Our mass spectrometric analyses 
provide a detailed accounting of receptor-activated alterations in the plasma membrane 
that are regulated by the actin cytoskeleton. 
INTRODUCTION 
Functional roles for lipid heterogeneity and lipid-based membrane domains in 
cellular processes have received increasing attention during the past decade [1, 2]. 
Central to this topic are regions of the plasma membrane containing lipids with liquid 
ordered (Lo)-like phase behavior, commonly called lipid rafts [1, 3]. Originally identified 
as a subset of plasma membrane lipids and proteins that are not solubilized by mild 
detergents such as Triton X-100 [4-6], these membrane domains have been implicated 
in a variety of cellular functions, including receptor signaling, vesicle trafficking to and 
from the plasma membrane, and host-pathogen interactions [7-9]. Studies on model 
membranes show that membrane domains composed predominately of cholesterol and 
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 sphingomyelin or saturated phosphoglycerolipids are in an Lo phase that is sufficient to 
confer detergent resistance and segregation from liquid disordered (Ld) regions of lipid 
bilayers [1]. However, because lipid rafts in cells have variable lipid and protein 
composition, are dynamic, and are difficult to detect by optical microscopy or other non-
destructive methods, their true nature and even their existence in live cells has been a 
subject of controversy [10, 11] and continues to be evaluated with the development of 
new approaches [12, 13]. 
Although use of detergent resistance as an indicator for lipid rafts in cells requires 
careful interpretation, this property continues to serve as a valuable correlative tool [12]. 
A complementary approach frequently used to visualize coalesced lipid rafts in live cells 
is to crosslink certain receptors or lipid raft components under conditions that result in 
large-scale co-clustering of other raft components [14-17]. Results from these 
fluorescence imaging experiments are generally consistent with predictions from 
detergent-dependent membrane fractionation [8, 13], and, used together with biological 
assays, they support the relevance of this biochemical approach to the functional 
characterization of lipid rafts and associated components. In mast cells, crosslinking of 
the high affinity IgE receptor, Fc!RI, causes its stable association with lipid rafts as 
assessed by cell lysis with low concentrations of detergent (e.g., 0.05% Triton X-100) 
and sucrose gradient fractionation. This association is highly correlated with the 
initiation of cell signaling mediated by native Fc!RI [18] or chimeric, single-chain IgE 
receptors [19]. 
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 Under experimental conditions that show co-redistribution of lipid raft 
components at the cell surface, F-actin is commonly found to co-localize with raft 
domains by fluorescence microscopy imaging, suggesting a structural relationship 
between lipid rafts and the cortical cytoskeleton [20-22]. Consistent with this 
observation, alteration of cholesterol content that inhibits initiation of IgE receptor 
signaling [17] can also perturb plasma membrane-cytoskeletal interactions [17]. Results 
in the present study provide new evidence from mass spectrometry for significant 
coupling between lipid rafts and the actin cytoskeleton.  
In a previous study [17], we used Fourier transform mass spectrometry (FTMS) 
with electrospray ionization (ESI/MS) to characterize the phospholipid (PL) composition 
of plasma membranes and detergent resistant membranes (DRMs) isolated from RBL 
mast cells. The unusual FTMS capabilities of resolving power and sensitivity identified 
unique molecular masses of nearly 100 components, including a number of new 
species, while mass isolation and dissociation of individual molecular ions provided 
fragment masses for reliable molecular characterization (24). We showed that both of 
these membrane preparations are enriched in sphingomyelin and phosphoglycerolipids 
with saturated or monounsaturated acyl chains, compared to phosphoglycerolipids with 
polyunsaturated acyl chains. However, the DRM preparations have significantly higher 
percentages of sphingomyelin and saturated acyl chains, as expected for Lo domains. 
In contrast, PLs extracted from the whole cells are highly enriched in polyunsaturated 
species. We discovered that stimulation of RBL cells via Fc!RI causes a substantial 
increase in the ratio of polyunsaturated to saturated plus monounsaturated PLs (P/S+M) 
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 recovered in DRMs. The structural and functional basis for this stimulated change was 
intriguing but unclear. In the present study, we collect and analyze extensive mass 
spectrometry data to characterize this DRM lipid compositional change and its temporal 
trend, and we find that this change follows first-order kinetics and depends on 
stimulated changes in the actin cytoskeleton. Our results point to sensitive, dynamic 
regulation of lipid rafts by the actin cytoskeleton that is modulated during receptor-
mediated cell activation. 
MATERIALS AND METHODS 
Cell Stimulation, DRM Vesicle Isolation, and Lipid Extraction.  
Methods used are similar to those described by Fridriksson et al. [23], with some 
modifications. RBL-2H3 cells [24] were sensitized overnight with a 2-5 molar excess 
over Fc!RI of purified anti-DNP IgE [25]. Cells were harvested, washed twice with 
buffered saline solution (BSS: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 
5.6 mM glucose, 20 mM HEPES, pH 7.4, 1 mg/ml BSA) and resuspended at 8 x 106 
cells/mL. Cells were stimulated with multivalent DNP-BSA (2-5 µg/ml) for 2 to 30 min at 
37°C. For some experiments, the Src family tyrosine kinase inhibitor PP1 (BioMol, 
Plymouth Meeting, PA) was added at 4 µM, 2 min prior to antigen stimulation. For other 
experiments, jasplakinolide (Invitrogen/Molecular Probes, Eugene, OR) was added at 3 
µM for 1 hour at 37°C prior to antigen stimulation. Alternatively, cells were stimulated 
with 0.9 µM A23187 (Calbiochem, San Diego, CA) for 5 or 15 min, or treated with 0.2-
2µM cytochalasin D (Sigma Chemical Co, St. Louis, MO) or 0.2 µM latrunculin A 
(Invitrogen/Molecular Probes) for 1, 2 or 10 min, all at 37°C.  
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 Following stimulation, cells were lysed by mixing 1:1 with 2x ice-cold lysis buffer 
(20 mM Tris-HCl, 100 mM NaCl, 2 mM sodium orthovanadate, 60 mM sodium 
pyrophosphate, 20 mM sodium glycerophosphate, 0.04 U/ml aprotinin, 0.02% sodium 
azide) containing 0.09% Triton X-100 and 2 mM 4-(2-aminoethyl)benzenesulfonyl 
fluoride hydrochloride (AEBSF) (Sigma). After 10 min at 4°C, 3.6 pmoles of 1,2-di-
nonadecanoyl-sn-glycero-3-phosphatidylcholine (Avanti; PC 38:0) was added as an 
exogenous lipid standard (accounts for 1-2 Mol% of total lipids detected). Then 10 ml of 
this cell lysate was mixed 1:1 with 80% sucrose (w/v) in HEPES/saline buffer (25 mM 
HEPES, 150 mM NaCl and 2 mM EDTA, pH 7.5). These lysates were placed in 
centrifuge tubes, then 5 ml of 35% sucrose and 5 ml of 5% sucrose in HEPES/saline 
buffer were carefully layered on top of the 40% sucrose solution containing the cell 
lysates. Gradients were centrifuged at 100,000 xg for 15-18 hr at 4°C using a Beckman 
SW-28 rotor in a Sorvall Discovery 100S ultracentrifuge. 
After centrifugation, two opaque bands were visible, and the upper band (3 mL), 
previously identified as containing the DRMs [23], was collected from the interface of the 
5% and 35% layers. The contents were diluted with 15 mL phosphate buffered saline 
(PBS) containing 1 mM EDTA and centrifuged at 300,000 xg for 30 min at 4°C in a 
Beckman Ti60 rotor. Pellets were resuspended in 400 µl PBS-EDTA, and lipids were 
extracted using a modified Bligh-Dyer method [26]: the suspended pellets were each 
mixed with 1.5 mL chloroform/methanol at a 1:2 ratio and vortexed, then 0.5 mL of 
chloroform was added, and samples were vortexed again. Finally, 0.5 mL of 2N HCl 
was added, and samples were vortexed and then centrifuged at 2000 xg for 5 min to 
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 achieve phase separation. The lower (chloroform) layer was collected and used for 
ESI/MS analysis. To determine plasmalogen content of DRMs, pellets were 
resuspended in 400 µl of 50 mM LiCl, pH 6.  50 mM LiCl was also used in place of 2 N 
HCL in the extraction process [27]. 
To determine the percentage of cellular PL recovered in DRMs, 2 X 106 cells in 
BSS were pelleted, resuspended in 400 ml PBS-EDTA and PL were extracted as 
described for DRMs. For organic phosphate analysis to quantify PL concentrations, 
extracted PL in chloroform from either DRMs (200 µl) or cells (1 ml) was treated as 
described previously [28], and the amount of organic phosphate was used as a measure 
of PL recovered. Comparison of PL recovered per cell equivalent of extracted DRMs 
and cells permits calculation of the % of PL recovered in DRMs. 
Tyrosine Phosphorylation Assay.  
RBL-2H3 cells were sensitized overnight with IgE as above, harvested and 
washed twice with BSS, and then resuspended at 2 x 106 cells/ml.  Cells were then 
stimulated with DNP-BSA (0.8 µg/ml) in the presence or absence of 4 µM PP1 at 37°C 
for times indicated. Samples were quenched by addition of 5x sample buffer (50% 
glycerol, 0.25 M Tris, pH 6.8), 5% (w/v) SDS, 0.05% (w/v) bromophenol blue) and 
boiling for 5 min.  Samples were electrophoresed and detected by western blotting with 
4G10 anti-phosphotyrosine [19]. 
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 Cholesterol Content Assay 
Free cholesterol in DRMs was assayed using the Amplex Red Cholesterol 
Assay Kit (Invitrogen/Molecular Probes) following kit instructions, except that 
cholesterol esterase was omitted from the DRM samples. Following specified 
incubations, samples were placed on ice, and sample fluorescence was measured 
with an SLM 8000C spectrofluorometer. We found that 10 µl aliquots of pelleted, 
resuspended DRMs contain cholesterol values in the linear region of the standard 
curve. 
Quantitative Analysis of Phospholipids Using Electrospray Ionization Mass 
Spectrometry (ESI/MS).  
Spectra were acquired on a modified 6T Finnigan FTMS instrument (Finnigan, 
Madison, WI) equipped with an electrospray ion source, as described previously [29]. 
Prior to nanospraying, lipid extracts prepared as described above were diluted 10-fold in 
49:49:2 (v/v/v) methanol:chloroform:acetic acid for the positive ion mode and 10-fold in 
1:1 (v/v) methanol:chloroform for the negative ion mode [30, 31]. Typically, less than 2 x 
105 cell equivalents of the lipid extract (<6 nmol of phospholipid) were needed to obtain 
complete positive and negative mode spectra. For determination of plasmalogen 
species in the extract, LiOH was added to a final concentration of 2mM prior to the 
analyses; in the positive ion spectra the lipid species were observed as Li adducts (+ 6 
Da).  For each sample, four separate aliquots were measured and mol % values (± 
standard deviation) were determined for each species. 
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 Relative instrument responses (peak intensity per mole of analyte) were 
determined using a standard mixture of phosphatidylcholine (PC): 
phosphatidylethanolamine (PE): sphingomyelin (SM): phosphatidylinositol (PI): 
phosphatidylglycerol (PG): phosphatidylserine (PS): phosphatidic acid (PA) at equimolar 
ratios for both the positive ion mode and the negative ion mode [23]. Variation of 
instrument response per mole with acyl chain length and degree of unsaturation was not 
evaluated, but it is far less than that with headgroups at the low concentration used here 
[32]. Any such variation will not affect the change of mol% values with experimental 
parameters on a relative basis. As previously established [33], below 100 µmol total 
lipids, there are no aggregated ions, and the ion counts are proportional to lipid 
concentrations in these limits. The detailed ESI/MS data were tabulated as mol% for 
each PL head group in terms of acyl chain length (number of carbon atoms) and 
number of double bonds (see Table 1). For kinetic analyses these values are summed 
for both acyl chains of PC, PE, PS, PI, PG, PA or for the single acyl chain of SM. The 
mol% data were compiled for samples taken at multiple time points after initiation of a 
specified treatment. Table 2.1 and Figures 2.3 and 2.5 show representative data from a 
single experiment. Figures 2.1, 2.2, and 2.4 show data from multiple experiments 
averaged together. 
Kinetic Analysis of PL changes 
For systematic analysis over multiple samples and experiments with different 
treatments, the PL composition data are compared in terms of headgroups, the total 
number of double bonds in the acyl chains (db0, db1, db2, db3, and db4+), and acyl 
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 chain length. A simple evaluation of time dependent changes monitors acyl chain 
saturation and represents the mol% abundance data as the lumped ratio P/(S+M), 
where P corresponds to polyunsaturated (db2, db3, and db4+) acyl chains, S 
corresponds to saturated (db0) acyl chains, and M corresponds to mono-unsaturated 
(db1) acyl chains (see Figure 2).  
For a comprehensive analysis of compositional changes with time, the mol% 
values are evaluated with a first-order kinetic model. Useful parameters for comparison 
are the value of the first order rate constant k together with the direction and magnitude 
of the concentration change. We consider a species with concentration C(t) that may 
increase or decrease with time after stimulation; Ci  corresponds to the initial (pre-
stimulation) concentration and Cf  corresponds to the final concentration that stabilizes 
after stimulation. 
[C(t) - Cf]/ [Ci – Cf] = exp(-kt) 
C(t) = (Ci – Cf)exp(-kt) + Cf    (1) 
For species with decreasing concentration, [Ci – Cf] > 0, and for species with 
increasing concentration, [Ci – Cf] < 0. The direction of the change is given by the value 
n = [Cf – Ci]/|Cf – Ci| Because of the absolute value in the denominator, n = -1 for 
species that decrease in concentration, and n= +1 for species that decrease in 
concentration. The lumped term km = nk represents the value of the rate constant and 
the direction of concentration change. 
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 For sufficiently short times, as compared to the time course of the concentration 
change, the exponential in Eqn 1 can be replaced by a truncated Taylor series, exp(-kt) 
~ 1 – kt, yielding a linear expression for C(t) vs t and an approximate first order rate 
constant ka: 
C(t) = Ci + (Cf – Ci)kat     (2) 
Note that the slope in this linear approximation, ks = (Cf – Ci)ka, is a lumped term 
representing the magnitude and direction of the concentration change times the value of 
ka. The mol% (C(t)) data are plotted according Eqn 1 (Figure 2.1.A and 2.1.B), or  Eqn 2 
(Figure 3). From these primary plots, the values of km = nk (Figure 2.1.C) or ks = (Cf – 
Ci)ka (Figures 4 and 5) are plotted as a function of the total number of double bonds in 
the acyl chains with specified headgroups. 
Data fitting for exponential curves over longer time periods (Eqn 1; Figures 2.1A 
and B) and linear approximation curves at short times (Eqn 2; Figure 2.3) was carried 
out with MATLAB. We determined the linear approximation to be valid for DNP-BSA 
stimulation by the following comparison: Using mol% at long times (Cf) obtained from 
fitting the data in Figure 1A with Eqn 1, the value for (Cf – Ci) was determined, and the 
approximate rate constant ka was calculated from (Cf – Ci)ka values obtained from the 
linear fit (Eqn 2, Figure 3). We find that these ka values are very similar to k values 
obtained directly from Figure 1A. Similarly, from a linear fit (Eqn 2) of the 0, 2, 5, 10 min 
data of Figure 1A, the slope (Cf – Ci)k values were determined. These are also very 
similar to the (Cf – Ci)ka values obtained from the slopes in Figure 2.3. This validation of 
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 the linear approximation for DNP-BSA stimulation allowed direct comparison of multiple 
treatments over the shorter time period (Figure 2.4).  
RESULTS 
Unsaturated PL Increase in DRM Fractions upon Receptor Mediated Cell Activation 
A complete PL analysis was carried out by ESI/MS for DRM samples from cells 
before and after stimulation with the antigen DNP-BSA at several time points, as 
represented by the experiment shown in Table 2.1. Notable in these representative data 
is the high mol% of total SM in DRMs from unstimulated cells (27.6 mol% of the total 
phospholipids), indicative of highly purified DRM preparations, and similar to SM values 
of 20-23 mol% for DRM and non-detergent lipid raft preparations from KB cells 
characterized by Pike et al. [27]. The mol% of SM decreases as a function of stimulation 
time while total PI increases with stimulation time as exemplified in Table 2.1. A 
compiled presentation of lipid compositional changes from many different experiments 
with DNP-BSA stimulation is shown in Figure 2.1.A, where the extensive data are 
represented in terms of headgroups (separate panels) and for each of these, the mol% 
of total PL (open circles, right ordinate). These compiled data show that, on average, 
SM decreased from 28% to 17% after 30 min of antigen stimulation, and PI increased 
from 17% to 34% within this period; the other major PLs (PC, PE and PS) show 
relatively small changes in total mol% as a function of stimulation time. 
Lipid changes with respect to acyl chain unsaturation were evaluated (Figure 
2.1.A, solid symbols, left ordinate). DNP-BSA stimulation time courses were measured 
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Table 2.1. Normalized mol % of PL in DRMs isolated from cells before and at specified 
times after DNP-BSA stimulation.  
aMinutes stimulated with antigen; bxx:y = total number of carbon atoms in the fatty acid 
chains: number of double bonds. Standard deviations (SD) are shown for the sums 
within each group. The data are averages over four measurements from a single 
representative experiment. Sum S, Sum M, and Sum P are the sums of the saturated 
(S, db0), monounsaturated (M, db1), and polyunsaturated (P, db2 – db4+) 
phospholipids (PL), respectively, where the degree of saturation refers to the number of 
double bonds in the the fatty acid chains. The total PL composition for each time point is 
100%.
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 in multiple experiments for stimulation times of typically 0, 2, 5, 10 min, and in some 
experiments up to 20 and 30 min. We observe generally that the PL with more 
unsaturated acyl chains (more double bonds) tend to increase in the DRM fractions with 
stimulation time, whereas those with saturated or mono-unsaturated acyl chains tend to 
decrease in these fractions. This is consistent with our previous observations made with 
DRMs derived from unstimulated cells and cells at a single (5 min) time point after DNP-
BSA stimulation [23]. That previous study compared the PL composition simply in terms 
of acyl chain saturation: saturated (S: 0 double bonds, db0), mono-unsaturated (M: 1 
double bond, db1), and polyunsaturated (P: 2 to 4 or more double bonds, db2 - db4+) 
and compiled the abundance data as the lumped ratio P/(S+M). This type of analysis  of 
data in the present study (Figure 2.2) showed that this simple ratio increases with cell 
stimulation. For stimulation by DNP-BSA at 37°C (Figure 2.2, solid squares, dark line), 
the ratio increases approximately 4-fold with a half-time of about 7 min and stabilization 
by 20 min, whereas there are no changes over 20 min in the absence of stimulant (open 
squares, dark line). In comparison, DNP-BSA stimulation at 18°C (solid triangles, dark 
line) results in a somewhat slower, 2-fold increase in the P/(S+M) ratio by 20 min, 
consistent with the temperature dependence for other antigen-stimulated signaling 
processes in these cells [34]. Stimulated cellular degranulation is not detectable at 18°C 
[34], indicating that the lipid changes we observe at this temperature are not a 
consequence of degranulation. 
We evaluated a first-order kinetic model (Eqn 1) for comprehensive evaluation of 
the detailed mol% data representing PL changes occurring in the DRM fractions after 
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Figure 2.1. Mol % of phospholipids (PL) in DRMs that contain 0, 1, 2, 3, and ≥ 4 double 
bonds (db0, db1, db2, db3, db4+, respectively) in the acyl chains versus (A) DNP-BSA 
antigen stimulation time (average of eight independent experiments) or (B) cytochalasin 
D stimulation time (average of four independent experiments) for each head group 
summed over head groups. Data points corresponding to specified number of double 
bonds (each of db0, db1, db2, db3, db4+) are fitted with an exponential decay 
corresponding to first-order kinetics (Eqn 1). Values of km = nk (units of min-1) are listed 
with each fitted curve. Errors bars show standard deviations from ≥ 4 separate 
experiments (0 and 10 min), or range of values from two separate experiments (2, 5, 
and 20 min). Data points with no error bars represent a single experiment (1 and 30 
min). (C) The km values (units of min-1) from Figures 1A and 1B versus the number of 
double bonds for each head group for DNP-BSA stimulation (squares, left ordinate) 
compared with cytochalasin D treatment (circles, right ordinate). 
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Figure 2.1.A 
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Figure 2.1.B (continued) 
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 Figure 2.1.C (continued) 
 
 
 
 
48
 cell stimulation. Figure 2.1A shows first-order kinetic fits for data compiled from eight 
independent experiments with DNP-BSA stimulation. The data are fitted in terms of the 
total number of double bonds in the acyl chains (db0, db1, db2, db3, and db4+; left 
ordinate) associated with each head group (separate panels) (The minor species PG 
and PA, whose low mol% and corresponding large error bars result in more erratic 
behavior, are not shown). Data accumulated over 30 min stimulation are fitted with Eqn 
1, which applies to species that decrease or increase in concentration. The quality of the 
fits shows that the compositional changes are consistent with a first-order kinetic model, 
and this analysis also provides a detailed accounting for our general observation that 
the degree of acyl chain unsaturation increases in DRM compartments after cells are 
stimulated with DNP-BSA ([23] and Figure 2.2). 
With Eqn 1, the rate constants, k, for each number of double bonds within each 
head group can be determined from the exponential fits to the data (Figure 2.1.A; solid 
symbols fit by Eqn 1, left ordinate). The lumped value km = nk (where n=+1 or –1 for 
increasing or decreasing concentration, respectively; see Materials and Methods) are 
listed with respective curves in Figure 1A. These km values for DNP-BSA stimulation are 
plotted as a function of the number of double bonds for each head group species in 
Figure 2.1.C (solid squares). These plots summarize succinctly the dependence of 
stimulated DRM compositional changes on the degree of acyl chain unsaturation. 
Values of k = |km| for each head group and for summed PLs are generally less than 0.3 
min-1 for DNP-BSA stimulation (Figure 2.1.C, left ordinate). It is notable in these plots 
that the x-axis is crossed as the km values go from negative (decreasing concentration) 
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Figure 2.2. Ratio of polyunsaturated (P, db2 – db4+) phospholipids to the sum of 
saturated (S, db0) and monounsaturated (M, db1) phospholipids (i.e., P/(S+M)) for the 
time course of stimulation by 5µg/ml DNP-BSA at 37°C (squares, average of eight 
independent experiments) and 18 °C (triangles), in the presence of 3 mM Jasplakinolide 
(white circles, average of two independent experiments), 4 µM PP1 (cross, average of 
two independent experiments), or absence of media Ca2+ (white diamonds), or by 2 µM 
cytochalasin D (circles, average of four independent experiments), 0.9 µM Ca2+ 
ionophore A23187 (diamonds). This ratio, P/(S+M), is also shown for DRMs from 
unstimulated cells incubated for 20 min at 37°C prior to DRM preparation (white 
squares). Error bars show standard deviations from ≥ 4 separate experiments or range 
from two separate experiments for each time point. Data points with no error bars 
represent only single experiment with that time point. 
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 to positive (increasing concentration). For PC and PE the km values go from negative to 
positive between two and three double bonds. For SM, with a single acyl chain, this 
change occurs between one and two double bonds. For PI, the concentration increases 
after DNP-BSA stimulation (positive km) for acyl chains with any number of double 
bonds. When the cumulative data are summed over all the lipid species (upper left 
panel of Figure 2.1.C) the transition from negative to positive km values occurs between 
one and two double bonds, justifying our choice of the ratio P/(S + M) in the simple data 
analysis used previously ([23] and Figure 2.2). 
A linear approximation to Eqn 1, given by Eqn 2, was also used to evaluate data 
sets for DNP-BSA stimulation that were collected over shorter time periods (0 – 10 min). 
As an example, Figure 2.3 presents the data from the representative experiment in 
Table 1 in terms of the total number of double bonds in the acyl chains (db0, db1, db2, 
db3, and db4+) associated with each head group (PC, SM, PE, PI, PS, and sum) as a 
function of stimulation time (0, 2, 5, and 10 min). These data, fitted with Eqn 2, yield a 
slope corresponding to the apparent rate constant ka times the direction and magnitude 
of the concentration change (Cf-Ci). These ks = (Cf-Ci)ka values are listed with respective 
fitted lines in Figure 2.3. As expected from preceding analyses of cumulative data with 
Eqn 1 (Figures 2.1.A and 2.1.C), the ks values for each PL head group tend to be more 
positive for a higher number of double bonds and more negative for a lower number of 
double bonds. 
Figure 2.4 (closed squares, dark line) plots the averaged ks = (Cf-Ci)ka values 
from five independent experiments with DNP-BSA stimulation as a function of the 
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Figure 2.3. Representative data (Table 1) plotted as Mol% of  DRM phospholipids that 
contain 0, 1, 2, 3, and ≥ 4 double bonds (db0, db1, db2, db3, and db4+, respectively) in 
the acyl chains versus antigen stimulation time for each head group and summed over 
head groups. Data points corresponding to each of db0, db1, db2, db3, db4+ are fitted 
with a linear function corresponding to first-order kinetics at short times (Eqn 2). Values 
of ks = (Cf-Ci)ka (units of Mol%/ min) are listed with each fitted curve. Error bars show 
the standard deviations from representative data in Table 1.  
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 number of double bonds for each head group species. As expected these plots reveal 
the same trend as Figure 2.1.C, i.e. there is a clear dependence of stimulated DRM 
compositional changes on the degree of acyl chain unsaturation, such that those with 
higher degrees of unsaturation increase after stimulation. We confirmed that results 
from Eqns 1 and 2 show good agreement for short time periods (< 10 min for DNP-BSA 
stimulation) as described in Materials and Methods. Therefore, we used the linear 
approximation (Eqn 2) to compare directly the DRM compositional changes caused by 
Fc!RI mediated activation with multiple other treatments, in many different experiments 
as described in sections below (Figure 2.4). 
 We considered alterations in the cholesterol levels or the total PL recovered as 
factors contributing to our consistent observation of substantial increases in the 
percentage of unsaturated PL in the DRM compartments after DNP-BSA stimulation. 
We previously showed under our current experimental conditions that cell lysis is 
complete and not significantly altered by stimulation [17, 18, 35]. Furthermore, >80% of 
a GD1b marker is recovered in low density DRM fractions under these conditions [17]. In 
the present study we found that there is a ~20% increase in cholesterol content of the 
DRM following stimulation by antigen for 10 min at 37°C, as determined with an 
enzymatic fluorescence assay for this sterol (Materials and Methods, data not shown). 
PL recovered in DRMs under the conditions used for their isolation in this study 
represent 11.2% + 2.6 (SD; n=3) of cellular PL, based on organic phosphate analysis of 
chloroform-soluble PL extracted from DRMs and intact cells (see Materials and 
Methods). These DRMs contain PL from both plasma membrane and endocytic 
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Figure 2.4. Values of ks = (Cf-Ci)ka (Eqn 2; units of Mol%/ min) versus number of double 
bonds in phospholipid fatty acid chains for DNP-BSA stimulation (average of five 
independent experiments, error bars show standard deviation) compared with antigen 
stimulation in the presence of PP1, Jasplakinolide, Ca2+-free media (same treatments 
and number of experiments as in Figure 2).  
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 recycling compartments (N Smith et al., unpublished results). To compare the relative 
amount of PL recovered in the DRM fraction before and after stimulation, a synthetic 
phospholipid standard, 1,2-di-nonadecanoyl-sn-glycero-3-phosphatidyl choline, was 
added to each cell lysate sample at a concentration permitting its co-quantification in 
ESI/MS analysis of the DRM fraction. As summarized in Table 2.2 (Treatments 1 and 2), 
this analysis shows that DNP-BSA stimulation causes ~40% molar increase in PLs 
recovered in the DRM fraction relative to that for unstimulated cells. This is greater than 
the stimulated increase in DRM cholesterol, suggesting that the stimulated increase in 
polyunsaturated PLs recovered in DRMs is not due simply to changes in the cholesterol 
concentration in these compartments. Therefore we investigated involvement of other 
cellular components in the reorganization of DRM PLs caused by Fc!RI-mediated cell 
activation. 
Mechanistic Basis for Observed Changes 
To probe the mechanism by which stimulation via Fc!RI causes a marked 
change in the PL composition of DRMs, we examined the effect of the Src family kinase 
inhibitor, PP1, on these stimulated changes. As shown in the simple analysis of Figure 
2.2 (P/(S+M) vs time), 4 mM PP1 has a small effect on the DNP-BSA-stimulated 
response (x, dashed line). At the concentration evaluated, PP1 effectively inhibits most 
antigen-stimulated tyrosine phosphorylation detected in whole cell western blots, 
although some Fc!RI " and LAT phosphorylation persists ([36] and Figure 2.5). The 
first-order kinetic analysis summarized in Figure 2.4 (ks = (Cf–Ci)ka vs db#; based on 
Eqn 2) shows that this concentration of PP1 present during antigen stimulation causes 
56
  
 
 
 
 
 
 
 
Table 2.2. Comparison of relative recoveries of phospholipids (PL) in DRMs isolated 
after specified treatments of the cells. The value in parentheses indicates the number of 
experiments for specific treatment. The ratio is the relative amount of total DRM PL to 
an internal standard lipid (see Materials and Methods) at each condition. This ratio value 
is averaged from ≥ 2 experiments for treatment 1, 2, and 5, or from single experiment 
for treatment 3, 4, 6, and 7, and normalized to treatment 1. Standard deviations are from 
multiple experiments, or for single experiment treatments were calculated from error 
propagation from standard deviations in four separate measurements. 
 
 
Treatment Stimulant Inhibitor Ratio 
1 (3) None  None 1.00 ±0.06 
2 (3) DNP-BSA  None 1.39 ±0.11 
3 (1) None  PP1 0.90 ±0.18 
4 (1) DNP-BSA PP1 1.29 ±0.09 
5 (2) Cytochalasin D  None 1.29 ±0.26 
6 (1) None  Jasplakinolide 0.85 ±0.12 
7 (1) DNP-BSA  Jasplakinolide 0.95 ±0.10 
 
 
 
 !!
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 very little difference in PL compositional changes (compare solid squares and x). Table 
2.2 (Treatments 3 and 4) shows that this concentration of PP1 causes only a small 
change in the DNP-BSA stimulated increase in recovery of PL in the DRM fraction. 
Together, these results suggest that the antigen-stimulated changes in PL composition 
of DRMs do not depend strongly on the tyrosine phosphorylation cascade that is 
initiated by Fc!RI crosslinking. 
Antigen stimulates a robust Ca2+ response in RBL mast cells, and this Ca2+ 
mobilization is necessary for degranulation [37, 38]. We investigated stimulated PL 
changes in DRMs caused by the Ca2+ ionophore A23187 that can stimulate RBL cell 
degranulation (in the absence of DNP-BSA). The simple analysis of Figure 2 shows that 
a stimulating dose of A23187 (0.9 µM) causes changes in PL composition very similar 
to those caused by DNP-BSA, but with faster kinetics (compare solid diamonds with 
solid squares). We also found that DNP-BSA stimulation of cells in buffer without 
extracellular Ca2+ (Figure 2.2, open diamonds) causes attenuation of the antigen-
stimulated increase in P/(S+M), but does not prevent it. Under these conditions, antigen 
stimulates a transient increase in intracellular Ca2+ without a sustaining influx of Ca2+ 
from the extracellular medium, which is insufficient in triggering degranulation [37, 38].  
In the analysis of Figure 2.4, DNP-BSA stimulation in the absence of extracellular Ca2+ 
(open diamonds) causes PL compositional changes similar to those caused by DNP-
BSA in the presence of extracellular Ca2+ (solid squares). These results show that a 
sustained increase in intracellular Ca2+ may contribute to, but is not necessary for, the 
antigen-stimulated changes in DRM lipid composition observed. 
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!!!!
Figure 2.5. PP1 inhibits tyrosine phosphorylation in RBL-2H3 cells.  RBL-2H3 cells at a 
concentration of 2 x 106 /ml were stimulated with DNP-BSA (0.8 µg/ml) in the presence 
or absence of 4 µM PP1 at 37°C for times indicated. Anti-phosphotyrosine western blot 
of whole cell lysate shows inhibition of antigen-stimulated tyrosine phosphorylation of 
Lyn, LAT, Fc!RI" and several higher MW proteins.   ! !!!
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 Role of the Cytoskeleton 
Cytochalasin D disrupts the actin cytoskeleton by capping the barbed end of actin 
microfilaments and preventing elongation, thereby effectively preventing stimulated 
polymerization of F-actin [39]. This inhibition of actin polymerization has been shown to 
enhance IgE receptor signaling in RBL mast cells [39, 40]. When testing whether 
cytochalasin D affects DNP-BSA-stimulated changes in DRM lipid composition, we were 
surprised to find that cytochalasin D alone causes similar changes, with faster kinetics, 
as indicated in Figure 2.2 (compare closed circles with closed squares). First-order 
kinetic analysis of cytochalasin effects provides detailed accounting of PL compositional 
changes according to headgroup and double bonds (Figure 2.1.B). A summary of this 
analysis in terms of km=nk values (eqn 1) reveals that, compared with antigen 
stimulation (Figure 2.1.C, squares, left ordinate), treatment of RBL cells with 2 µM 
cytochalasin D (Figure 2.1.C, circles, right ordinate) causes significantly faster changes 
in DRM lipid composition for each head group: The km values are as much as 6-fold 
larger for cytochalasin D stimulation. Figure 2.1.C also shows that the dependence of km 
values on the acyl chain unsaturation is similar to DNP-BSA for all the major PL head 
groups, with some differences for PI. Latrunculin A is another inhibitor of actin 
polymerization that disrupts the actin cytoskeleton by a different mechanism: 
sequestration of monomeric G-actin to inhibit its incorporation into polymeric F-actin 
[41]. Changes similar to those for 2 µM cytochalasin D (Figure 2.1.C, circles) also 
occurred with 0.2 µM latrunculin A or with cytochalasin D at doses as low as 0.2 µM 
(data not shown). Only very small changes in net F-actin content occur under these 
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 conditions of cytochalasin D treatment [39], indicating that the DRM lipid composition is 
sensitive to relatively subtle changes in F-actin. 
Overall, our results indicate that the mechanistic basis for the antigen-stimulated 
change in PL composition of DRMs may be stimulated depolymerization of cortical F-
actin, which partially redistributes to other intracellular locations [42]. To test this 
explanation, we examined the effect of jasplakinolide, which is known to stabilize F-actin 
[43], on antigen-stimulated changes in the PL composition of DRMs. We found that 3 
µM jasplakinolide has no discernible effect on DRM composition in the absence of 
stimulation (Figure 2.2, open circle at 0 min). However, this reagent effectively inhibits 
the antigen-stimulated changes in PL composition as shown in Figure 2.2 (open circle at 
10 min) and in Figure 2.4 (open circles). Consistent with these observations, 
jasplakinolide inhibits the antigen-stimulated increase in the relative amount of PLs 
fractionating with DRMs (Table 2.2, Treatments 1, 2, 6 and 7), whereas cytochalasin D 
causes PL increase similarly to antigen stimulation (Table 2.2, Treatment 1, 2 and 5). 
Our results show that the actin cytoskeleton regulates the structural composition and 
stability of plasma membrane domains that fractionate as DRMs. Correspondingly, we 
conclude that antigen and IgE receptor mediated changes in the distribution of F-actin 
substantially modify the composition and/or stability during cell signaling of these 
membrane domains represented by the DRMs.  
 
61
 Dependence of DRM Compositional Change after Antigen Stimulation on Length of Acyl 
Chains 
Compositional changes in terms of acyl chain length associated with each head 
group were also evaluated after DNP-BSA stimulation with the first-order kinetic model. 
For this purpose, acyl chains associated with all head groups were evaluated according 
to Eqn 2, in terms of both combined length of their acyl chains and total number of 
double bonds. These results are summarized for a single representative experiment 
(Table 2.1) in Figure 2.6, which compiles the chain length results for the major 
phospholipids PC, PE, PI (SM with one rather than two acyl chains gave similar results). 
Compared on this same graph is the dependence of total DRM lipid compositional 
changes on the number of double bonds (solid squares and dark line reproduced from 
upper left panel in Figure 2.4). Whereas the dependence of lipid compositional change 
on the number double bonds is pronounced, as described above, there is negligible 
dependence on the chain length. 
DISCUSSION 
 Our detailed PL analysis in the present study builds on previous observations to 
further our understanding of the interactions between lipid raft membrane domains and 
the actin cytoskeleton, and the regulation of these interactions by IgE receptor (Fc!RI) 
signaling. Published studies on structural and functional roles for lipid rafts in cell 
biology number in the thousands, strongly implicating their critical participation in cellular 
homeostasis and stimulated responses. Yet these compartments remain elusive to 
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Figure 2.6. Representative data (Table 1) evaluated for cells stimulated with DNP-BSA 
and dependence of DRM phospholipid compositional changes on total acyl chain length. 
Values of ks = (Cf-Ci)ka (Eqn 2; units of Mol%/ min) versus number of double bonds are 
shown for separate chain lengths corresponding to 32, 34, 36, 38, and ≥ 40 carbons in 
both acyl chains (c32, c34, c36, c38, c40+, respectively, summed over seven head 
groups). The solid squares and dark line correspond to ks values versus number of 
double bonds summed over all head groups (double bond effect; duplicated from the 
upper left panel of Figure 4) 
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 experimental definition because of their lipid and protein heterogeneity and their 
dynamic nature in living cells. Biochemical isolation of subcellular components is an 
essential part of structure-function analysis in live cells, even while recognizing that the 
procedures involved perturb their structures relative to those in live cells. Isolation of 
lipid rafts by detergent fractionation or other methods suffers the same pitfalls of this 
general approach, but it provides the necessary means for molecular characterization 
that can be further tested and refined in live cell experiments. DRM preparations have 
proven to be a useful correlative tool in elucidating the functional role of lipid rafts in 
Fc!RI signaling [8]. 
We showed previously with ESI/MS that DRM preparations from RBL mast cells 
contain ~100 distinct PL species [23], highlighting the complexity that exists in these 
membranes. In the present study we confirmed and extended our initial observation that 
antigen-crosslinking of IgE receptors stimulates changes in the PL composition of DRMs 
isolated before and after this cell activation. Furthermore, we discovered that this 
substantial compositional change depends on stimulated alterations in the actin 
cytoskeleton, and appears largely independent of the tyrosine phosphorylation cascade 
that is activated in parallel to these cytoskeletal changes. This finding is surprising, as it 
indicates that the PL composition of detergent-resistant lipid rafts is much more 
sensitive to cytoskeletal regulation than to various phospholipases whose activation is 
stimulated by tyrosine phosphorylation [44, 45]. Consistent with this, only small changes 
in the total PL composition of RBL mast cells are detected due to antigen stimulation 
[46], indicating that net gain or loss of specific PL species due to stimulated PL turnover 
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 is likely to provide a relatively minor contribution to the large changes in DRM PL 
composition that we observe. 
 Our results implicate the actin cytoskeleton as strongly influencing the PL 
composition of DRM preparations. Relatively small changes in net F-actin content 
caused by cytochalasin D or latrunculin A cause large and rapid changes in this 
composition, and antigen-stimulated changes are prevented by jasplakinolide. We 
observe net increases in the amount of PLs isolated as DRMs, and preferential 
increases in polyunsaturated lipids caused by inhibitors of F-actin polymerization or by 
antigen stimulation. These results suggest that membrane interactions with the actin 
cytoskeleton limit recovery of detergent-resistant lipids in resting cells, and that cell 
stimulation or direct inhibition of F-actin polymerization reduces these interactions. 
Although antigen stimulation causes a net increase in stimulated actin polymerization 
[39], it is possible that spatially localized actin depolymerization [41] is chiefly 
responsible for the increase in detergent resistant PL that are recovered under these 
conditions. 
 Our detailed kinetic analysis of extensive mass spectrometry data for DRMs 
provides a comprehensive means for investigating and comparing temporal changes in 
lipid composition that are initiated by various stimulants in the signaling pathway. This 
analysis compares mol % content of individual lipid species within the total lipids 
collected in the isolated membranes, and thereby structural and physical changes that 
accompany specific cell stimulating conditions. In a previous study [47], Milne et al. 
described a lipid array study using ESI-MS coupled with computational approaches to 
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 identify lipid pattern of total cellular lipids, and changes in the pattern as indicated by the 
relative change in peak abundance over the defined time course of antigen stimulation 
in B cells. Our kinetic study presents an effective way to characterize lipid compositional 
change in the context of functionally relevant membrane domains and pinpoints subtle 
changes related to specific stimulating conditions. Thus, our kinetic approach should be 
a valuable tool for lipidomic studies towards understanding membrane signaling. 
Our ESI/MS analysis is carried out on DRMs isolated after cell lysis in relatively 
low concentration of TX-100 (0.045%). These conditions were chosen because they 
discriminate between crosslinked and uncrosslinked IgE receptors as DRM 
components, whereas other components of lipid rafts, such as the GPI-anchored protein 
Thy-1, are efficiently recovered in DRMs in the presence or absence of IgE receptor 
crosslinking [17, 18, 48]. It is possible that different sensitivity to antigen stimulation or 
F-actin inhibitors would be observed at higher concentrations of detergent, but 
substantial detergent interference under these conditions precludes accurate mass 
spectrometric analysis of the PL composition [23]. Special LiCl extraction conditions 
gave essentially the same results, with no indication of plasmalogen species at m/z of 
720.5, 722.5, 770.6, and 774.6 as reported by others [27, 49, 50]. This may reflect 
differences in the membrane preparations or cell growth conditions. It is notable that 
cytochalasin D does not change the % recovery of crosslinked IgE receptors with DRMs 
under the conditions of our experiments. However, this treatment does decrease the 
density of detergent-resistant Fc!RI-containing membranes, as separated in sucrose 
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 gradients, consistent with cytoskeletal interactions by these detergent-resistant 
receptors in the absence of cytochalasin D [21]. 
 The changes in DRM PL composition we observe are stimulated by the Ca2+ 
ionophore, A23187 (Figure 2). They are also stimulated by antigen in the absence of 
extracellular Ca2+ (Figures 2 and 4), a condition that inhibits degranulation and most 
signaling processes downstream of Fc!RI [37, 51]. Interestingly, activation of 
permeabilized mast cells by either micromolar Ca2+ or GTP#-S in the presence of EGTA 
results in redistribution of F-actin from the periphery to the cell interior in a process that 
is similar to that stimulated in intact mast cells [52, 53]. These results suggest that F-
actin redistribution from the cell cortex can be elicited by both Ca2+-dependent and Ca2+-
independent stimuli, and this may be relevant to the PL changes in DRM that we 
observe. 
 A model to explain our results is that loss of F-actin proximal to the plasma 
membrane caused by antigen activation or by inhibitors of actin polymerization perturbs 
the structural regulation of nanoscopic Ld/Lo-like phase separation. This could result in 
lipid redistributions that enhance the recovery of polyunsaturated PLs, particularly those 
with PI head groups, in DRM fractions. Preferential interactions of 
polyphosphatidylinositol PLs with the actin cytoskeleton at the inner leaflet of the plasma 
membrane [54, 55] may be relevant to this process, and the negative charge of PI may 
also contribute to these interactions. In this scenario, disruption of interactions between 
PI and structural proteins by antigen stimulation or by inhibitors of actin polymerization 
could result in increased recovery of PI in detergent–resistant, low density membranes. 
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 Future efforts are aimed at detecting in intact cells the membrane structural changes 
manifested by our ESI/MS analysis of DRM PLs. To this end, biophysical methods such 
as resonance energy transfer [56, 57], fluorescence correlation spectroscopy [58], and 
electron spin resonance [59] are proving use to be useful approaches to studying 
membrane lipid heterogeneity in live cells.  
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CHAPTER THREE 
Sphingosine Derivatives Inhibit Cell Signaling by Electrostatically Neutralizing 
Polyphosphoinositides at the Plasma Membrane1 
SUMMARY 
Mast cell stimulation via IgE receptors causes activation of multiple processes, 
including Ca2+ mobilization, granule exocytosis, and outward trafficking of recycling 
endosomes to the plasma membrane. We used fluorescein-conjugated cholera toxin B 
(FITC-CTxB) to label GM1 in recycling endsomes and to monitor antigen-stimulated 
trafficking to the plasma membrane in both fluorimeter and imaging-based assays. We 
find that the sphingosine derivatives D-sphingosine and N,Nʼ-dimethylsphingosine 
effectively inhibit this outward trafficking response, whereas a quarternary ammonium 
derivative, N,Nʼ,Nʼʼ-trimethylsphingosine, does not inhibit. This pattern of inhibition is 
also found for Ca2+ mobilization and secretory lysosomal exocytosis, indicating a 
general effect on Ca2+-dependent signaling processes. This inhibition correlates with the 
capacity of sphingosine derivatives to flip to the inner leaflet of the plasma membrane 
that is manifested as changes in plasma membrane-associated FITC-CTxB 
fluorescence and cytoplasmic pH. Using a fluorescently labeled MARCKS effector 
domain to monitor plasma membrane-associated polyphosphoinositides, we find that 
these sphingosine derivatives displace the electrostatic binding of this MARCKS effector 
domain to the plasma membrane in parallel with their capacity to inhibit Ca2+-dependent !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Published as N. L. Smith,  S. Hammond, D. Gadi, A. Wagenknecht-Wiesner, B. Baird and D. 
Holowka, Sphingosine Derivatives Inhibit Cell Signaling by Electrostatically Neutralizing 
Polyphosphoinositides at the Plasma Membrane. Self/Nonself , 2010. 1(2): p.133-43.  Reprinted 
with permission. 
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signaling. Our results support roles for plasma membrane polyphosphoinositides in Ca2+ 
signaling and stimulated exocytosis, and they illuminate a mechanism by which D-
sphingosine regulates signaling responses in mammalian cells. 
INTRODUCTION  
Mast cells play important roles in inflammation and allergic disease.  In response 
to antigen-mediated crosslinking, IgE receptors, Fc!RI, initiate a complex signaling 
cascade that results in exocytosis of secretory lysosomes and stimulated production of 
numerous cytokines in these cells [1]. Previously, our laboratory developed a 
fluorescence assay for trafficking of recycling endosomes in RBL mast cells that 
monitors pH-dependent changes in the fluorescence of FITC-CTxB and FITC-anti-
transferrin receptor mAb, and we showed that antigen stimulates increased recycling 
endosomal trafficking to the plasma membrane [2]. This trafficking response was found 
to be largely insensitive to inhibitors of downstream enzymes in secretory lysosomal 
exocytosis, including PI3-kinase and protein kinase C, but was reduced by the absence 
of extracellular Ca2+ and by U73122, an inhibitor of inositol 1,4,5-triphosphate 
production leading to Ca2+ mobilization [3]. 
Recycling endosomes were first identified as a perinuclear pool of tubular and 
vesicular membranes containing transferrin receptors [4]. This membrane pool is mildly 
acidic and is distinct from the early and sorting endosomes as well as from the Golgi 
complex [5]. It has been shown to participate in regulating the directionality of epithelial 
cell migration [6] and the maintenance of cell polarity [7, 8], as well as in phagocytosis 
[9]  and cytokinesis [10]. Furthermore, there is evidence that recycling endosomes play 
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roles in various diseases, including enhancement of HIV viral particle release [11] and 
influence neuro-degenerative diseases such as Alzheimerʼs disease [12]. Studies have 
also provided evidence for their role in stimulated secretion of cytokines in 
hematopoietic cells [13]. 
  In the course of investigating selective inhibition of stimulated recycling 
endosome trafficking to the plasma membrane, we found that certain sphingosine 
derivatives are particularly effective inhibitors of this process in RBL mast cells. This 
inhibition correlates with inhibition of stimulated Ca2+ mobilization that is important for 
exocytosis of recycling enodsomes as well as secretory lysosomes. Furthermore, this 
inhibition depends on the capacity of sphingosine bases to flip to the inner leaflet of the 
plasma membrane and to mediate electrostatic neutralization of polyphosphoinositides 
at this cytoplasmic interface. These results confirm an important role for Ca2+ signaling 
in stimulation of recycling endosomal trafficking, and they provide new insights into the 
mechanism by which both exogenous and endogenous sphingosines can regulate 
stimulated signaling in eukaryotic cells. 
MATERIALS AND METHODS 
Reagents 
 FITC-cholera toxin B subunit (FITC-CTxB), D-sphingosine, cytochalasin D, 4-
methylumbelliferyl-N-acetyl-"-D-glucosaminide, and nigericin were obtained from Sigma 
–Aldrich Chem. Co. (Saint Louis, MO USA).  BCECF-AM, indo-1 AM, and Alexa488-
CTxB were purchased from Invitrogen Corp. (Carlsbad, CA USA).  A23187 was from 
EMD (San Diego, CA USA). N,Nʼ-dimethylsphingosine and N,Nʼ,Nʼʼ-trimethylsphingosine 
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were purchased from Avanti Polar Lipids (Alabastar, AL, USA).  Mouse monoclonal anti-
dinitrophenyl (DNP) IgE was purified as previously described [14].  Multivalent antigen, 
DNP-BSA, contained an average of 15 DNP groups as previously described [2]. 
Cell Culture 
RBL-2H3 mast cells were cultured in minimum essential media with 20% fetal 
bovine serum (Atlanta Biologicals) and 10 µg/ml gentamicin sulfate (RBL Media) as 
described previously [15]. All tissue culture reagents were obtained from Invitrogen 
unless otherwise noted.  For antigen stimulation, cells were sensitized with 2-5 fold 
molar excess of anti-DNP IgE for 2-24 hr prior to experiments.  Confluent cells were 
harvested with 135 mM NaCl, 5mM KCl, 20 mM Hepes, 1.5 mM EDTA, pH 7.4, and 
resuspended in either buffered saline solution (BSS:  135 mM NaCl, 5 mM KCL, 1.8 mM 
CaCl2, 1 mM MgCl2, 5.6 mM glucose, 1 mg/ml BSA and 20 mM HEPES, pH 7.4) or RBL 
media with 20 mM HEPES. 
Cholera Toxin B Trafficking 
For steady state spectrofluorimeter experiments, RBL-2H3 cells were harvested 
and resuspended at 4 x106 cells/ml in RBL media with 20 mM Hepes.  FITC-CTxB was 
added to a final concentration of 3 µg/ml and incubated at 37°C for 2 hours.  Cells were 
washed 2 times and resuspended at a final concentration of 2 x 106 cells/ml in BBS, 
stirred continuously in an acrylic cuvette and maintained at a temperature of 37°C. 
Fluorescence measurements were made with and SLM 8000C fluorescence 
spectrophotometer as previously described [2]. Following additions as indicated in figure 
legends, cells were stimulated with either 4 µg/ml DNP-BSA in the presence or absence 
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of 2 mM cytochalasin D or with 1 µM calcium ionophore A23187, and changes in FITC 
fluorescence were monitored. 
For analysis, Excel (Microsoft) software was used.  Briefly, using recorded pre-
stimulation data, the TREND function was used to generate a linear baseline prediction 
that extended over the stimulation time course.  This baseline was then subtracted from 
the stimulated data and the resulting data were normalized for variations in initial 
fluorescence. 
Degranulation 
IgE-sensitized RBL-2H3 cells were harvested and resuspended in BSS at 2x106 
cells/ml with 2 µM cytochalasin D.  Cells were incubated with sphingosine derivatives for 
5 minutes prior to stimulation.  Stimulated cells were incubated in a water bath with 
shaking at 37°C for 1 hr, then placed on ice for 10 minutes, and centrifuged for 5 
minutes at 900 rpm at 4°C as previously described [16].  Following centrifugation, 25 µl 
cell supernatants were plated in triplicate in black flat bottomed 96 well plates (Costar) 
with 100 µl substrate solution (1.2 mM 4-methylumbelliferyl-N-acetyl-"-D-glucosaminide 
in acetate buffer (0.12 M acetic acid, pH 4.4) and processed for measurement of b-
hexosaminidase activity as previously described [17]. 
Measurement of Intracellular pH 
RBL cells were harvested and resuspended in BSS at 1x107cells/ml and 
equilibrated to 37°C. BCECF-AM (3.3. µg/ml) was loaded into cells by incubating for 1-
1.5 minutes, then diluting to 2x106 cells/ml and rotating slowly for 30 minutes at 37°C.  
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Washed cells were used at a final concentration of 1x106 cells/ml, and fluorescence was 
measured using SLM 8000C fluorescence spectrophotometer, with excitation at 490 nm 
and emission at 510 nm. Changes in pH were determined using a calibration curve 
generated by dilution of cells into calibration buffer at pH values of 6, 6.5, 7, 7.5 and 8 in 
the presence of 10 µM nigericin [18]. 
Measurement of Intracellular Ca2+ 
 Stimulated Ca2+ responses were monitored as described previously [15].  Briefly, 
RBL cells were loaded with the calcium indicator indo-1 AM, washed, and calcium 
mobilization in response to stimulation was measured using SLM 8000C fluorescence 
spectrophotometer.  Time-integrated responses were determined as the area under the 
stimulated timecourse minus the baseline over 400 sec, normalized to the maximal 
response in Triton X-100 lysed cells [19].  
Confocal Fluorescence Microscopy 
          Cells were labeled with Alexa488-CTxB as described for FITC-CTxB above, 
incubated with or without sphingosine derivatives in BSS for 10 min at 37oC, then fixed 
in 4% paraformaldehyde for 15 minutes at room temperature.   Fixed cells were imaged 
with a BioRad MRC 600 confocal system and a Zeiss Axiovert 10 microscope and 100x 
objective. 
 For detection of interactions between sphingosine derivatives and 
polyphosphoinositdes at the plasma membrane, mRFP-MARCKS EDSA3 was expressed 
in RBL cells by transient transfection with Fugene HD (Roche Diagnostics, Indianapolis, 
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IN) as previously described [20]. mRFP-MARCKS EDSA3 was made from YFP-MARCKS 
ED [21] (Construct a gift from Dr. Tobias Meyer (Stanford University)) by exchanging 
YFP for mRFP by using the Nhe I and Hind III restriction sites. Subsequently, the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene) was used to insert successive 
mutations of serines 159, 163 and 170 (full length MARCKS notation) to alanines. 
Changes were confirmed by DNA sequence analysis. For these experiments, 
transfected cells in MatTek 35mm culture dishes (MatTek Corp., Ashland, MA) were 
treated with sphingosine derivatives or other agents as described in Results, then fixed 
and imaged as above using a 63x achromatically corrected objective (NA 1.4). Line 
scan analysis of equatorial confocal sections with Image J (NIH) was used to determine 
the ratio of plasma membrane to cytoplasmic localization for mRFP-MARCKS EDSA3 
after various treatments. Ratios determined for each sample are averages of 15-20 cells 
in 4-5 images.  
To monitor GM1 trafficking to the plasma membrane by quantitative confocal 
imaging, RBL cells in MatTek culture dishes were first incubated with 5 µg/ml unlabeled 
CTxB and 2 µg/ml DiI-C16 (Molecular Probes/Invitrogen) for 5 min at 25oC to block 
plasma membrane-associated GM1 and to label the plasma membrane. Cells washed in 
BSS were then imaged in the presence of 1 µg/ml Alexa488-CTxB and 2 µM 
cytochalasin D, with or without 8 µM D-sphingosine, and stimulated by 4.8 µM A23187 
at 25oC to minimize label exchange and internalization. Confocal images were acquired 
using a Leica TCS SP2 upright microscope system (Leica Microsystems, Exton, PA) 
with a 63x, 0.9 NA HCX APO LU-V-I water immersion objective. Green and red images 
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were collected sequentially to minimize bleed-through, with a rate of 3 sec/frame. For 
Alexa488-CTxB, lex=488, lem=500-550; for DiI-C16, lex=543, lem=560-630. Image analysis 
was carried out as previously described [22]. This method uses the plasma membrane-
localized DiI-C16 label to create a binary plasma membrane mask that is used to define 
the Alexa488 fluorescence of interest. The average intensity of Alexa488-CTxB 
fluorescence in this region is calculated for each frame and plotted as a function of time. 
RESULTS 
Sphingosine derivatives cause transient increases in surface FITC-CTxB fluorescence 
that correlates with insertion and flipping in the plasma membrane. 
 In our previous study of recycling endosome trafficking, we determined that Ca2+ 
influx is necessary for sustained outward trafficking of recycling endosomes in RBL 
mast cells [2]. Ca2+ mobilization during IgE-Fc!RI-mediated signaling involves both 
release of Ca2+ from stores and influx via the store-operated Ca2+ entry (SOCE) channel 
Orai1/CRACM1 [23, 24]. It was shown previously that sphingosine derivatives effectively 
block SOCE [25], so we examined the effects of several sphingosine derivatives on 
outward trafficking of FITC-CTxB in RBL cells.   
In initial experiments, we found that addition of 8 µM D-sphingosine or N,Nʼ-
dimethylsphingosine (DMS) to cells labeled with FITC-CTxB at 37°C caused a rapid 
increase in FITC fluorescence that decayed back to its original intensity after ~10 min 
(Figure 3.1A and data not shown).  To determine whether this response is due to 
stimulated outward trafficking of CTxB from recycling endosomes, cells were labeled at 
4°C to confine labeling to the plasma membrane [2].  Under these conditions, a similar 
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Figure 3.1.  Sphingosine derivatives cause transient increases in the fluorescence of 
FITC-CTxB bound to GM1 that correlates with cytoplasmic alkalinization.  (A-C) RBL-
2H3 cells were labeled with FITC-CTxB 37°C or 4°C, and 8 µM DMS or TMS were 
added as indicated. (D) Confocal equatorial images of RBL-2H3 cells labeled with 
Alexa488-CTxB for 2 hr at 37ºC, then treated with 8 µM D-sphingosine (D-spg), DMS, or 
TMS for 10 minutes prior to  fixation and imaging Scale bar = 10 µm. (E) Changes in 
BCECF fluorescence in labeled RBL-2H3 cells in response to sphingosine derivatives (8 
µM) or solvent (0.05%v/v DMSO) alone. Data in A-E are representative of at least 3 
independent experiments.  
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transient increase in FITC fluorescence was observed upon addition of these 
derivatives, with no detectable change in the cellular distribution of label (Figure 3.1B 
and data not shown), indicating that this reflects a change in plasma membrane-
associated FITC fluorescence. By comparison, addition of, N,Nʼ,Nʼʼ-trimethylsphingosine 
(TMS),  the quaternary ammonium derivative, to cells labeled with FITC-CTxB at 37oC 
causes a similar rapid increase in FITC-CTxB fluorescence, but this higher level of 
fluorescence is more sustained over the same timescale (Figure 3.1C). Under these 
conditions, none of these sphingosine derivatives cause visible changes in the 
distributions of FITC-CTxB or Alexa488-CTxB  (Figure 3.1D) at the plasma membrane 
and the recycling endosomal pool.  
In other experiments, we found that cells labeled with pH-insensitive Alexa488-
CTxB showed a similar, transient increase fluorescence in response to DMS, 
suggesting that it represents transient relief of self-quenching of the CTxB conjugates at 
the cell surface, rather than a pH-dependent effect on FITC fluorescence (data not 
shown).  Furthermore, these sphingosine derivatives do not alter the fluorescence of 
CTxB conjugates in solution or that of FITC-IgE bound to Fc!RI at the cell surface (data 
not shown), indicating an effect that depends on the specific protein ligand (CTxB) 
bound to GM1 at the cell surface.  
These results suggest that the increase in fluorescence observed is due to the 
insertion of the sphingosine compounds into the outer leaflet of the plasma membrane, 
which relieves FITC-CTxB self-quenching at the cell surface. D-sphingosine and DMS in 
Triton X-100 micelles and lipid bilayers have pKa values of 8.5 [26] and 8.8 [27], 
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respectively, and thus exist largely as protonated, positively charged species at pH 7.2, 
whereas the quarternary amine derivative TMS is positively charged at all pH values. 
Because of this charge, the latter derivative has a very low probability of flipping to the 
inner leaflet of the plasma membrane at any time [28], whereas this probability is 
significant for DMS and D-sphingosine, which both undergo deprotonation at a small but 
finite probability at pH 7.2. Thus, the biphasic nature of the FITC-CTxB fluorescence 
change induced by DMS and D-sphingosine is likely due to their insertion, then time-
dependent flipping to the inner leaflet of the plasma membrane. In this process, the 
uncharged sphingosine species would regain a proton at the inner leaflet as dictated by 
its pKa and the cytoplasmic pH (~7.4).  
To test this hypothesis, we loaded RBL-2H3 cells in suspension with cell 
permeable BCECF-AM, a fluorescein-based pH sensor [18], and monitored BCECF 
fluorescence during addition of sphingosine derivatives.   As shown in Figure 3.1E, 8 
µM D-sphingosine and DMS both caused a time-dependent increase in the cytoplasmic 
pH by 0.2-0.3 pH units that becomes maximal after 100-200 sec. By comparison, the 
same concentration of TMS caused a much slower increase in BCECF fluorescence 
that was only a little larger than the baseline change in the presence of solvent alone. 
These results indicate that the transient increase in FITC-CTxB fluorescence caused by 
D-sphingosine and DMS can be accounted for by their insertion into the plasma 
membrane, followed by their flipping to its inner leaflet upon deprotonation, where they 
become reprotonated and thereby increase the cytoplasmic pH. For TMS, the slow 
decline of FITC-CTxB fluorescence following its rapid increase, and the slow, small 
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increase in BCECF fluorescence following addition of TMS that are observed (Figs. 
3.1C and E) may be due to impurities in this preparation, such as small amounts of 
DMS. 
D-sphingosine and DMS inhibit outward trafficking of FITC-CTxB-labeled recycling 
endosomes.  
As previously described, antigen stimulates a rapid increase in FITC 
fluorescence from RBL cells that are sensitized with IgE and labeled with FITC-CTxB at 
37oC (Figure 3.2A, left panel), and this was shown to reflect stimulated outward 
trafficking of labeled recycling endosomes [2]. As illustrated in Figure 3.2A, right panel, 
addition of the inhibitor of actin polymerization, cytochalasin D, prior to stimulation 
enhances the magnitude and duration of the stimulated trafficking response [2]. 
Because cytochalasin D provides a stronger, more sustained response to antigen, we 
carried out subsequent trafficking experiments under these conditions. To evaluate the 
effects of sphingosine derivatives on stimulated trafficking of FITC-CTxB-labeled 
recycling endosomes, RBL cells sensitized with IgE and labeled with FITC-CTxB at 
37oC were treated with different sphingosine derivatives for 10 min prior to addition of 
cytochalasin D and antigen. The fluorescence baseline was monitored for several 
minutes subsequent to addition of cytochalasin D, and this was extrapolated and 
subtracted as described in Materials and Methods. 
As shown in Figure 3.2B, both D-sphingosine and DMS substantially reduce the 
trafficking response to antigen, with some differences in the time courses of these 
attenuated responses. In contrast, TMS does not alter the magnitude or kinetics of the 
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Figure 3.2. D-sphingosine and DMS, but not TMS, inhibit antigen-stimulated FITC-
CTxB/GM1 trafficking. (A) RBL cells exhibit outward trafficking of FITC-CTxB due to 
antigen (left panel) that is enhanced by cytochalasin D (Cyto D; right panel). (B) 
Representative time courses for stimulated trafficking in the presence or absence of 
sphingosine derivatives (8 µM) as indicated. (C) Summary of the effects of sphingosines 
on trafficking responses integrated for 420 s. Data are averages from 4 independent 
experiments, +/- SD. 
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stimulated response.  Figure 3.2C compares the integrated responses to Ag in the 
presence and absence of these sphingosine derivates as averages of four independent 
experiments. As indicated, 8 µM D-sphingosine or DMS both inhibit this integrated 
response by ~60%. In other experiments, we found that lower concentrations of these 
derivatives inhibit to lesser extents: 4 µM D-sphingosine causes less than half of the 
inhibition observed at 8 µM (data not shown). At concentrations of these derivatives 
greater than 10 µM, some cell lysis is variably detected, as indicated by progressive 
leakage of the Ca2+ indicator, indo-1 (data not shown). In subsequent experiments, we 
compared the effects of these sphingosine derivatives at the optimal dose of 8 µM. In 
other experiments, we found that the stereoisomer of D-sphingosine, L-sphingosine, 
inhibits the outward trafficking of FITC-CTxB bound to GM1 to a similar extent at similar 
concentrations (data not shown), suggesting that stereospecific binding to a target 
protein is unlikely to be the mechanism of inhibition. 
We subsequently tested the effects of sphingosine derivatives on outward 
trafficking of FITC-CTxB/GM1 stimulated by the Ca2+ ionophore A23187.  A23187 is a 
mobile carrier of divalent cations that increases intracellular Ca2+ levels in the absence 
of inositol 1,4,5-trisphosphate (IP3)-dependent antigen-stimulated Ca2+ release from 
intracellular stores, thereby allowing us to bypass early signaling steps. In initial 
experiments we found that stimulation with A23187 caused robust outward trafficking, 
even in the absence of cytochalasin D (Fig. 3.3A). Under these conditions, D-
sphingosine and DMS substantially inhibit outward trafficking of FITC-CTxB bound to 
GM1, and DMS is somewhat more effective than D-sphingosine (Fig. 3.3A and B). The 
89
  
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Sphingosine derivatives inhibit recycling endosome trafficking triggered by 
calcium ionophore. (A) Representative time courses showing that D-sphingosine and 
DMS, but not TMS, inhibit calcium ionophore-stimulated trafficking of FITC-CTxB/GM1.  
RBL cells were stimulated with 1 mM A23187 in the presence or absence of 8 µM 
sphingosine derivatives. (B) Summary of inhibitory effects averaging 3 independent 
experiments, +/- SD. 
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basis for this difference is unclear.  Similarly, we found that D-sphingosine and DMS 
inhibit outward trafficking of FITC-CTxB stimulated by thapsigargin, which stimulates 
SOCE by inhibiting SERCA pumps in the endoplasmic reticulum (ER; data not shown). 
Together, these results indicate that sphingosine derivatives inhibit FITC-CTxB 
trafficking downstream from the earliest signaling events stimulated by Fc!RI. In fact, no 
significant change in stimulated phosphorylation of Fc!RI " and # subunits is detected 
following addition of the sphingosine derivatives tested in this study (data not shown). 
To evaluate whether outward trafficking of recycling endosomes occurs in 
adherent RBL mast cells, we developed an imaging method to detect this process. For 
these experiments, we first blocked GM1 at the plasma membrane with unlabeled CTxB, 
then stimulated cells in the presence of excess Alexa488-CTxB and monitored its 
binding to newly-trafficked GM1 at the plasma membrane using an imaging analysis 
method that we previously developed [22]. As shown in Figure 3.4A, A23187 stimulates 
a significant increase in the trafficking of GM1 to the plasma membrane in adherent RBL 
cells. Furthermore, D-sphingosine inhibits this stimulated outward trafficking of GM1 by 
~60% under these conditions (Fig. 3.4B), consistent with results for stimulated 
trafficking of FITC-CTxB bound to GM1 in suspended RBL cells (Fig. 3.3). Thus, GM1 
outward trafficking is stimulated in adherent RBL cells, indicating that this process is not 
restricted to suspended cells or to CTxB/GM1 complexes. Furthermore, these results 
establish an alternative, single cells imaging assay for stimulated outward trafficking of 
recycling endosomes. 
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Figure 3.4. Live cell imaging of GM1 trafficking to the plasma membrane in response to 
stimulation by calcium ionophore. Dynamics are monitored as mean plasma membrane 
fluorescence of Alexa488-CTxB in the absence (A) or presence (B) of 8 μM D-
sphingosine, normalized to each pre-stimulation average.  Gray bars indicate time of 
A23187 addition.  Each condition represents average data for 15-28 individual cells from 
4-5 independent experiments.  Error bars show SEM. 
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Degranulation of secretory lysosomes is inhibited by sphingosine derivatives. 
  To determine whether sphingosines inhibit stimulated release of secretory 
lysosomes in these cells, we carried out degranulation assays with suspended RBL-2H3 
cells in the presence of cytochalasin D to match the conditions used in our FITC-CTxB 
recycling endosome trafficking experiment. As shown in Figure 3.5, both D-sphingosine 
and DMS inhibit degranulation responses similar to the extents that they inhibit FITC-
CTxB outward trafficking. As in the previous trafficking experiments, TMS had little 
effect on the degranulation response, consistent with its incapacity to flip to the inner 
leaflet of the plasma membrane. 
 Sphingosine derivatives inhibit Ca2+ mobilization in stimulated RBL mast cells.  
Because DMS and D-sphingosine inhibit both RE trafficking and degranulation 
responses, it is likely that they inhibit a signaling step that is important for both.  
Although Ca2+ mobilization and protein kinase C (PKC) activation are important for 
secretory granule exocytosis in these cells [29, 30], inhibition of PKC has little effect on 
CTxB/GM1 outward trafficking [2]. Ca2+ mobilization has two well-identified phases in 
RBL-mediated signaling:  release from intracellular stores via IP3 and IP3 receptors on 
the ER followed by extracellular Ca2+ influx through Orai1 [31]. 
To evaluate whether sphingosine derivatives affect stimulated Ca2+ release from 
stores as well as influx, we stimulated RBL cells in the absence of extracellular Ca2+, 
then replenished Ca2+ after several hundred seconds.  In untreated cells, antigen 
addition causes a rapid increase in the intracellular Ca2+ concentration that returns to 
baseline following store depletion (Figure 3.6A). When Ca2+ is added back into the 
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Figure 3.5. Degranulation responses in RBL-2H3 cells are similarly inhibited by D-
sphingosine and DMS, but not TMS.  Degranulation measured by "-hexosaminidase 
release following antigen stimulation at concentrations indicated in the presence of 2 µM 
cytochalasin D +/- sphingosine derivatives, expressed as fraction of control (antigen-
stimulated) cell degranulation.  Average of 3 independent experiments, +/- SD. !!!!!
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Figure 3.6. Sphingosine derivatives inhibit release from Ca2+ stores in addition to 
blocking Ca2+ influx. (A-D) RBL cells labeled with indo-1,  then washed into Ca2+-free 
buffer, were treated with sphingosine derivatives (8 µM), followed by antigen (0.8 µg/ml 
DNP-BSA) and Ca2+ (2 mM) as indicated. Data are representative of 2-4 independent 
experiments. (E) Summary of indo-1-monitored time-integrated responses to antigen in 
the presence of extracellular Ca2+, with or without 8 µM sphingosine derivatives. Data 
are averages from 4-5 independent experiments, +/- SD. 
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extracellular buffer, stimulated Ca2+ influx results in a sustained increase in cytoplasmic 
Ca2+.  Addition of D-sphingosine or DMS to unstimulated cells causes small and/or 
transient increases in cytoplasmic Ca2+, and subsequent addition of antigen results in 
reduced stimulated release from stores. In four separate experiments with 8 µM D-
sphingosine, antigen-stimulated Ca2+ release from stores was reduced by 85 +/- 19% 
(SD). Similar to trafficking and degranulation responses, treatment with TMS has 
negligible effects on antigen-induced calcium release from stores (Figure 3.6D). 
Addition of Ca2+ subsequent to antigen for D-sphingosine and DMS-treated cells results 
in smaller responses than with antigen alone, whereas the antigen response in TMS-
treated cells is identical to that of untreated cells (Fig. 3.6, A-D). These results indicate 
that D-sphingosine and DMS inhibit both antigen-stimulated Ca2+ release from stores, 
as well as stimulated Ca2+ influx. 
To quantify effects of sphingosine derivatives on Ca2+ responses in the presence 
of extracellular Ca2+, we compared time-integrated Ca2+ responses to antigen. As 
summarized in Figure 3.6E, both D-sphingosine and DMS block much of the antigen-
stimulated Ca2+ response when compared to either untreated cells or those treated with 
TMS. These results, together with others described above, make it likely that D-
sphingosine and DMS inhibit degranulation and outward trafficking of recycling 
endosomes at least in part by inhibiting Ca2+ mobilization, which is important for these 
more downstream exocytotic processes. Consistent with this, we find that these 
derivatives similarly inhibit the sustained, influx phase of A23187-mediated Ca2+ 
mobilization and A23187-stimulated degranulation (data not shown).  These results are 
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accountable by the inhibition of store-operated Ca2+ entry by these long chain bases, as 
this process is activated by A23187, as well as by antigen and thapsigarin, and is 
important for stimulated degranulation in mast cells [24]. 
D-Sphingosine and DMS displace the polybasic MARCKS effector domain from 
interactions with polyphosphtidylinositols at the plasma membrane. 
 To investigate the mechanism by which D-sphingosine and DMS inhibit Ca2+ 
mobilization and Ca2+-dependent secretory processes, we utilized the polybasic 
myristoylated, alanine-rich PKC substrate effector domain (MARCKS ED), which is a 25 
amino acid sequence containing 13 basic residues that binds tightly to the plasma 
membrane via interactions with acidic phospholipids [32]. Meyer and colleagues showed 
that this association with the inner leaflet of the plasma membrane is dependent on 
interactions with polyphosphatidylinositides (see discussion, [21]). Full-length MARCKS 
dissociates from the plasma membrane in response to PKC-mediated phosphorylation 
of three serine residues in the effector domain. We mutated these residues to alanines 
to prevent this dissociation and used this MARCKS EDSA3 as an inhibitor of 
phosphoinositide accessibility (Gadi et al., submitted for publication).  
As shown in Figure 3.7A, MARCK EDSA3, tagged with a monomeric red 
fluorescent protein (mRFP), associates preferentially with the plasma membrane, with 
some additional label in the cytoplasm and nucleus to varying extents. Consistent with 
expectations, activation of PKC by 8 nM phorbol 12-myristate 13-acetate causes 
dissociation of mRFP-MARCKS ED from the plasma membrane but does not induce the 
dissociation of mRFP-MARCKS EDSA3 (Gadi et al., submitted for publication). To 
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quantify the partitioning of mRFP-MARCKS EDSA3 between the plasma membrane and 
the cytoplasm, we measured the intensity profile of a line across individual cells as 
illustrated in Figure 3.7A and described in Materials and Methods. In six separate 
experiments in which the ratio of plasma membrane to cytoplasmic intensity of mRFP-
MARCKS EDSA3 was quantified in at least 15 cells per sample for each experiment, the 
average value for this ratio in control cells is 7.0 +/- 0.9 (SEM). 
To establish whether mRFP-MARCKS EDSA3 could be displaced from the plasma 
membrane by perturbations known to alter polyphosphatidylinositide levels, we 
measured its plasma membrane to cytoplasmic fluorescence ratio to evaluate the 
effects of antigen stimulation and pharmacological inhibitors of polyphosphoinositide 
kinases (Figure 3.7). Wortmannin is a potent inhibitor of phosphatidylinositol (PI)3- 
kinases [33], but at a concentration sufficient to completely inhibit this enzyme family 
(200 nM), wortmannin did not induce detectable dissociation of mRFP-MARCKS EDSA3 
from the plasma membrane (data not shown). At higher concentrations, wortmannin is 
an effective inhibitor of Type II PI4-kinases [34], with Kiʼs of ~100 nM. As shown in 
Figure 3.7B, treatment of these cells with 10 µM wortmannin for 10 min at 37oC reduced 
the association of mRFP-MARCKS EDSA3 with the plasma membrane by ~30%, 
suggesting that PI4-P contributes to the binding of this probe to the plasma membrane.  
Antigen stimulation of PI 4,5-bisphosphate (PIP2) hydrolysis is expected to 
reduce the effective concentration of PIP2 at the plasma membrane and thereby reduce 
the binding of MARCKS ED [21, 31]. However, antigen stimulation of RBL cells causes 
them to ruffle and flatten [35], making it difficult to quantify mRFP-MARCKS EDSA3 at the 
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Figure 3.7. Dissociation of mRFP-MARCKS EDSA3 from the plasma membrane due to 
various treatments. A) Representative inverted confocal images showing mRFP-
MARCKS EDSA3-expressing RBL cells in the absence (first (left) panel) or following 
treatment with 10 mM wortmannin (WT) and 0.8 mg/ml antigen (second panel), 8 mM 
DMS (third panel), or 8 mM TMS (fourth panel). Lines through cells in each panel 
illustrate sections chosen for line scan analysis, and profiles for these are shown as 
inserts in each panel. (B) Summary of effects of various treatments on the normalized 
ratio of mRFP-MARCKS EDSA3 fluorescence at the plasma membrane to average 
cytoplasmic fluorescence determined as described in Materials and Methods. Data 
represents the average of 3-4 experiments per sample (>50 cells total per sample), +/- 
SD. 
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plasma membrane. Wortmannin prevents these morphological changes while permitting 
stimulated hydrolysis of PIP2, as evidenced by antigen-stimulated, IP3-dependent Ca2+ 
mobilization under these conditions (data not shown). As shown in Figure 3.7B, antigen 
stimulation in the presence of 10 µM wortmannin further reduces the association of 
mRFP-MARCKS EDSA3 at the plasma membrane compared to wortmannin alone, 
consistent with sensitivity of this association to PIP2 hydrolysis. 
We next determined whether sphingosine derivatives can displace mRFP-
MARCKS EDSA3 from the plasma membrane under conditions in which these long chain 
bases inhibit signaling. As shown in Figure 3.7B, addition of 8 µM D-sphingosine for 10 
min at 37oC causes substantial displacement of mRFP-MARCKS EDSA3 from the 
plasma membrane, and DMS at the same concentration causes a slightly larger 
displacement of ~50%, similar to that causes by 10 µM wortmannin + antigen. In 
contrast, TMS causes a relatively small reduction (<20%) in the plasma membrane to 
cytoplasmic ratio of mRFP-MARCKS EDSA3. This effect may be due in part to impurities 
in the TMS preparation that can flip to the inner leaflet or, alternatively, to an increased 
plasma membrane surface area that is induced when TMS partitions into the outer 
leaflet (Figure 3.1).  
Taken together, these results provide evidence that sphingosine derivatives that 
flip from the outer to the inner leaflet of the plasma membrane substantially reduce the 
binding of mRFP-MARCKS EDSA3 to the plasma membrane. Because of the 
electrostatic basis for this association, it is likely that the positively charged headgroups 
of D-sphingosine and DMS provide electrostatic neutralization of polyphosphoinositides 
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at the inner leaflet of the plasma membrane, thus competing with mRFP-MARCKS 
EDSA3 for binding to these negatively charged phospholipids. 
DISCUSSION 
The plasma membrane is a dynamic organelle, with continuous turnover of lipids 
and proteins mediated by membrane trafficking and other processes. Recycling 
endosomes, also know as the endosomal recycling compartment, provide a pool of 
readily available membrane components that can be trafficked to the cell surface under 
resting and stimulatory conditions [2, 36]. The small GTPases Rab11 and Arf6 have 
been identified as regulators of recycling endosomes [37-39]. Mutation of Rab11 to an 
inactive GTPase inhibits trafficking of transferrin-containing recycling endosomes [40], 
whereas an analogous mutation in Arf6 inhibits trafficking of GM1, but not transferrin 
receptors, from recycling endosomes to the plasma membrane, suggesting that at least 
two distinct subsets of recycling endosomes participate in these processes [41].  
Although much is now known about the proteins and signaling pathways that 
regulate trafficking of recycling endosomes, the roles of this trafficking in cell physiology 
are poorly understood in most cell types. To begin to investigate these roles in mast 
cells, we characterized the effects of sphingosine derivatives on antigen-stimulated 
outward trafficking of FITC-CTxB-labeled recycling endosomes.  We found that D-
sphingosine and DMS are similarly effective inhibitors of this process, and this inhibition 
correlates with their capacity to flip from the outer leaflet of the plasma membrane to its 
inner leaflet, as monitored by both transient relief of FITC-CTxB self-quenching at the 
plasma membrane, and by a time-dependent increase in cytoplasmic pH. In contrast to 
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these sphingosines, most TMS remains in the outer leaflet of the plasma membrane, as 
monitored by a more sustained increase in FITC-CTxB fluorescence and a smaller, 
more slowly developing increase in cytoplasmic pH (Figure 3.1). Consistent with these 
differences, TMS does not inhibit stimulated outward trafficking of FITC-CTxB-labeled 
recycling endosomes (Figure 3.2 and 3.3). Similarly, D-sphingosine and DMS inhibit 
antigen-stimulated degranulation responses by ~60% under these conditions, whereas 
TMS inhibits this response to a much smaller extent (Figure 3.5). Recently, D-
sphingosine has been shown to inhibit exocytotic release of insulin and Glut4 
expression at the plasma membrane of beta cells, and a similar electrostatic 
mechanism of inhibition has been implicated [42]. 
Similar trends are observed for the effects of these derivatives on antigen-
stimulated Ca2+ responses. These results are consistent with a previous study that 
demonstrated inhibition of IP3- and thapsigargin-stimulated, Ca2+ release-activated 
Ca2+(CRAC) channels by D-sphingosine and DMS [25]. In a more recent study, we 
showed that these derivatives inhibit store-operated Ca2+ entry by interfering with the 
coupling between the CRAC channel, Orai1, and the ER Ca2+ sensor protein, STIM1 
[20]. However, we now find that these sphingosine derivatives inhibit antigen-stimulated 
Ca2+ release from ER stores, indicating an additional effect on antigen-stimulated Ca2+ 
responses at a step that precedes store-operated Ca2+ entry (Figure 3.6). Similar to 
results for stimulated outward trafficking of recycling endosomes and degranulation, we 
find that TMS fails to inhibit both antigen-stimulated Ca2+ release from stores and Ca2+ 
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influx, suggesting that the redistribution of D-sphingosine and DMS to the inner leaflet of 
the plasma membrane are important for their inhibitory effects.  
In some previous studies, inhibition of Ca2+ mobilization and other signaling 
processes by DMS was suggested to be due to inhibition of the production of 
sphingosine-1-phosphate by sphingosine kinases [43, 44]. From our present results and 
those of Mathes et al. [25], this explanation seems unlikely, as both DMS and the 
substrate for sphingosine-1-kinase, D-sphingosine, similarly inhibit Ca2+ mobilization 
and exocytosis of both recycling endosomes and secretory lysosomes. Although more 
complex mechanisms, such as substrate inhibiton of sphingosine 1-kinase, cannot be 
excluded [45], the simplest explanation for our results is that sphingosine derivatives 
inhibit antigen-stimulated signaling processes by a different mechanism than 
interference with sphingosine-1-phosphate production. In this regard, Olivera et al. 
showed that knockout of sphingosine kinase 2, which inhibits Ca2+ mobilization in mast 
cells, significantly increases intracellular levels of D-sphingosine [46]. Thus, we suggest 
that alterations in endogenous levels of D-sphingosine may directly modulate Ca2+ and 
other signaling processes. 
One mechanism by which basic lipids such as sphingosines might alter signaling 
pathways is electrostatic neutralization of acidic lipids. These lipids, including 
polyphosphatidylinositides, are preferentially localized at the inner leaflet of the plasma 
membrane, and they serve multiple roles in cell signaling [47]. PIP2, for example, serves 
as a substrate for phospholipase C-mediated production of IP3 in the initiation of store-
operated Ca2+ entry [48], and it has also been implicated in exocytotic processes via 
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plasma membrane targeting of Ca2+-sensing proteins such as synaptotagmins [49]. As 
described above, Meyer and colleagues investigated the roles of polyphosphoinositides 
in plasma membrane-targeting of various signaling proteins, and they showed that the 
strong association of the polybasic effector domain of the PKC substrate MARCKS with 
the plasma membrane is largely due to electrostatic interactions with 
polyphosphatidylinositides [21]. We took advantage of these observations to test 
whether sphingosines can compete for electrostatic interactions between 
polyphosphatidylinositides at the plasma membrane and mRFP-MARCKS ED that is 
mutated to prevent its PKC-mediated dissociation. We found that both D-sphingosine 
and DMS substantially reduce the plasma membrane-to-cytoplasmic ratio of mRFP-
MARCKS EDSA3, whereas TMS causes a smaller decrease in this ratio (Figure 3.7).  
Interestingly, wortmannin at a concentration that effectively inhibits PI3-kinases 
(200 nM) does not significantly reduce association of mRFP-MARCKS EDSA3, whereas 
10 µM wortmannin, which also inhibits PI4-P synthesis [34], causes substantial 
dissociation that is enhanced by antigen, most likely due to stimulated PIP2 hydrolysis 
(Figure 3.7B). These results suggest that PI4-P contributes to the electrostatic 
association of mRFP-MARCKS EDSA3 with the plasma membrane, in addition to the 
contribution of PIP2. The similar extent of mRFP-MARCKS EDSA3 dissociation caused 
by D-sphingosine and DMS compared to that caused by 10 µM wortmannin and antigen 
suggests that these sphingosine derivatives effectively compete with mRFP-MARCKS 
EDSA3 for binding to PIP2 and PI4-P at the plasma membrane.  
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These results, taken together, indicate that D-sphingosine and DMS are effective 
inhibitors of Fc!RI-mediated signaling because of their capacity to compete 
electrostatically with proteins for binding to polyphosphatidylinositols at the inner leaflet 
of the plasma membrane. However, we cannot exclude roles for electrostatic 
neutralization of other classes of negatively charged phospholipids by these 
sphingosine derivatives for their inhibitory effects on Ca2+ mobilization leading to 
stimulated exocytosis of recycling endosomes and secretory lysosomes.  Further 
studies will be necessary to assess more directly the phospholipid specificity of these 
inhibitory effects. None-the-less, our results show that electrostatic neutralization of 
negatively charged phospholipids, including polyphosphoinositides, is likely to be 
relevant to a large number of studies in which sphingosine derivatives have been shown 
to be effective inhibitors of cell signaling. 
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CHAPTER FOUR 
Recycling Endosomal Contribution to the Secretion of IL-4 and TNF! in RBL Mast 
Cells 
SUMMARY 
In mast cells, crosslinking of FcεRI-IgE by multivalent antigen results in a 
complex signaling cascade that culminates in the secretion of preformed allergic 
mediators from secretory granules.  Additionally, this signaling cascade activates the 
transcription of various gene products, including cytokines, which play important roles in 
the adaptive immune response. Our ELISA measurements show that cytokines IL-4 and 
TNFα are secreted following stimulation. Confocal microscopy shows that cytokine IL-4 
is produced de novo in RBL mast cells following multivalent antigen stimulation. We 
observe intracellular localization of IL-4 with both Golgi and recycling endosomal 
markers, but not with markers for secretory lysosomes. Using pharmacological 
inhibitors, we find that PI3-kinases, and protein kinase C (PKC) isoforms are necessary 
for initiation of signaling by FcεRI that leads to cytokine secretion, but the two enzymes 
are dispensible for the sustained secretory phase. In contrast, secretion of IL-4 and 
TNFα is enhanced to different extents by both inhibition of actin polymerization and by 
siRNA knockdown of the GTPase Rab11A. These results support a role for recycling 
endosomal (RE) trafficking of newly synthesized cytokines in stimulated mast cells. We 
are developing tools such as a GFP-tagged TNF! construct and specific inactivation of 
RE trafficking to further test this hypothesis and to address other questions regarding 
the regulation and function of recycling endosomes. 
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INTRODUCTION 
Signaling in mast cells, initiated by antigen-mediated cross-linking of Fc"RI/IgE 
complexes, triggers multiple effector functions. The most commonly associated result of 
mast cell signaling is the rapid release of preformed mediators, such as histamine, from 
secretory granules.  On longer time scales, this signaling also activates the production 
of a number of immunologically relevant molecules, from eicosanoids to cytokines. Mast 
cell signaling is predominately associated with allergic disease, inflammation, and 
asthma [1], but it is also important in host defense to helminths [2], in innate immunity 
[3] and, in some cases, in limiting inflammation [4]. 
 It is widely accepted that cytokines play  crucial roles in the orchestration and 
regulation of immune responses. In immune cells, cytokine synthesis is triggered 
through activation of a number of receptor families including multichain immune 
recongition receptors (MIRR), cytokine receptors and Toll-like receptors (TLR).  The 
various signal transduction cascades that emanate from these receptors have been 
extensively studied.   
Less well studied are the mechanisms that control and regulate cytokine 
secretion.  The protein biosynthetic pathway generally involves protein synthesis on ER-
associated ribosomes, protein modification in the ER, and transport to the Golgi for 
further post-translational modification prior to plasma membrane trafficking and 
secretion. The precise mechanisms that regulate secretion of cytokines via vesicular 
transport downstream of the Golgi have recently gained attention, and they highlight a 
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role for RE for cytokine secretion [5]. RE containing TNF! have been shown to traffic to 
sites of phagocytosis in macrophages [6]. Furthermore, there is evidence that 
subcompartments of the RE may differentially traffic IL-6 and TNF! [7]. This is 
reminiscent of a study by Huse et al. in which activated T cells show spatially discrete 
cytokine secretion patterns [8].  Recently, cytokine secretion in NK cells was shown to 
be dependent on RE trafficking but functionally independent of granule exocytosis [9].  
Similarly, our laboratory has shown that RE outward trafficking is spatially distinct from 
granule exocytosis in mast cells [10].   
Mast cells predominantly secrete cytokines associated with Th2-mediated 
immunity, such as IL-3, IL-4, IL-13 and TNF! [2].  Determining the intracellular 
mechanisms that control both the spatial and temporal aspects of cytokine export in 
mast cells may lead to new therapies for managing the damaging effects of allergy-
associated inflammation that occurs as a result of mast cell signaling.   
To this end, we used RBL mast cells to begin to probe the intracellular pathways 
that govern cytokine secretion. We began by confirming that RBL mast cells secrete 
both IL-4 and TNF! in response to stimulation by multivalent antigen.  Furthermore, we 
show visual evidence that newly synthesized IL-4 localizes to RE following antigen 
stimulation.  Pharmacological inhibition of PI3 kinase and PKC reveal these kinases are 
essential for Fc"RI early signaling events leading to cytokine secretion but are 
dispensable at later timepoints.  IL-4 and TNF! secretion have differential sensitivity to 
cytochalasin D, suggesting the actin cyotskeleton may contribute to cytokine secretion 
in multiple ways.  Cytokine secretion is also halted by D-sphingosine, an inhibitor of RE 
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trafficking.  Similar to other immune cell types, our results suggest that mast cell 
cytokine secretion is a regulated process that involves RE.  Furthermore, our results 
point to future directions for probing the involvement of RE in cytokine secretion.  
MATERIALS AND METHODS 
Chemicals and Reagents 
 FITC-cholera toxin B (FITC-CTxB), cytochalasin D, diaminobenzidine and all 
other chemicals, unless otherwise indicated, were purchased from Sigma-Aldrich.  All 
tissue culture reagents were obtained from Invitrogen Corp.  Transferrin-HRP was 
purchased from Rockland.  Anti-DNP IgE was purified as described previously [11]. The 
following antibodies were purchased: anti-rat IL-3# (Peprotech), anti-rat IL-4 (R&D 
Biosystems), anti-rat CD63, anti-rat GM130 and anti-rat transferrin (BD Biosciences). 
AlexaFluor-conjugated secondary antibodies were purchase from Invitrogen Corp. 
Cell Culture  
RBL mast cells were passed weekly to maintain a monolayer culture as 
described previously [12].  For experiments, cells were sensitized with 1 µg/ml anti-DNP 
IgE over night.  
For knockdown experiments, Rab11A siRNA sequences (Ambion, Inc. catalog 
numbers AM16708A siRNA IDs 189852 (#1) and 53555 (#2)), or a negative control 
sequence was used (target sequence NNUUAACCUUACCGAGGGUCGAA) 
(Darmacon, Inc) were used. siRNA was introduced by electroporation of 1 µM siRNA 
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into cells at a concentration of 1x107/ml.  Transfected cells were plated in complete RBL 
media (minimum essential media (MEM) with L-glutamine containing 20% fetal bovine 
serum and 50 µg/ml Gentamicin) for 48 hours prior to experiments. 
For transient transfections, cells were sparsely plated (1-3x105/ml) on no. 1.5 
coverslips or in 35 mm glass bottom dishes (MatTek). After overnight culture, media 
was replaced by OPTIMEM and cells were transfected using 2 ug DNA and 8 µl Fugene 
HD (Roche Diagnostics) per ml media for 1 hour followed by addition of 1 ng/ml phorbol 
12,13-dibutyrate for 3-5hr [13].  Samples were then washed into complete RBL media 
and incubated 16-24 hours to allow for protein expression. 
ELISAs 
IgE-sensitized cells were plated in triplicate at a concentration of 3 x105 cells/ 
well in a 96 well plate overnight. Stimulation with 10 ng/ml DNP-BSA was performed in 
complete RBL media buffered with 20 mM HEPES.  Some experiments were conducted 
in the presence of wortmannin (200 nM), bisindolyl malemide (BIM, 100 µM) or 2 µM 
cytochalasin D. These agents were added either just prior to or one hour after initiation 
of antigen stimulation in order to differentiate between early signaling and downstream 
effector functions. To assay cytokine secretion, IL-4 and TNF! ELISA kits (BD 
Biosciences) and tetramethylbenzidine (TMB) substrate (KPL, Inc.) were used 
according to manufacturers instructions. Plates were read with a Spectra Fluor plate 
reader (Tecan, Inc.). 
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Generation of GFP-TNF! Construct 
The AcGPF-TNF! construct was generated using rat TNF! cDNA (Open 
Biosystems/ThermoFisher). The TNF! sequence was cloned into pAcGFP-C1 
Clonetech, Inc) using the HindIII and EcoRI restrictions sites within the multiple cloning 
site, producing and N-terminal GFP-tagged TNF! construct.  This construct was 
generated in collaboration with Dr. Alice Wagenknecht-Wiesner (Cornell University). 
Construct was assessed by confocal microscopy using the fixation protocol described 
below. 
Confocal Microscopy 
 To assess de novo cytokine production, sensitized RBL cells plated on 35 mm 
glass bottom dishes (MatTek) were stimulated with 10 ng/ml DNP-BSA for 3 hours 
followed by fixation with 4% paraformaldehyde and 0.1% glutaraldehyde in phosphate 
buffered saline (PBS; 10 minutes at room temperature).  Excess fixative was quenched 
with 10 mg/ml BSA in PBS with 0.01% azide.  Samples were images on a on a SP2 
confocal system (Leica). 
RE Inactivation and RE Trafficking Assay 
Specific inactivation of RE was performed using a method described previously 
[7, 14].  Briefly, transferrin-HRP (10 µg/ml) was added to sensitized RBL cells  
(6x106/ml) that had been labeled with FITC-CTxB for one hour.  Surface-bound 
transferrin-HRP was removed by 2 brief washes with 150 mM NaCl with 20 mM citric 
acid (pH 5) and then washed into BSS (135 mM NaCl, 5 mM KCL, 1 mM MgCl2, 1.8 mM 
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CaCl2, 5.6 mM glucose 20 mM HEPES, pH 7.4, 1 mg/ml BSA).  0.1 mg/ml 
Diaminobenzidine (DAB) and 0.025% H2O2 was added to samples and allowed to 
incubate on ice and protected from light for 1 hour. Cells were washed into BSS and 
FITC-CTxB trafficking was assessed by fluorimetry [15]. 
Statistical Analyses 
 Statistical analysis was performed with Prism software (Graphpad). All bar 
graphs display mean ± SD unless otherwise noted.   Statistical significance was 
determined by 1-way ANOVA (Analysis of Variance) followed by Tukeyʼs post-test.  
Level of significance is denoted as follows: * P<0.05, ** P<0.01, *** P<0.001 and **** 
P<0.0001. 
RESULTS 
RBL mast cells synthesize and secrete IL-4 and TNF! in response to antigen 
stimulation. 
 IL-4 is synthesized as a soluble molecule, whereas TNF! is synthesized as a 
type II transmembrane protein and later cleaved. We hypothesized that these 
differences in synthesis would result in differential biosynthetic trafficking, therefore we 
chose to compare IL-4 and TNF! secretion upon antigen stimulation.  Figure 4.1 shows 
secretion of each cytokine in response to antigen stimulation.   For IL-4, secretion starts 
two hours after receptor cross-linking and continues to occur for at least 4 to 8 hours 
(Figure 4.1A). In contrast, the majority of TNF! secretion occurs on a slightly 
accelerated timescale, and most of the secretion occurs within two hours of stimulation 
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at considerably lower levels than IL-4 (Figure 4.1B). Results may suggest that the 
kinetic differences in secretion of these two cytokines are due to differential biosynthetic 
trafficking, but we cannot exclude the possibility that the regulation is occurring at the 
level of transcription or translation. 
To assess the intracellular pathway for IL-4 prior to secretion, we used 
immunofluorescence confocal microscopy.  In the absence of stimulation, we see no 
cytokine label in these cells. Following stimulation by multivalent antigen we detect IL-4 
in a subset (<10%) of RBL cells (Figure 4.2, left panels). We observe some 
colocalization with GM130 labeling in cis-Golgi (Figure 4.2B), as one might expect for a 
protein traveling the biosynthetic pathway following gene transcription and protein 
translation. Furthermore, this label is partially coincident with CTxB marking RE (Figure 
4.2A), suggesting, in agreement with other studies [6, 9], that RE may play a role in 
cytokine secretion.  In contrast, these cytokines show no overlap with lysosomal marker 
CD63 (Figure 4.2C), indicating that is not likely that they are exported via secretory 
lysosomes. We see similar sub-cellular distribution of another cytokine, IL-3# (Figure 
4D-F). We attempted to look at TNF! synthesis following antigen stimulation in RBL 
cells by microscopy but were unable to find an antibody that labeled under standard 
fixation and labeling protocols.  We conclude that cytokine production is largely due to 
new synthesis, not preformed stores, and our data suggest that IL-4 follows a 
biosynthetic pathway that takes it through the Golgi complex and RE, but not via 
secretory lysosomes. 
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Figure 4.1. RBL mast cells secrete newly synthesized IL-4 and TNF! following antigen 
stimulation.  Histograms show representative ELISA measurements of (A) IL-4 and (B) 
TNF! secretion following stimulation with DNP-BSA. Error bars represent SD. 
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Figure 4.2. Newly synthesized IL-4 is detected in the perinuclear RE/golgi region 
following antigen stimulation.  Confocal microscopy images of RBL cells fixed 3 hours 
post stimulation show relative overlap with (A) Alexa 555-CTxB (recycling endosomes, 
red), (B) anti-GM-130 (Golgi, red) or (C) anti-CD63 (lysosome, red).  In all cases, IL-4 is 
immuno-labeled (green).  IL-3# is also synthesized in response to antigen stimulation in 
RBL mast cells.  Confocal microscopy images show relative overlap with (D) Alexa 555-
CTxB (RE, red), (E) anti-GM-130 (golgi, red) or (F) anti-CD63 (lysosome, red).  In all 
cases, IL-3# is immuno-labeled (green). Scale bar is 10 μm. 
123
  
 
 
 
RE
LysosomeIL-4
IL-4
IL-4 Golgi
ĂP
A
B
C
merge
124
Figure 4.2. (continued) 
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Pharmacologic Inhibitors reveal temporal requirements for PI3 kinases and PKC in 
cytokine secretion. 
 To begin to determine requirements for cytokine secretion resulting from 
signaling through the IgE/Fc"RI receptor system, we used a variety of known inhibitors 
of key signaling components.  Treatment with the Src-family kinase inhibitor, PPI, prior 
to antigen stimulation blocks cytokine secretion (data not shown), consistent with 
phosphorylation of Fc"RI by Lyn kinase as a necessary signal.  Treatment with either 
200 nM wortmannin, a dose that specifically inhibits PI3 kinases, or with the PKC 
inhibitor bisindolyl maleimide (BIM; 100 µM) prior to receptor engagement also results in 
nearly complete abrogation of IL-4 secretion (Figure 4.3, BIM Pre and wortmannin Pre). 
These results indicate that the early signaling steps involving PI3 kinase and PKC, 
which are likewise important for RBL mast cell degranulation, are also important for 
cytokine secretion. A possible explanation is that these kinases are necessary for the 
initiation of gene transcription of cytokines. To address this issue, we added these 
inhibitors one hour after the addition of antigen to allow for the initiation gene 
transcription. Under this condition, IL-4 secretion occurs, but PKC inhibition still results 
in significant reduction of IL-4 secretion (Figure 4.3, BIM Post).  We observe similar 
trends in TNF! secretion (data not shown), although the quantity of TNF! secreted 
under these conditions approaches the lower detection limits of our ELISA, precluding 
robust data analysis.   These results suggest that following the initiation of signal 
transduction, inhibition of these kinases has little or no effect on cytokine secretion, 
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Figure 4.3. Pharmacological manipulation of IL-4 secretion reveals early requirement 
for PI3K and PKC activity. Representative ELISA measurements showing the effects of 
200 nM wortmannin (brown) and 100 uM bis-indolyl maleimide (BIM, blue) added either 
just prior to (Pre) or 1 hour after (Post) antigen stimulation. All supernatant samples 
collected 4 hours post stimulation. Error bars represent SD, * denotes p< 0.05 and *** 
denotes p<0.001. 
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indicating that PI3 kinases and PKC are not essential for the biosynthetic export of 
these cytokines. 
Blocking actin polymerization selectively enhances cytokine secretion. 
Cytochalasin D blocks actin polymerization by binding monomeric G actin, 
thereby preventing filament formation.  It is known that treating RBL cells with 
cytochalasin D enhances Fc"RI receptor tyrosine phosphorylation [16], degranulation 
[17], and stimulated recycling endosomal trafficking [18].  In the context of IL-4 
secretion, we find that either cytochalasin D pre-treatment (Figure 4.4A, white bars) or 
addition following antigen stimulation (Figure 4.4A, green bars) robustly enhances 
secretion.  Similarly, pre-treatment with cytochalasin D significantly enhances secretion 
of TNF! at two and four hours post stimulation (Figure 4.4B, white bars).  However, 
when cytochalasin D is added after the initiation of signaling, there are no significant 
changes in TNF! secretion at either timepoint (Figure 4.4B. green bars). That 
cytochalasin D added after the initiation of signaling shows differential effects on IL-4 
and TNF! secretion suggests that actin dynamics differentially affects exocytosis of 
these two cytokines. 
Rab11A siRNA knockdown modestly enhances cytokine secretion. 
 Our initial interest in the regulation of cytokine secretion was prompted by the 
possible involvement of RE trafficking in cytokine secretion [6].  Rab11A is a GTPase 
known to be involved in the regulation of transferrin (TfR) receptor trafficking via RE 
[19]. Therefore, we used RNA interference (RNAi) techniques to probe the involvement 
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 Figure 4.4. Addition of cytochalasin D either before or after antigen stimulation 
enhances IL-4 secretion, while only pretreatment enhances TNF! secretion. 
Representative IL-4(A) and TNF! (B) ELISA measurements of antigen-stimulated RBL 
cells pretreated (pre, white) or following antigen stimulation (1 hour) (post, green) with 
cytochalasin D (Cyto D). For IL-4 treatments, samples were collected 4 hours after 
stimulation. Error bars represent SD, * denotes p<0.05, * denotes p<0.01 and **** 
denotes p<0.0001. 
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of Rab11A in RBL cell cytokine secretion.  Figure 4.5A demonstrates that we were able 
to use two different siRNA sequences (see Material and Methods) and get efficient 
knockdown of Rab11A protein.  When these cells were used in cytokine secretion 
assays, we see that both IL-4 (Figure 4.5B) and TNF! (Figure 4.5C) secretion are 
modestly enhanced by Rab11A knockdown. This enhancement is slightly more 
pronounced for TNF! secretion. Consistent with these results, antigen-stimulated RE 
trafficking monitored using FITC-CTxB is modestly enhanced in siRNA treated cells 
(Figure4.5D). The enhancement may be partially explained by a modest acceleration in 
the growth rate of siRNA treated cells (data not shown).  
Characterization of GFP-TNF! construct and RE inactivation assays. 
Our results are consistent with a role for RE in cytokine secretion in that 
treatments that modulate RE trafficking also modulate cytokine secretion, but additional 
work is needed to confirm the involvement of this organelle in cytokine secretion. To this 
end, we generated a GFP-TNF! construct (see schematic in Figure 4.6A) for use in live 
microscopy experiments. When this construct is expressed in RBL cells, it is generally 
localized at the plasma membrane and to small vesicular structures throughout the 
cytoplasm, perhaps with some peri-nuclear localization (Figure 4.6, left panels).  In 
some cells, we can see partial localization with RE markers CTxB (Figure 4.6B) and TfR 
(Figure 4.6C).  Additionally, it is excluded from the Golgi complex (Figure 4.6D).  
Another useful technique we have begun to utilize is specific inhibition of RE 
trafficking by chemically inactivating RE. This is a method developed in the laboratory of 
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 Figure 4.5. Rab11A knockdown potentiates cytokine secretion. (A) Western blotting 
shows the efficiency of siRNA knockdown of endogenous Rab11A by two different 
siRNA sequences, 1 and 2, compared to cells transfected with either nothing (none) or a 
control siRNA sequence (control). (B) Representative ELISA measurements comparing 
IL-4 secretion in control siRNA (black), siRNA 1 (red) or siRNA 2 (blue). (C) TNF! 
secretion in parallel samples. (D) Plot of antigen mediated RE trafficking in Rab11A 
knockdown cells (representative of 2 experiments). Error bars represent SD, * denotes 
p<0.05, ** denotes p<0.01, *** denotes p<0.001 and **** denotes p<0.0001. 
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Figure 4.6. Initial GFP-TNF! construct characterization by confocal microscopy. (A) 
Schematic of construct. (B) Two representative images of GFP-TNF! (green) showing 
relative overlap with RE labeled by Alexa555-CTxB. (C) representative images showing 
extent of GFP-TNF! colocalization with TfR or GM-130 immunolabeled with primary 
antibodies followed with Alexa555 secondary antibodies. 
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I. Mellman [14] and subsequently used by Manderson et al. [7].  RE are specifically 
inactivated by targeting horseradish peroxidase (HRP)-conjugated transferrin to the RE, 
followed by an HRP-mediated oxidation process that renders the RE non-functional. 
Figure 4.7 demonstrates that this approach can be used to reduce antigen-stimulated 
outward trafficking of FITC-CTxB labeled RE.  It will be interesting to see if this 
treatment reduces cytokine secretion in response to antigen signaling. 
DISCUSSION  
The versatile nature of mast cells is often underappreciated.  While most 
common symptoms of allergies are caused by mast cell secretion of histamine, mast 
cells also secrete cytokines that attract multiple immune effector cells.  In allergic 
responses, this can lead to additional inflammatory responses and extensive tissue 
remodeling. Furthermore, it is also established that mast cells can contribute to the 
initiation of important host defense to pathogens, primarily through the secretion of 
cytokines. Determining the intracellular mechanisms that regulate cytokine secretion in 
mast cells is important for both situations: Understanding how/if regulated cytokine 
secretion occurs has important implications for limiting allergic disease and for 
generating effective immune responses that may be mediated through mast cells.  
 Murray et al., demonstrated TNF! secretion via RE in macrophages [6]. This 
result prompted us to hypothesize that mast cells might use a similar mechanism to 
regulate secretion.  Our studies confirmed that IgE/Fc"RI signaling in RBL mast cells 
triggers the production and secretion of cytokines IL-4 and TNF!. Furthermore, 
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Figure 4.7. Antigen-stimulated RE trafficking is reduced by chemical inactivation of RE. 
Figure shows representative FITC-CTxB trafficking in response to antigen in control 
(black) or diaminobenzidine (DAB)-peroxidase inactivated (red) RBL cells.   
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secretion of IL-4 and TNF! is not synchronous, suggesting possible differences in the 
regulated secretion of these two cytokines. Similarly, in macrophages, IL-6 and TNF! 
reside in different subcompartments of the RE prior to secretion [7]. In RBL mast cells 
we detect colocalization of newly synthesized IL-4 with the RE marker CTxB, suggesting 
that RE contribute to intracellular cytokine trafficking.   
 To distinguish between factors necessary for activation of transcription and 
secretion, we added pharmacological inhibitors either prior to antigen stimulation or after 
one hour, at which time gene transcription should have been induced [20].  Our 
pharmacological studies with wortmannin and BIM demonstrate that IL-4 has similar 
requirements for PI3 kinase and PKC activity for gene transcription as has been 
previously demonstrated for TNF! [21, 22]. Interestingly, our experiments exploring the 
effects of cytochalasin D demonstrate that the secretion of IL-4 and TNF! are 
differentially sensitive to actin depolymerization. Our results support the hypothesis that 
the secretion of IL-4 is generally negatively regulated by the actin cytoskeleton, whereas 
TNF! secretion per se is not regulated by this mechanism.  
 Rab11 is a known regulator of RE trafficking, as overexpression of dominant 
negative Rab11 retards RE processes [19].  We hypothesized that siRNA-mediated 
knockdown of Rab11A would delay or reduce secretion of IL-4 and/or TNF!. To our 
surprise, Rab11A knockdown enhanced the secretion of both cytokines. A possible 
explanation for this is that the RE is composes of different subpopulations are known to 
be regulated by different GTPases, particularly Rab11 and Arf6. If, in fact, Arf6 regulates 
cytokine secretion, one would expect Rab11A knockdown to have either little or a 
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compensatory enhancing effect [23]. In the future, additional knockdown studies that 
systematically reduce expression of these regulatory GTPases, alone or in combination, 
may be instructive. Alternatively we could use dominant negative or constitutively active 
mutant forms of Rab11 and Arf6, known to alter RE trafficking [19, 24]. 
 Visualizing TNF! by immunofluorescence proved to be technically challenging. 
To circumvent this issue we constructed a GPF-TNF! construct using rat cDNA for 
TNF!. Functionally we expect this construct to be similar to that used by Stowe and 
colleagues [6, 7, 25]. Initial characterizations show some RE localization during steady 
state expression. A fluorescently tagged TNF! construct opens the possibility of looking 
at live trafficking processes. In particular, utilizing this construct in conjunction with a 
patterned antigen surface [10, 26, 27] we could probe the possibility of directional TNF! 
trafficking in mast cells. Additionally, using cycloheximide to block new protein synthesis 
may help us more directly address issues of cytokine trafficking. 
 RE trafficking in RBL mast cells has proven to be relatively insensitive to 
inhibition of PKC or PI3 kinases [18], and future studies into cytokine secretion and RE 
trafficking in RBL cells would benefit from additional methods to interfere with theses 
processes.  To this end we have begun to utilize a method to chemically inactivate the 
RE [14].  Preliminary experiments demonstrate that antigen-stimulated RE trafficking is 
at least partially sensitive to RE inactivation. This is in contrast to our results showing 
that Rab11A knockdown does not effect RE trafficking. Together these results support 
the hypothesis that the RE is, in fact, a heterogeneous organelle that has differential 
regulation [23]. Our initial research into the involvement of RE in mast cell cytokine 
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secretion has raised new questions, but these new tools should facilitate our ongoing 
investigation of these mechanisms. 
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CHAPTER FIVE 
Recycling Endosomal Membranes Contribute to Toxoplasma gondii 
Parasitophorous Vacuole Formation in Mast Cells 
SUMMARY 
Toxoplasma gondii is an obligate intracellular parasite that resides within a 
specialized organelle known as the parasitophorous vacuole (PV) in the host cell. T. 
gondii is a ubiquitous pathogen, infecting most mammalian and avian species, and is 
the causative agent of Toxoplasmosis. Determining how T. gondii utilizes the host cell 
membranes in the formation and remodeling of the PV membrane (PVM) will provide 
important information in understanding how productive infections are established. 
Initially, T. gondii forms the PV from plasma membrane (PM) as the parasite invades a 
host cell. However, it is not completely clear how the PVM is maintained and/or 
remodeled following initial infection. The recycling endosome (RE) is now appreciated 
as a complex organelle that contributes to multiple trafficking processes in many cell 
types and, in particular, has been shown to play a role in cellular processes that require 
extensive membrane remodeling such as migration and cell division.  In RBL mast cells, 
we previously established that cholera toxin B (CTxB) bound to the ganglioside GM1 
localizes to RE membranes upon internalization, and antigen stimulation via IgE/Fc!RI 
receptor complexes results in stimulated outward trafficking of the RE [1].  We provide 
evidence that RE membranes contribute to the PVM of T. gondii using RBL mast cells 
as a model system.  Compared to conditions in which GM1 labeling by CTxB is 
restricted to the PM, labeling of the RE pool of GM1 enhances the accumulation of CTxB 
label in the PVM during the first hour following invasion. Furthermore, this preferential 
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labeling at the PVM by RE-derived membranes is observed in several different cell 
types.  Additionally, we provide evidence that other recycling endosomal markers 
localize at the PVM. Collectively, these results show for the first time that RE contribute 
to nascent PV of T. gondii.   
INTRODUCTION 
The success of intracellular pathogens is dependent on their capacity to interact 
with the host cell in such a way that minimizes or controls immune recognition and 
maximizes survival and proliferative capacity. Toxoplasma gondii, like most 
apicomplexan parasites, meets this requirement by residing within a parasitophorous 
vacuole (PV), a specialized organelle from which the parasite can gain nutrients from 
the host cell while generally evading host recognition and degradation [2]. The nascent 
PV is formed as the T. gondii tachyzoite invades the cell, through a highly coordinated 
mechanism involving the formation of a moving junction containing parasite-derived 
proteins that are secreted by two specialized organelles, micronemes and the roptries 
[3]. This moving junction anchors at the host plasma membrane (PM) [4], via an 
unknown receptor or recognition motif, and facilitates parasite entry in such way that 
most plasma membrane proteins are excluded from the PM that makes up the nascent 
PV [5].  The PV membrane (PVM) is largely devoid of integral plasma membrane 
proteins, but contains host-derived glycophosphatidylinositol (GPI)- linked proteins and 
gangliosides in addition to various lipid species [6].  
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As an obligate organism, T. gondii scavenges various materials essential to its 
survival. T.gondii is known to be auxotrophic for multiple metabolites, including the 
amino acids tryptophan [7] and arginine [8]. Additionally, It has been established that 
parasites acquire needed cholesterol by taking advantage of a host pathway that utilizes 
endocytosed low-density lipoprotein (LDL) to provide cholesterol [9]. Intracellular 
parasites have also been shown to form tight associations with both host mitochondria 
and endoplasmic reticulum (ER) [2], and it has been hypothesized that these 
associations provide access to the necessary lipids and membrane for maintenance of 
the PVM.   
An organelle known to be a large reservoir of lipids is the recycling endosomal 
complex (RE).  The RE is a mildy acidic, tubulovesicular membrane pool that is distinct 
from the traditional endo-lysosomal pathway that often has a peri-nuclear localization, 
although this is cell type-dependent.  This organelle acts as a junction where cargo and 
membrane from both sorting endosomes and the Golgi apparatus traffic before 
continuing to the cell surface or undergoing retrograde transport back to the Golgi 
complex [10]. Traditional markers of the RE include the plasma membrane constituents 
such as the transferrin receptor (TfR) [11, 12] and the ganglioside GM1 [1]. In recent 
years, a body of evidence has grown to suggest that the RE is a heterogenous pool with 
multiple trafficking routes under the regulatory control of various proteins including the 
small GTPases Rab 11 [13] and Arf 6 [14]and the SNARE proteins VAMP 3 [15].  
Interestingly, increased and directional trafficking of recycling endosomes is often seen 
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in membrane intensive cellular processes such as cytokinesis [16], migration [17, 18] 
and phagocyotis [15]. 
The establishment of the PV and its subsequent growth during parasite 
replication necessitate the acquisition of large amounts host derived membrane.  We 
sought to determine if the host RE contributes to the PVM during the early stages of PV 
development. RBL-2H3 mast cells are a useful model system for studying processes 
involving RE [1, 19]: they have a morphologically discrete peri-nuclear RE compartment 
and recycling rates that are useful for experimental observation and manipulation. 
Through live cell and fixed cell confocal microscopy, we found evidence that the RE 
does contributes significantly to the nascent PVM.   
MATERIALS AND METHODS 
Chemicals, Reagents and DNA Plasmids. 
Alexa488-cholera toxin B (A488-CTxB) was purchased from Invitrogen and FITC-
CTxB was purchased from Sigma/Aldrich.  Unless otherwise noted, all other chemicals 
were purchase from Sigma/Aldrich, and all tissue culture reagents were purchased from 
Invitrogen. Anti-DNP IgE was purified as described previously [20] and conjugated with 
Alexa488 succinimydl ester  (Invitrogen). 
The following DNA plasmids were used in the course of our study: Lyn-EGFP 
[21], PM-EGFP [22], PH-PLC"-EGFP [23], PH-Akt-EGFP [24], and TfR-pHlorin[25]. 
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Cells and Parasites 
RBL-2H3 Culture 
RBL-2H3 mast cells were grown in monolayer culture and harvested as 
previously described [26]. 
Rat Bone Marrow-Derived Mast Cells (rBMMCs) 
rBMMCs were isolated as previously described [27]. Briefly, bone marrow stem 
cells isolated from 6-10 wk Lewis rat femurs were washed in Hanks buffered saline and 
cultured in DMEM with horse serum (20%), gentamicin sulfate (50 µg/ml), penicillin (100 
U/ml), streptomycin (100 µg/ml) and L-glutamine (4 mM). Additionally media was 
supplemented with the growth factors IL-3# (10 U/ml) and GM-CSF (50 ng/ml).   The 
cell population becomes over 90% pure after 10-14 days in culture, as assayed by 
Alcian blue staining. All rBMMCS were used between days 14-28 of culture. 
Mouse Bone Marrow-Derived Macrophages (BMM!s) and Dendritic Cells (BMDCs) 
C57BL/6 mice were purchased from either The Jackson Laboratory (Bar Harbor, 
ME) or Taconic Farms (Germantown, NY) and used between 6-8 weeks of age. All mice 
were maintained in the Transgenic Mouse Core Facility at the Cornell University College 
of Veterinary Medicine, accredited by American Association of Accrediation of 
Laboratory Animal Care. BMM$s were isolated as described previously [28]. Briefly, 
bone marrow-isolated from femurs was cultured in macrophage media (DMEM 
containing fetal calf serum (10 %)(Hyclone), sodium pyruvate (1mM), nonessential 
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amino acids (0.1 mM), L929 cell supernatant (20%), pencillin (100 U/ml) and 
streptomycin (100 µg/ml)). Media was changed on day 3, and cells were used on day 5 
after nonadherent cells were removed.  BMDCs were isolated as described previously 
[29].  Briefly, bone marrow from femurs were cultured in dendritic cell media (RPMI 
containing fetal calf serum (10%), penicillin (100 U/ml), streptomycin (100 µl/ml) and 
GM-CSF (20 ng/ml).  Media was changed on days 3 and 6 post bone marrow collection, 
and BMDCs were used on day 9. 
Parasites 
 RH-tomato, which have been engineered to express the tomato fluorescent 
protein, (generated by Dr. B. Striepen (University of Georgia) and kindly provided by Dr. 
E. Robey (University of California, Berkeley)) and RH strain tachyziotes were used in 
this study. Tachyzoites were maintained in vitro via passage through human foreskin 
fibroblast cultures in DMEM with FCS (1%), penicillin (100 U/ml) and streptomycin (100 
µg/ml).  Prior to use, tachyzoites were passed through a 3 µm track-etched membrane 
filter (Whatman) to remove fibroblast debris. Infections in all cell types were 
synchronized by brief centrifugation (200xg for 4 minutes) at a multiplicity of infection of 
10:1 unless otherwise indicated.  
Transfections 
Cells were sparsely plated (1-3x105/ml) on no. 1.5 coverslips or in 35 mm glass 
bottom dishes (MatTek). After overnight incubation, media was replaced by OPTIMEM 
and DNA constructs of interest were transfected using 2 µg DNA and 8 µl Fugene HD 
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(Roche Diagnostics) per ml media for 1 hour before addition of 1 ng/ml phorbol 12,13-
dibutyrate for 3-5hr [30].  Samples were then washed into normal media and incubated 
16-24 hours to allow for protein expression. 
Confocal Fluorescence Microscopy 
For live imaging, RBL-2H3 cells were plated at 2-3x105 cells per 35 mm glass 
bottom dish (MatTek).  Following overnight culture, cells were washed into a buffered 
saline solution (BSS: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5.6 mM 
glucose, 20 mM HEPES, pH 7.4, 1 mg/ml BSA).  Cells were labeled with A488-CtxB as 
previously described [19]. RH-tomato tachyzoites were introduced as described above, 
and imaging was performed at 37°C on a SP5 confocal microscope (Leica).  
Fixed cell imaging samples were prepared as follows. For experiments labeling 
GM1, FITC-CTxB was added either 1.5-2 hrs prior to infection to label both plasma 
membrane and recycling endosomes or just prior to infection to label only the plasma 
membrane. Alexa-488 conjugated Anti-2,4-dinitrophenyl (DNP) IgE was used to label 
Fc!RI receptors on RBL-2H3 cells. Following tachyzoite infection (less than 1 hour), 
coverslips were washed with BBS and fixed with 4% paraformaldehyde plus 0.1% 
glutaraldehyde in phosphate buffered saline (PBS; 10 minutes at room temperature). 
Excess fixative was quenched by 10 mg/ml BSA in PBS with 0.01% azide. For immuno-
labeling, an anti-GRA7 antibody (gift from Dr. I. Coppens, John Hopkins University) was 
used followed by secondary labeling with Alexa-555 anti-rabbit IgG (Invitrogen). 
Coverslips were mounted on slides using Prolong Gold (Invitrogen) to minimize 
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photobleaching.  Fixed samples were imaged on an SP2 confocal microscope (Leica).  
When scoring the PVM for host membrane accumulation, a parasite was considered 
positive if membrane label accumulation was observed around at least half of the 
parasite. 
Live Cell Ca2+ Imaging 
 Single cells Ca2+ measurements in infected and control cells were conducted 
using Fluo-4 AM as described previously [31] on the Leica SP5 confocal system with an 
image acquisition rate of 1 Hz.  
Statistical Analyses 
 Analyses were conducted using Prism Software (GraphPad).  One-way ANOVA 
(Analysis of Variance) was performed followed by Tukeyʼs post-test to assess statistical 
significance. P values less than 0.05 were considered significant.  
RESULTS 
Toxoplasma gondii rapidly sheds host GM1 from the nascent parasitophorous vacuole in 
RBL-2H3 mast cells. 
Although T. gondii displays a preference for certain cell types such as 
macrophages and dendritic cells in vivo [32, 33], they are capable of infecting a large 
variety of cells in vitro, and these are often used to probe parasite-host cell interactions 
[34]. We assessed the ability of tachyzoites to invade RBL mast cells by live confocal 
microscopy. As expected, due to their relative promiscuity in a variety of host cells, T. 
gondii actively invades RBL cells, and as early as 10 minutes after introduction of RH-
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tomato tachyzoites to adherent cells by centrifugation, we readily see infection in large 
percentage of cells.  After one hour, infection rates typically exceed 60%. Consistent 
with other cell types, invasion is rapid, the entire process taking tens of seconds (see 
below). Furthermore, the invasion and infection are productive as parasite replication 
and cell lysis are seen if infection is monitored for 24 hours (Figure 5.1B).   
Residing within reside within the PV allows Toxoplasma to evade degradation by 
host cell lysosomes. The vacuolar membrane is largely devoid of plasma membrane 
proteins, and the formation of a parasite-mediated moving junction during invasion has 
been hypothesized to account for the controlled composition of the parasitophorous 
vacuolar membrane (PVM) [6, 35]. One host marker reported to populate the 
parasitophorous vacuole shortly after infection is the ganglioside GM1 labeled by the B 
subunit of Cholera toxin (CTxB) [6].  At steady state, CTxB label in RBL cells populates 
both the plasma membrane and RE. As shown in Figure 5.1A and Movie M5.1, we find 
that during invasion in RBL cells plasma membrane-derived GM1 is quickly lost from the 
parisitophorous vacuole shortly after parasite entry. This rapid disappearance of CTxB 
label suggests CTxB-labeled GM1 seen previously in PVMs is not simply retained from 
the plasma membrane that surrounds the parasite as it invades. 
Recycling endosomal membrane label surrounds intracellular tachyzoites. 
In RBL cells, GM1 populates both the plasma membrane and the peri-nuclear RE 
compartment [1, 19].  The RE serves as a reservoir of host membrane, and we 
hypothesized that membrane from this organelle might contribute to the forming 
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Figure 5.1. Upon invasion, T. gondii tachyzoites rapidly shed plasma membrane 
associated CTxB-GM1. RBL-2H3 mast cells with plasma membrane and recycling 
endosomes labeled with Alexa488-CTxB (green) were incubated with RH-tomato (red) 
tachyzoites (MOI 10:1). (A) Live cell confocal microscopy of two cells during tachyzoite 
invasion. White arrows indicated invading parasite (Movie M5.1). (B) Parasite replication 
can be seen 24 hours post-infection.  
10 20 30 40 6050
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parasitophorous vacuole at early times following infection.  To test this hypothesis we 
took advantage our ability to differentially label the plasma membrane RE pool with 
CTxB in RBL cells. If cells are labeled for short times (less than 30 minutes at 37°C), the 
label stays primarily at the plasma membrane, although some trafficking to the RE can 
occur over that time. Under this labeling condition during infection CTxB-GM1 is largely 
absent from the membrane surrounding the tachyzoite (Figure 5.2A, movie M5.2). 
Longer incubations at 37°C substantially increases trafficking of GM1 to the recycling 
endosomal pool, such that both the plasma membrane and recycling endosomes are 
labeled with CTxB [1]. Under these conditions, robust labeling of PVM is observed 
(Figure 5.2B, movie M5.3).  In other cell types, trans-membrane plasma membrane 
proteins such as CD44 are commonly excluded from the PVM [6].  In mast cells, Fc!RI 
is the high affinity receptor for IgE that is a multi-subunit, transmembrane protein in the 
plasma membrane. We find that Fc!RI labeled by Alexa488-IgE is excluded from the 
PVM (Figure 5.2C).  
To quantify these observations, we scored internalized parasites in more than 80 
cells for each condition to determine the percentage of parasites that have association 
with host membrane label under the conditions described above. As shown in Figure  
5.2D, we find that cells with CTxB of recycling endosomes exhibit more than 60% of 
PVMs labeled, whereas cells with primarily plasma membrane label at the time of 
infection exhibit less than half this percentage of labeled PVMs.  In comparison, 
IgE/Fc!RI label is detected in less than 5% of the PVMs. 
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 Figure 5.2. Recycling endosomal CTxB-GM1 efficiently labels PV of T. gondii. 
Representative confocal Z-sections of RBL mast cells infected with RH-tomato 
tachyzoites (red) for % 1hour. (A) Plasma membrane labeling with FITC-CTxB (green), 
(B) plasma membrane (PM) and recycling endosomal (RE) with FITC-CTxB (green) and 
(C) Fc!RI labeling by Alexa488-IgE (green). (Movies M5.2-3)(D) Percentage positive 
vacuoles for conditions (A-C) (n=83,165,109 for conditions (A), (B) and (C), 
respectively). Error bars represent SEM. 
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Recycling endosomal GM1 co-localizes with parasite derived GRA7 in the nascent PVM. 
The appearance of CTxB-GM1 around intracellular tachyzoites does not exclude 
the possibility that the host membrane is simply accumulating, not actually an integral 
part of the PV.  To address this issue, we compared the distribution of a parasite-
derived PV resident protein, GRA7 [36] with CTxB label. Samples were fixed after 20 
minutes of infection and parasite GRA7 was immuno-fluorescently labeled following 
permeabilization. As shown in Figure 5.3A, GRA7 and CTxB show a high degree of co-
localization at the PV when both the RE and PM are labeled by CTxB.  As expected, 
when only the plasma membrane is CTxB-labeled there is very little CTxB label at the 
PV as delineated by GRA7 labeling (Figure 5.3B).  This result shows that the CTxB-
GM1, derived from recycling endosomes, labels host-derived membrane in the PVM. 
Markers from RE derived membranes also appear in PV in primary cell types.  
We further investigated whether PV labeling by CTxB-GM1 is a general feature of 
infected cells or particular to RBL mast cells. Using primary mast cells derived from rat 
bone marrow (rBMMCs), similar differential labeling of RE and PM with CTxB is 
observed.  As in the RBL-2H3 cells, primarily plasma membrane labeling with CTxB-
GM1 results in little label in the PVM (Figure 5.4A). In contrast, when RE and PM are 
labeled by CTxB, CTxB label is apparent at the PVM (Figure 5.4B). 
While mast cells are a good model for characterizing recycling endosomal 
trafficking, they are not a cell type that is frequently infected in vivo.  Both dendritic cells 
and macrophages are known to be targets of T. gondii in vivo. We sought to determine if 
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Figure 5.3. Parasite-derived GRA7 and host RE GM1 colocalize to the PV within 20 
minutes of invasion. Z-sections from confocal microscopy of RBL mast cells incubated 
with RH-tomato parasites for 20 minutes. (A) FITC-CTxB (green) labels both recycling 
endosomes and plasma membrane anti-GRA7 followed by Alexa555 secondary 
antibody (red) marks the parasitophorous vacuole of the tachyzoite. (B) FITC-CTxB 
primarily labels plasma membrane. Images are representative of two experiments. 
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Figure 5.4. Recycling endosomes contribute to the parasitophorous vacuole in bone 
marrow-derived mast cells, dendritic cells and macrophages. Equatorial sections from 
confocal microscopy of fixed, RH-tomato (red) infected (% one hour) cells from various 
immune lineages.  (A,B) Rat bone marrow-derived mast cells (BMMCs).  (C,D) Mouse 
bone marrow-derived dendritic cells (BMDCs). (E) Mouse bone marrow-derived 
macrophages (BMM$). The left pairs of images represent conditions with minimal RE-
derived CTxB (A,C) and the right pairs are conditions where both the RE and PM are 
labeled with CTxB (B,D,E)  Images representative of 2-3 experiments. 
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the results seen in mast cells are also apparent in mouse bone marrow dendritic cells 
(BMDCs) and macrophages (BMM$s). Initial experiments showed that BMDCs have 
similar CTxB-GM1 internalization kinetics to mast cells, allowing us to employ the same 
CTxB-GM1 labeling scheme described above.  As with mast cells, if only the plasma 
membrane is labeled, CTxB labeling is largely absent from the PVM (Figure 5.4C).  RE 
morphology in BMDCs is somewhat more disperse than in mast cells, but it still has a 
perinuclear concentration.  In cells where both PM and RE contain CTxB-GM1, some 
CTxB label appears at the parasite perimeter (Figure 5.4D). 
BMM$s have markedly different intracellular subcellular distributions CTxB-GM1.  
Moreover, BMM$s CTxB-GM1 internalization is quite rapid.  Within ten minutes of CTxB 
addition, significant internal CTxB-GM1 label is located through out the cytoplasm in 
addition to uniform plasma membrane label.  Due to this difference, the labeling scheme 
that we used for mast cells and BMDCs does not allow us to differentially compare 
plasma membrane versus recycling endosomal contribution to the PVM in BMM$s.  We 
reasoned that as recycling rates are some much faster in the BMM$s we could add 
CTxB to pre-infected cells and ask if this CTxB appears at the PVM at later time points. 
Positive label around the parasite would indicate that there is trafficking of CTxB-GM1 
containing membrane to the PVM.  Using this strategy we observe CTxB-GM1 in the 
PVM around some parasites (Figure 5.4E).  We do not see this labeling around all 
parasites, suggesting that GM1 localization in the PVM is somewhat transient, perhaps 
indicating the parasite has some active mechanism for sorting some membrane 
components out of the host membrane it co-opts for the PVM.  Collectively, these 
157
results suggest that RE contribution to the PVM is not a unique feature of infection in 
RBL-2H3 mast cells but rather is a general phenomenon that occurs in multiple infected 
cell types.  
Inner leaflet plasma membrane markers are excluded from the PVM. 
Our results with Fc!RI/IgE (Figure 5.2) and previous results [6] showed that host-
derived transmembrane proteins at the plasma membrane are excluded from the 
nascent PV. To investigate whether inner leaflet-associated lipids or lipid-anchored 
proteins from the plasma membrane are localized to the PVM, we employed transient 
transfection of RBL-2H3 cells with two closely related, fluorescently labeled constructs, 
Lyn–EGFP and PM-EGFP. Lyn kinase associates with the inner leaflet of the plasma 
membrane through two N-terminal lipid modifications, a palmytolation and a 
myristolation. The PM-EGFP construct is the short protein sequence of Lyn that 
contains these two lipid modifications.  Both constructs show good plasma membrane 
localization, but there is no accumulation of either marker around intracellular parasites 
(Figure 5.5A,B).  
Phosphoinositide (PI) lipid species contribute to important signaling pathways as 
second messengers and help to designate organellar membrane identity.  PH domains 
from different proteins have varying specificities for PI species.  The PH domains from 
PLC" and Akt have high specificity for PIP2 and PIP3, respectively. We used GPF 
constructs of these two PH domains to determine if the PV contains PIP2 or PIP3. 
Neither construct showed significant accumulation at the PV (Figure 5.5C,D). 
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Figure 5.5. RE markers localize to PV while markers of plasma membrane inner 
leaflet and phosphoinositides are excluded. (A-F) Representative confocal Z-sections of 
transiently transfected and fixed RBL-2H3 mast cells infected for % one hour with RH-
tomato tachyzoites. (A, B) Lyn-EGFP and PM-EGFP are inner leaflet plasma membrane 
markers. (C, D) PHPLC"-GFP and PHAkt-GFP bind to PIP2 and PIP3, respectively. (E, F) 
TfR-pHlorin and YFP-GPI are two markers known to associate with recycling 
endosomes. Arrowheads indicate lack of PV label and arrows highlight PV label by host 
RE markers. All images are representative of two or more experiments. 
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In stark contrast to our results with inner leaflet plasma membrane and PH-
domain affinity PI markers, known RE markers do localize to the PVM.  Transferrin 
receptor (TfR) has long been known to concentrate in RE [12].  Figure 5.5E 
demonstrates that we can occasionally see TfR at that PVM.  Our laboratory has 
recently determined that GPI-anchored proteins populate the RE (Wilson and Holowka, 
unpublished results), and these RE traffic in response to antigen much like CTxB/GM1. 
The same glycosylphosphoinositol (GPI) anchored construct also shows remarkable 
localization with the PV (Figure 5.5F). This is consistent with observations by Mordue et 
al. [6], although they conclude that GPI-anchored proteins are from the plasma 
membrane.  Accumulated data in our lab would suggest they, in fact, come from the RE. 
Collectively, our imaging studies show a strong correlation between recycling 
endosomal localization and appearance in the PVM (summarized in Table 5.1). 
T. gondii invasion induces a Ca2+ wave. 
 In RBL cells, stimulated RE trafficking is a Ca2+ dependent process.  One 
possible mechanism for Toxoplasma-stimulated RE trafficking to the PV is an invasion-
induced Ca2+ response to parasite. To investigate this possibility, we monitored fluo-4 
fluorescence as a measure of Ca2+ levels in RBL cells incubated with RH-tomato 
parasites. Figure 5.6 shows selected frames of a movie (M5.4) in which parasite entry 
results in the initiation of a global Ca2+ wave. In each of the two cases shown, the Ca2+ 
wave propagates from the site of parasite entry (white arrows) across the cell. We 
suggest that this host response might initiate RE trafficking to the PVM, and that this 
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Table 5.1 
  
Marker 
Relative PV 
association* 
Recycling 
Endosome 
  
 Cholera toxin B- GM1 (PM + RE) +++ 
 Transferrin Receptor-pHlorin + 
 YFP-GPI +++ 
Plasma Membrane    
outer leaflet Cholera toxin B- GM1 (PM) + 
 IgE-Fc!RI - 
inner leaflet Lyn-EGFP - 
 PM-EGFP - 
Phosphoinositides   
 PIP2 (PHPLC"-GFP) - 
 PIP3 (PHAkt-GFP) - 
*Scoring: +++(> 50% association), + (30-50% association), - (< 10% association) 
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Figure 5.6.  Parasite invasion triggers global Ca2+ wave. (A) Live confocal microscopy 
of fluo-4 loaded RBL-2H3 mast cells incubated with RH-tomato parasites (see movie 
M5.4). Arrows highlight time-dependent, transient fluorescence increase indicative of 
Ca2+ wave. Top and bottom panels show two individual cells and are representative 
examples from two experiments. 
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Ca2+ wave may also be responsible for a previously unidentified host Ca2+ response that 
is required for T. gondii-mediated MAPK signaling [37]. 
DISCUSSION 
The moving junction that is formed at the site of T. gondii entry appears to 
selectively sort PM components from the membrane that initially forms the PV [6]. The 
PV is considered to be a non-fusogenic entity that avoids interactions with the endo-
lysosomal system [2, 38]. The membrane systems of living cells are highly dynamic 
structures, and it has been estimated that the lipid population of the plasma membrane 
turns over hourly [39].  With that level of ongoing trafficking, it is difficult to envision how 
the PVM could maintain complete segregation from various membrane pools. 
Furthermore, it is clear that the PV must expand to accommodate the replicating 
parasites. To accommodate this requirement, the parasite may utilize membrane or lipid 
trafficking within the host cell.  High-resolution electron microscopy has revealed that 
the PV is closely associated with host ER and mitochondria, and it has been 
hypothesized that these organelles may serve as a lipid sources for the PVM [2].  
Most PM transmembrane proteins are excluded from the nascent PV, whereas 
host lipids, including gangliosides such as GM1 as well as GPI-linked proteins, are 
readily found in PVM of intracellular parasites [6]. The assumption has been that these 
components are taken from the PM upon invasion. Our live microscopy experiments, in 
which we observe rapid loss of PM-derived CTxB/GM1 label, suggest that the situation 
is not that simple.  However, the RE compartment is also enriched in GM1 and GPI-
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linked proteins [1], (unpublished results).   Our investigation of T. gondii invasion in RBL 
mast cells demonstrates, for the first time, that RE are contributors to the nascent PV.  
 Previously, Mordue et al. [38] dismissed the possibility of RE involvement in PV 
formation based on the absence of TfR labeling at the PV. While it is true that TfR is 
commonly used marker for RE, it is not a definitive test of RE contribution [40]. We 
argue that RBL cells are well-suited to the study of RE trafficking process for two 
reasons: (1) the concentrated perinuclear spatial localization of RE label and (2) the RE 
an PM compartments can be differentially labeled [1].  Using this system, we 
demonstrate that label of CTxB/GM1 from the RE pool significantly contributes to 
membrane surrounding intracellular parasites. This system has the limitation that 
differential PM/RE labeling can only be achieved for rather short times at physiological 
temperature (< 30 minutes). Therefore alternative methods to maximize the difference 
between the labeled pools either with by stripping surface FITC-CTxB or replacing with 
unlabeled CTxB [19] may be useful in future studies. Alternatively, quenching surface 
FITC fluorescence with trypan blue [41] could aid in distinguishing between PM and RE 
contributions to the PVM. Despite the limitations of our differential labeling method our 
results clearly show that CTxB/GM1 label is co-incident with parasite-derived GRA7 in 
the PVM only under conditions where RE are labeled. Consistent with previous studies 
[6], we also see strong localization of a GPI-anchored protein to the PV.  We have 
substantial evidence that GPI-anchored proteins traffic via RE (Wilson and Holowka, 
unpublished results), so we posit that these components seen in the PVM are derived 
most directly from RE, rather than the PM.   
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To date, this is the first evidence that an intracellular host organelle contributes to 
the PVM. However, in a recent study, host-derived lipids were found to be the major 
source of lipids populating the intravacuolar network [42], an extensive network of 
tubules and vesicles that fills the luminal space of the PV [43, 44]. The authors 
hypothesize that these lipids may come from the host ER, but it is possible that other 
host membranes, such as the RE, contribute to these structures.  
 In attempting to better characterize the composition of the nascent PV, we also 
examined inner leaflet components. To our surprise, both lipid anchored proteins (Lyn-
EGFP and PM-EGFP) and phosphoinositide lipid species (PIP2 and PIP3) also appear to 
be absent from the PVM.  There is no precedent for this finding, and both the 
mechanism and the reason for such segregation are unclear at this time. 
How RE might be triggered to traffic to PVM is still a mystery.  Previously, we 
demonstrated that stimulated RE exocytosis is a Ca2+-dependent process [1, 19]. Here 
we show that invasion can induce a single Ca2+ wave in host cells. It is tempting to 
speculate that this signal might, through unknown mechanisms, direct RE to the PVM.  
Previous studies have demonstrated that stimulated RE traffic is a robust process, 
refractory to many methods of inhibition [1]. Furthermore, the importance of this 
trafficking mechanism in T. gondii infection is still an unknown quantity.  The most 
straightforward way to address this issue is to determine if modulation of RE trafficking 
effects the progression of Toxoplasma infection. RE trafficking is regulated by several 
GTPases including Rab11 and Arf6 [13, 14], and over expression of dominant negative, 
wild-type or constitutively active constructs are used to manipulate the efficiency of RE 
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trafficking. Alternatively, a chemically derived mutant version of RBL mast cells, 
B6A4C1 has multiple defects including a defect in lipid biosynthesis that results in a lack 
of ganglioside production [45]. This cell line does not bind CTxB and has a reduction in 
antigen stimulated RE trafficking (J. Wilson, unpublished results). Another option is the 
pharmacological inhibition of RE trafficking with phospholipase A2 antagonists [46]. 
Asking any of these conditions effects parasite replication is one method to determine 
the importance of RE contribution to the PVM. That T. gondii can hijack the normal 
recycling might provide new insights concerning how RE trafficking is regulated; such 
findings would have important implications, not only for Toxoplasma infection but also 
for the basic understanding the regulation of host RE trafficking.  
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CHAPTER SIX 
Toxoplasma gondii Inhibits Mast Cell Degranulation by Inhibiting  
PLC!1-mediated Ca2+ Mobilization 
SUMMARY 
T. gondii infects a wide variety of cell types, including many of the hematopoietic 
lineage. To better understand its capacity to subvert normal immune responses, we 
investigated the effects of Toxoplasma on specific pathways that are mobilized during 
IgE/Fc"RI signaling that leads to granule exocytosis in mast cells. In the current study 
we used the well-studied RBL mast cell model to probe the capacity of T. gondii to 
modulate immune signaling within the first hour of infection.  We find that T. gondii 
inhibits antigen-stimulated degranulation in infected cells in a strain-independent 
manner.  Under these conditions, we find that, whereas antigen-triggered Fc"RI tyrosine 
phosphorylation is unchanged by parasite infection, stimulated cytoplasmic Ca2+ 
mobilization is reduced.  In particular, antigen-mediated Ca2+ release from stores is 
reduced in infected cells. Furthermore, stimulation-dependent PLC!1 tyrosine 
phosphorylation is also inhibited by infection. Therefore, we postulate that the inhibitory 
effects are likely due to parasite-mediated inhibition of PLC! activation resulting in 
reduced cleaveage of PIP2. Interestingly, inhibition of IgE/Fc"RI signaling is retained 
when tachyzoite invasion is arrested via cytochalasin D treatment, suggesting inhibition 
of PLC! may be mediated by a parasite-derived factor that is secreted during the 
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invasion process.  Our study provides direct evidence, for the first time, that initiation of 
immune subversion by T. gondii occurs concurrently with invasion.  
INTRODUCTION 
 The apicomplexan Toxoplasma gondii has evolved to be an extremely successful 
obligate intracellular parasite. It uses a multitude of mammalian and avian species as 
intermediate hosts. The Center for Disease Control and Prevention estimates 22.5% of 
U.S. population is latently infected with T. gondii. In most hosts, infection is 
asymptomatic and continues throughout their lifetimes.  Nevertheless, under certain 
conditions, such as immuno-compromised individuals, acute Toxoplasmosis poses 
serious health risks [1].  
  T. gondii invades host cells through a process of active invasion that is markedly 
different from phagocytosis, and through this process is able to avoid fusion with the 
phagolysosomal system [2]. One of the reasons for the success of Toxoplasma as an 
intracellular pathogen is its development of immuno-modulatory mechanisms to evade 
and control the host response to infection [3, 4]. In vivo infection results in a strong 
protective immune response that is necessary for the host and, as a result, for parasite 
survival [5].  At the same time, it is established that infection actively suppresses 
production of many proinflammatory cytokines [4]. Virulence factors such as ROP 16 
and ROP 18 are secreted from parasite rhoptries and may act to directly modulate host 
cell signaling [6, 7]. Despite this breadth of knowledge, much remains unknown. For 
example, it has been unclear how rapidly Toxoplasma effects immuno-modulation, and 
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the molecular mechanisms that mediate this immuno-modulation are largely unknown. 
Studies of T. gondii invasion in the context of an immune model where signaling is 
completed rapidly, on the order of tens of minutes, could provide key insights into 
mechanisms of Toxoplasma immune subversion. 
 Mast cells are of hematopoietic lineage, express the high affinity receptor for IgE, 
Fc"RI, and are primary mediators of the allergic response [8]. They are also appreciated 
as key players in innate immunity and defense against helminths [9]. Multivalent antigen 
crosslinking of IgE-Fc"RI complexes on the cell surface is the first step in the cascade of 
signaling events that results in the exocytosis of preformed mediators, such as 
histamine and serine proteases with a time course of minutes [8].  Fc"RI belongs to the 
family of multichain immune recognition receptors (MIRRs) that also include B-cell and 
T-cell receptors [10]. Signal transduction through Fc"RI has been extensively studied 
and involves PLC! activation leading to calcium mobilization and PKC activation that are 
both necessary for stimulated granule exocytosis. These common signaling pathways 
are also shared by other immunoreceptors [11].  
 In the present study we use RBL mast cells to investigate the capacity of 
Toxoplasma to rapidly modulate immune signaling. We find that within an hour of the 
initiation of infection, parasites significantly inhibit antigen-mediated degranulation. 
Furthermore, whereas stimulated Ca2+ mobilization initiated by IP3 production is 
inhibited, stimulated Fc"RI receptor phosphorylation remains uninhibited.  Additional 
experiments reveal that PLC!1 activation is inhibited by Toxoplasma infection, and this 
inhibition prevails in the presence of cytochalasin D to prevent parasite invasion.  
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Collectively, these results support a model in which T. gondii inhibits Fc"RI receptor 
signaling by an unidentified product, likely secreted as invasion occurs, which acts by 
blocking the functional activation of PLC!1 that normally results in hydrolysis of 
phosphatidylinositol 4,5-bisphphosphate (PIP2) to produce the second messengers IP3 
and DAG.  
MATERIALS AND METHODS 
Chemicals and Reagents 
 Indo-1-AM and Fluo-4-AM were purchased from Invitrogen Corp. 4-
methylumbelliferyl-N-acetyl-#-D-glucosaminide, cytochalasin D, FITC-dextran, and 
thapsigargin were purchase from Sigma-Aldrich. Unless otherwise noted all other tissue 
culture reagents were purchased from Invitrogen and all other chemicals were 
purchased from Sigma-Aldrich. Anti-DNP IgE was purified as described previously [12].  
Cells and Parasites 
RBL-2H3  Mast  Cells 
 RBL-2H3 mast cells were maintained in monolayer culture through weekly 
passage as described previously [13]. For stimulation, cells were sensitized with 1 µg/ml 
anti-DNP IgE for 4-24 hours 
Parasites 
RH, PTG, CTG, Veg and RH-tomato strains of parasites were used in this study.  
The RH-tomato strain of parasite, stably expressing tomato fluorescent protein, was 
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generated by Dr. B. Striepen (University of Georgia; kindly provided by Dr. E. Robey 
(University of California, Berkeley)). All tachyzoites were maintained in vitro via passage 
through human foreskin fibroblast cultures in DMEM with FCS (1%), penicillin (100 
U/ml) and streptomycin (100 µg/ml) (Fibroblast media).  For experiments, tachyzoites 
were harvested and passed through a 3 µm track-etched membrane filter (Whatman) to 
remove fibroblast debris. Infections were performed at a multiplicity of infection (MOI) of 
10:1 unless otherwise indicated and were synchronized by brief centrifugation (200xg 
for 4 minutes). 
Degranulation 
!-Hexosaminidase Release 
Cells were sensitized and plated in triplicate at a density of 5x105/well and 
incubated overnight.  The next day, cells were washed with fibroblast media and 
parasites were introduced as described above.  For some experiments, 1 µM 
cytochalasin D was added during infection to prevent invasion.  Following infection, cells 
were washed three times with buffered saline solution (BSS:135 mM NaCl, 5 mM KCl, 1 
mM MgCl2, 1.8 mM CaCl2, 5.6 mM glucose, 20 mM HEPES, pH 7.4, 1 mg/ml BSA) and 
#-hexosaminidase was assessed as described previously [14]. 
Live Cell Degranulation Imaging 
Sensitized cells were plated overnight in 35 mm glass bottom dishes (MatTek) in 
the presence of FITC-dextran (1 mg/ml) and 5-HT serotonin (0.2 mM).  The next day, 
cells were washed with fibroblast media and infected with RH-tomato tachyzoites as 
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described above.  Following one hour of infection, cells were washed three times with 
BSS.  Imaging was conducted at 37°C on a SP5 confocal microscope (Leica) at an 
image acquisition rate of 1.7 Hz.  Cells were monitored for 1 minute prior to addition of 
antigen (10 ng/ml), then monitored for an additional 9 minutes.   
Western Blotting 
Sensitized, adherent cells were infected as described above.  Following infection, 
cells were stimulated for 0 to 10 minutes and whole cell western blotting samples were 
prepared and blotted as described previously [15].  Samples were run on Tris-glycine 
gels under non-reducing conditions.  For assessment of receptor phosphorylation, anti-
phosphotyrosine (clone 4G10) (Millipore) was used and the # subunit was identified 
based on molecular weight.  To assess sample loading, a stimulation insensitive 
phosphotyrosine band from the original blot, or $-tubulin reprobing with anti-tubulin 
(clone N.593, U.S. Biologicals) was used.  To determine relative intensity, first a ratio of 
band intensity for # to loading control was taken. Samples were then compared to the 
control sample at 10 minutes post-stimulation. PLC!1 and PLC!1-Y783 were probed with 
antibodies from Santa Cruz Biotechnology and Cell Signaling Technology, respectively.  
Intracellular Ca2+ Measurements 
Fluorimetry 
Measurement of intracellular Ca2+ mobilization in response to 10 ng/ml DNP-BSA 
or 200 nM thapsigargin was carried out in tachyzoite infected cells using indo-1 as a 
Ca2+ indicator dye as described previously [16].  Time-integrated responses were 
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determined as the area under the stimulated timecourse minus the baseline over 400 
sec, normalized to the maximal response in Triton X-100 lysed cells [17]. 
Live Cell Ca2+ Imaging 
 Single cells Ca2+ measurements in infected and control cells were conducted 
using Fluo-4 AM as described previously [18] on the Leica SP5 confocal system with an 
image acquisition rate of 0.5 Hz.  
 Analysis of Ca2+ oscillations in individual cells was performed using Matlab 
software (Mathworks).  Briefly, code was written to track the location and average 
fluorescence intensity of the green channel (Fluor-4) within a circular region of interest 
(ROI) in the cytoplasm of each cell. These measurements were plotted with respect to 
time, and the number of oscillations for each ROI, reflected by increases in fluorescence 
intensity, was enumerated.  
Measurements of Polyphosphoinositide (PIP2 and PIP3) Localization  
Cells were sparsely plated (1-3x105/ml) on no. 1.5 coverslips or in 35 mm glass 
bottom dishes (MatTek). After overnight culture, cells were transfected with either PH-
PLC%-EGFP [19] and PH-Akt-EGFP [20] using 2 µg DNA and 8 µl Fugene HD (Roche 
Diagnostics) in 1 ml OptiMEM for 1 hour before addition of 1 ng/ml phorbol 12,13-
dibutyrate for 3-5hr [21].  Samples were then washed into full media and cultured for 16-
24 hours to allow for protein expression. 
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Transfected cells were infected for 1-2 hours with RH-tomato parasites followed 
by fixation with 4% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffered 
saline (PBS; 10 minutes at room temperature). Excess fixative was quenched by 10 
mg/ml BSA in PBS with 0.01% azide. Fixed cells were imaged on a SP2 confocal 
system (Leica). Line scan analysis of equatorial cross sections using ImageJ (NIH) was 
performed using average fluorescence values to determine the ratio of PH domain 
plasma membrane to cytoplasmic concentrations [16]. 
Statistical Analyses 
 Statistical analysis was performed with Prism software (Graphpad). All bar 
graphs display mean ± SEM unless otherwise noted.   Statistical significance was 
determined by 1-way ANOVA (Analysis of Variance) followed by Tukeyʼs post test.  
Level of significance is denoted as follows: * P<0.05, ** P<0.01, *** P<0.001 and **** 
P<0.0001. 
RESULTS 
Toxoplasma gondii infection rapidly inhibits antigen-mediated mast cell degranulation. 
 T. gondii is well know to actively modulate normal signaling in the immune cells it 
infects. However, most studies have focused on the immuno-modulatory effects that 
occur on longer timescales.  We sought to determine if T. gondii acutely affects signal 
transduction at very early time points following infection.  Mast cell signaling through the 
IgE receptor Fc"RI is a well-studied immune signaling pathway that occurs on the time 
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scale of minutes. The end result of this signaling is granule fusion and release of 
histamine, serine proteases and proteoglycans in a process termed degranulation [22].   
 We infected RBL-2H3 mast cells with type I (RH), II (PTG) or type III (CTG or 
Veg) tachyzoites for one hour and assessed the capacity of the infected cells to 
degranulate in response to multivalent antigen. Under theses conditions, infection rates 
are between 50-70%. We find in a bulk assay that acute T. gondii infection reduces 
degranulation by approximately 50%, irrespective of the genotype of parasite used 
(Figure 6.1A). This inhibition directly correlates with multiplicity of infection (MOI), 
suggesting that inhibition is dependent on infection (Figure 6.1B). Furthermore, we used 
RH-tomato parasites in live imaging experiments to assess degranulation by FITC-
dextran release (Figure 6.1C, movie M6.1). FITC-dextran is loaded in to the granules, 
and remains quenched until the acidic contents of the lysosome are neutralized upon 
fusion. It is apparent from these experiments that infected cells do not respond 
efficiently and show more delayed exocytosis. Neighboring uninfected cells respond 
robustly to antigen as seen by release of FITC-dextran from granules (black arrows) and 
apparent flattening and ruffling (Movie M6.1).  Taken together, these results indicate 
that T. gondii inhibits mast cell degranulation, and this inhibition correlates with infection 
and is not merely a bystander effect. 
Fc"RI receptor phosphorylation is not altered by T. gondii infection. 
 Following the crosslinking of IgE-receptor complexes by multivalent antigen, 
phosphorylation of tyrosine residues within ITAMs in the cytoplasmic segments of the # 
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Figure 6.1. Acute T. gondii infection inhibits antigen-mediated mast cell degranulation. 
(A) RBL mast cells infected were with type I (RH, red), type II (PTG, blue) or type III 
(CTG or Veg, green) tachyzoites for 1 hr at an MOI of 10:1 (resulting in 50-70% 
infection), and antigen-stimulated (1ng/ml) degranulation assessed by #-
hexosaminindase release. Results summarize an average of 5 to 7 experiments, and 
error bars represent SEM (*, P<0.05; ***, P<0.001 compared to control uninfected cells). 
(B) Inhibition of degranulation increases with increasing MOI. (C) Live fluorescent 
confocal microscopy of degranulation events monitored by FITC-dextran bursts (green) 
in RBL cells infected with RH-tomato tachyzoites (red) and uninfected RBL cells in the 
same field. White arrows (0 s frame) indicate infected cells. Black arrows highlight 
degranulation events in uninfected cells (see supplemental movie M6.1). 
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and ! subunits of Fc"RI is the initial step in signaling that leads to degranulation. To 
determine the mechanism by which T. gondii inhibits mast cell degranulation, we first 
asked if receptor phosphorylation in response to antigen is normal in infected cells. In 
contrast to the significant inhibition of degranulation responses, Fc"RI-# phosphorylation 
following stimulation, assayed by anti-phosphotyrosine western blotting, is largely 
unchanged by Toxoplasma infection (Figure 6.2A).  For confirmation, we quantified the 
relative level of # subunit phosphorylation and detected no significant change in the 
parasite-infected samples, regardless of parasite type (Figure 6.2B). Given this result, 
we conclude that parasite inhibition is acting downstream of receptor phosphorylation in 
the degranulation signaling cascade. 
Ca2+ mobilization in response to antigen is reduced in Toxoplasma-infected RBL-2H3 
mast cells. 
 Ca2+ release from ER stores, followed by store operated Ca2+ entry (SOCE) are 
important downstream process in the sequellae that lead to degranulation in mast cells 
[23]. Measurement of intracellular Ca2+ in suspended RBL cells reveals that infection by 
T. gondii significantly reduces the Ca2+ response to antigen (Figure 6.3A). Integration of 
Ca2+ responses over 10 minutes shows on average a 39% reduction in Ca2+ mobilizaton 
(Figure 6.3B). While all three types of parasites significantly inihibit Ca2+ influx, it is 
interesting to note that the type II strain, PTG, is the most consistent and dramatic in its 
inhbition, reducing the net Ca2+ response by half.  In these bulk population 
measurements, it is difficult to evaluate what percentage of infected cells is inhibited. To 
better address this question, we conducted live cell imaging experiments to evalulate 
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 Figure 6.2. Fc"RI receptor tyrosine phosphorylation is not altered in T. gondii infected 
cells. IgE-sensitized RBL cells were infected for 1 hr with RH, PTG or CTG tachyzoites 
as indicated.  Antigen-stimulated cells were lysed at 0, 2 or 10 minutes after addition of 
DNP-BSA (10 ng/ml). (A) Representative blot. Top panel shows phosphorylation of # 
subunit of the Fc"RI receptor. Bottom panel shows loading control ($-tubulin) (B) 
Quantification of # subunit band intensity (see material and methods for details). Error 
bars represent SEM of 2-4 independent experiments. 
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Figure 6.3. T. gondii infection reduces antigen-mediated calcium responses in RBL 
mast cells. (A) Representative Indo-1 fluorescence measurements of Ca2+ responses to 
10 ng/ml antigen in control uninfected (black), RH-infected (red), PTG-infected (blue) or 
CTG-infected (green) infected cells (MOI 10:1). (B) Integrated calcium responses over 
300 seconds of stimulation as a percentage of control Ca2+ response. Histogram shows 
averages for 3-5 independent experiments. (C) Live Fluo-4 (green) Ca2+ imaging in 
uninfected or RH-tomato (red) infected RBL-cells. (see supplemental movies M6.2 and 
M6.3). Quantification of the percentage of responding cells (D) or average number of 
calcium oscillations per cell in 10 minutes (E) in these live calcium imaging experiments 
(n=174 cells over 3 experiments).  Error bars represent SEM (* is P<0.05, *** is 
P<0.001, and **** is P<0.0001 relative to uninfected cells). 
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Ca2+ responses in individual cells. Figure 6.3C, top panel, and movie M6.2 show that 
control uninfected cells show robust Ca2+ signaling in response to antigen, with 94% of 
the cells responding with an average of 12 oscillations during a 10-minute period.  In 
contrast, as shown in Fig. 6.3C, bottom, and movie M6.3, the RH-tomato infected cells 
are much less responsive, such that only 58% of cells with one or more parasites inside 
respond, typically with a slower onset, and with an average of 6 oscillations over the 
same time period. These parameters are compared in Figures 6.3D and E. 
 It is known that intracellular parasites interact extensively with the ER [24], and 
one possibility is that these interactions somehow block the exit of Ca2+ from the ER 
during antigen-stimulated, IP3-dependent depletion of ER Ca2+. Receptor-mediated, IP3-
dependent release of Ca2+ from ER stores can be bypassed by treating cells with 
thapsigargin, a SERCA pump inhibitor, resulting in passive leakage of Ca2+ from the ER 
that activates SOCE. Under this treatment, cells infected with any type of parasite have 
comparable Ca2+ responses to uninfected cells (Figure 6.4 A,B), showing that T. gondii 
is not directly blocking SOCE.  Collectively, these results indicate that a common factor, 
shared by the three genotypes of parasite, inhibits granule exocytosis via a mechanism 
that inhibits Ca2+ mobilization upstream of SOCE.  
T. gondii does not markedly change the abundance of phosphoinositides at the plasma 
membrane of infected cells. 
 Antigen stimulation of Fc"RI activates phospholipase C!  (PLC!), resulting in 
cleavage of phosphatidylinositol 4,5-bisphphosphate (PIP2) to diacylglycerol (DAG) and 
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Figure 6.4. Infection does not affect calcium responses to ER store release by 
thapsigargin. (A) Representative Indo-1 fluorescence measurements of calcium 
responses to 200 nM thapsigargin in control (black), RH (red), PTG (blue) or 
CTG (green) infected cells (MOI 10:1). (B) Integrated calcium responses over 
300 seconds of stimulation as a percentage of control calcium response. Bars 
represent average of 3-5 independent experiments. Error bars represent SEM. 
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inositol 1,4,5-trisphosphate (IP3). This, in turn, triggers Ca2+ release from ER stores via 
IP3 receptors at the ER. One possible mechanism of inhibition of this process is that 
intracellular parasites might sequester PIP2, such that it is no longer available for 
cleavage by PLC!.  To address this possibility, we assessed whether infection by 
Toxoplasma alters the plasma membrane association of GFP-tagged PH-PLC% that is 
highly specific for PIP2 [25]. The relative concentration of PIP2 at the plasma membrane 
was assessed by determining the ratio GFP-PH-PLC% at this membrane to its 
concentration in the cytoplasm as illustrated in Figure 6.5A. As summarized in Figure 
6.5B, we find that infection does not change the ratio of plasma membrane to 
cytoplasmic fluorescence, indicating that T. gondii does not reduce PIP2 levels at the 
plasma membrane, and thus does not apparently inhibit antigen-stimulated Ca2+ 
mobilization by this mechanism. In Chapter 5 we also documented that PIP2 is not 
sequestered in the PVM. 
Previously, it was shown that phosphorylation of PLC!1 is dependent on PI3 
kinase (PI3K) [26].  We reasoned if T. gondii infection alters PI3K activity, we should 
see a change in the amount of phosphatidylinositol 3,4,5-trisphosphate (PIP3) at the 
plasma membrane. Similar to detection of PIP2 with GFP-PLC% PH domain, we could 
use a GFP-tagged PH domain (PH-Akt) that specifically binds PI 3,4-P2 and PIP3 as an 
affinity tag to assess the relative amount of these species at the plasma membrane.   
We found that, like PIP2, there does not appear to be a gross change in the 
amount of PIP3 at the plasma membrane (Figure 6.5C, D). These results make it 
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Figure 6.5. PIP2 and PIP3 levels at the plasma membrane are not altered by T. gondii 
infection. (A) Representative images showing uninfected (top) or RH-tomato infected 
(bottom) RBL cells transiently transfected with EGFP-PH-PLC%. Accompanying 
fluorescence intensity profiles are taken along the white lines indicated in each image.  
(B) Ratio of plasma membrane to cytoplasmic EGFP-PH-PLC% fluorescence (given by 
intensity profiles as shown in (A)) as a relative measure of PIP2 at the plasma 
membrane. (C) Representative images showing uninfected (top) or RH-tomato infected 
(bottom) RBL cells transiently transfected with EGFP-PH-Akt. Accompanying 
fluorescence intensity profiles are taken along the white lines indicated in each image.  
(D) Ratio of plasma membrane to cytoplasmic EGFP-PH-Akt fluorescence as a relative 
measure of PIP3 at the plasma membrane. Data in (B) and (D) represent at least 30 
cells for each condition collected over 3 experiments. Error bars indicate SEM.! 
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Figure 6.5. (continued) 
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unlikely that changes in PIP3 levels are the cause of reduced Ca2+ mobilization caused 
by Toxoplasma infection. 
PLC# activation is reduced in Toxoplasma-infected RBL-2H3 cells. 
 Since phosphoinositide availability at the plasma membrane does not appear to 
be significantly changed in infected RBL cells, we next asked whether the parasite-
mediated inhibition is due to a defect in PLC!1 activitation. In order for PLC!1 to 
enzymatically cleave PIP2, it must be recruited to the plasma membrane and 
phosphorylated at tyrosine 783 (Y783). Western blotting with anti-pY783-PLC!1 shows 
that this antigen-stimulated phosphorylation is reduced in infected samples following 
antigen stimulation (Figure 6.6A).  At 10 minutes post-stimulation in the presence of RH 
parasite, pY783-PLC!1 is reduced by ~50% (figure 6.6B).  
 To further assess the activity of PLC!, we asked if antigen-mediated IP3 
generation was reduced in T. gondii infected RBL cells. Specifically, we looked at 
calcium mobilization in the absence of extracellular calcium as a measurement of PLC! 
functionality. Figure 6.6C is a representative experiment that shows all parasite types 
significantly reduce the amount of calcium released from stores in response to antigen. 
Over multiple experiments, parasite infection reduces the peak calcium release by 37, 
50 and 49% for RH, PTG and CTG, respectively (Figure 6.6D). Together, these results 
support a mechanism in which T. gondii acts to inhibit PLC! activation through blocking 
the tyrosine phosphorylation of this lipase.  
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Figure 6.6. PLC!1 activity is reduced in T. gondii-infected RBL-2H3 cells. (A) 
Representative Indo-1 fluorescence measurements of Ca2+ responses to 10 ng/ml DNP-
BSA in the absence of extracellular Ca2+ in control uninfected (black), RH-infected (red), 
PTG-infected (blue) or CTG-infected (green) cells (MOI 10:1). (B) Peak calcium 
responses as a percentage of control Ca2+ response. Histogram shows averages of 3 
independent experiments. Error bars represent SEM (* is P<0.05 and ** is P<0.01 
relative to control cells). (C) Western blot of phospho-PLC!1 (pY-783) (top) or total 
PLC!1 (bottom) in control or RH infected (MOI 10:1, 1 hr) cells lysed at 0, 2, 5, or 10 
minutes after addition of DNP-BSA (10 ng/ml). (D) Ratio of phospho-PLC!1 (pY-783) to 
total PLC!1 shown in (C).  
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Inhibition of mast cell signling by T. gondii requires parasite attachment, but not 
complete invasion. 
 Our single cell Ca2+ and degranulation measurements indicate that the inhibitory 
action of T. gondii requires direct contact between the host cell and parasite, and 
possibly parasite entry.  To more directly address these issues, we initially compared 
the effect of infecting RBL cells with the RH parasite strain to incubation with the 
supernatant from an equivalent number of parasites on antigen-stimulated 
degranulation.  As shown in Figure 6.7A, neither the RH supernatant nor the 
supernatant from RH-infected fibroblasts were capable of inhibition antigen-stimulated 
degranulation under conditions in which infection by intact parasites was effective. In 
fact, the supernatant from the RH parasites caused a modest potentiation of the 
degranulation response to antigen.  Additionally, degranulation cannot be inhibited by 
heat-killed or fixed parasites (data not shown). 
Invasion is dependent on the parasite cytoskeleton [27]. Therefore, infections 
carried out in the presence of the actin inhibitor cytochalasin D result in a frustrated 
state where parasites can attach and secrete proteins into the host cell but cannot 
complete invasion [27]. Cytochalasin D is known to enhance degranulation responses of 
RBL cells to antigen [28], and, as expected, we see robust stimulated degranulation 
under these conditions (Figure 7.7B). However, degranulation in the presence of 
cytochalasin D and RH parasites is reduced by 50% compared to that in the absence of 
the parasites (Figure 7.7B). Microscopic observations under these conditions show, as 
expected, that infection rates in the presence of cytochalasin D are quite low (Figure 
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 Figure 6.7. Tachyzoite attachment, but not invasion, is necessary for inhibition of 
degranulation. (A) RBL-2H3 cells were incubated with parasites (RH) or with 
supernatants from parasites (RH sup) or infected fibroblast supernatant (infected cell 
sup). Degranulation assessed by #-hexosaminindase release after 1 hour of infection as 
described in Materials and Methods. (B) T. gondii infections (MOI 10:1) were carried out 
in the presence of cytochalasin D (1 µM) to prevent invasion. Histogram shows 
averages from triplicate samples and error bars represent SD.  (C) Confocal microscopy 
of RBL cells infected with RH tomato parasites in the presence or absence of 
cytochalasin D. Data are representative of 2-3 independent experiments. !
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7.7C), consistent with the conclusion that inhibition under these conditions is due to 
attached, not intracellular parasites.  This result indicates that the agent responsible for 
mediating inhibition of degranulation, likely by acting on PLC! activation, is secreted 
very early during the invasion process. 
DISCUSSION 
 Based on its global prevalence and ability to infect a multitude of hosts, T. gondii 
is seen as one of the worldʼs most successful parasites. Its success is due, in part, to 
the arsenal of immune-modulatory mechanisms it employs. Recent evidence 
demonstrates T. gondii disrupts normal chromatin remodeling resulting in the 
downregulation of cytokine expression [29].  These parasites also secrete proteins that 
act on signaling steps upstream of cytokine gene transcription, dramatically altering the 
type of immune response generated [3]. These examples suggest that a major strategy 
of T. gondii immune subversion is one of efficiency. That is, the parasite precisely 
targets cell signaling mechanisms that results in broad changes that overall benefit 
parasite survival and replication. Our current study uncovers another central target of 
parasite interference. 
In vivo, T. gondii is known to preferentially infect immune effector cells, including 
macrophages and dendritic cells [30, 31]. For many immune cells, effector function is 
measured by cytokine production, a process that can often take several hours or even 
days to occur. We set out to determine if T. gondii has the capacity to interfere with 
signaling steps that happen more immediately. Fc"RI-triggered degranulation in mast 
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cells occurs within minutes of stimulation and continues for at least an hour. As a result, 
this is an appropriate model to investigate how infection may acutely modulate immune 
signaling. Intracellular Ca2+ levels are tightly regulated and elevation of intracellular Ca2+ 
is critical in immune responses in multiple cell types and contexts [11, 32, 33]. 
Intracellular parasites are sensitive to host Ca2+ responses, in fact, exogenously 
stimulating Ca2+ influx by treatment with calcium ionophore triggers tachzioyte egress 
[34]. 
  Ca2+ mobilization is an important and well-studied aspect of IgE/Fc"RI-mediated 
signaling in mast cells.  When our initial experiments revealed that parasite infection 
suppresses degranulation responses in RBL cells, it immediately suggested that 
parasites might act at the level of Ca2+ mobilization. We showed that parasite infection 
can block antigen-mediated, but not thapsigargin-triggered, Ca2+ elevation, indicating 
that infection acts upstream of Ca2+ release from stores. Inhibition of Ca2+ mobilization 
in the absence of extracellular Ca2+ further supports this explanation. Hydrolysis of PIP2 
mediated by PLC! to produce IP3 and DAG is a critically important in Ca2+ mobilization 
by antigen.  One possible mechanism to account for decreased Ca2+ store release in 
response to antigen is that the parasite alters the amount or availability of PLC!ʼs 
substrate, PIP2, at the plasma membrane. Our results make this unlikely, as we detect 
no significant change in the association of PH-PLC% with PIP2 at the plasma membrane 
due to infection by T. gondii.  We do, however, see a reduction the level of activating 
tyrosine phosphorylation of PLC!1 during infection, suggesting that Toxoplasma is not 
actively reducing the amount of PIP2 but rather the hostʼs capacity hydrolyze that PIP2. 
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PLC!1 activity in mast cells is regulated by PI3 kinase-mediated production of 
PIP3 [26], but our results indicate that the parasite doe not significantly changes the 
level of PIP3, in infected cells. Our data collectively suggest a model in which a T. gondii 
derived protein acts directly to reduce the activity of PLC!1, thereby reducing the levels 
of IP3 and inhibiting subsequent signaling steps. 
Additionally, our work suggests that the factor is a secreted product released by 
the parasite at very early steps during the invasion process.  Previous work determined 
that invasion is a multi-step process. In early steps, parasites attach to the host plasma 
membrane and release the contents of the rhoptries [27].  Genomic sequencing 
revealed that rhoptry proteins of the ROP family, including ROP16 and ROP18, which 
are secreted during invasion, are key virulence factors in T. gondii infection [6, 7]. 
Recently, ROP16 has been shown to directly phosphorylate host proteins [35, 36].  
Their temporal release, relation to virulence and immunomodulatory capabilites [35, 37] 
make ROP proteins attractive candidates for the Toxplasma secreted factor responsible 
for the reduction of PLC!1 activity. Future work should aim to determine which parasite-
derived protein(s) are responsible for the inhibition we observe. 
 Furthermore, it will be important to assess whether downregulation of PLC! 
signaling is manifest in other immune cells that are targeted by T. gondii.  To this end, 
there is initial evidence that T. gondii infection reduces fMLP-triggered Ca2+ signaling in 
mouse neutrophils (Abi Abdallah and Denkers, unpublished results).  Collectively, these 
results suggest that T. gondii targets PLC activation as a mechanism to globally down 
regulate immune signaling that occurs via Ca2+ mobilization.   
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CHAPTER SEVEN 
Summary and Future Directions 
While mast cells are best known for the detrimental effects of allergies and 
asthma, which alone make them an important subject of investigation, they can also 
play more diverse effector roles in the immune system.  Furthermore, the well-studied 
FcεRI signaling pathway serves as a useful model for related, and sometimes more 
complicated, signaling pathways in other immune cells types.  The breadth of this thesis 
demonstrates how studying the cellular responses of mast cells under various 
conditions can reveal a tremendous amount of information in subjects as diverse as 
membrane heterogeneity and the molecular mechanisms of parasitic 
immunomodulation. 
For many years, it was thought that the precise nature of the lipid environment 
surrounding signaling proteins was not important for the signaling outcome, but rather 
simply an environment through which the proteins could freely diffuse. Research in our 
lab and others has demonstrated the important regulatory contributions that ordered 
lipid microenvironments make to immune signaling [1].  The relevance of these so-
called lipid rafts has not been without controversy, in part because of the non-
physiological methods used for examination as well as the transient and nanoscale 
features of these membrane domains [2, 3]. 
While using non-physiological methods requires some caution, they are still 
useful correlative tools.  One such method is detergent resistant fractionation of cellular 
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membranes, and this provided the foundation for the mass spectrometric analysis 
described in Chapter 2.  We established that stimulation-induced changes in the lipid 
composition of DRMs are mimicked by destabilizing the actin cytoskeleton and 
prevented by stabilizing the actin cytoskeleton.  These results imply that regulation of 
the actin cytoskeleton plays a large role in regulating the lipid composition of the DRMs.  
By extension, our results suggest an important interplay between cytoskeletal proteins 
and the lipids involved in the membrane heterogeneity surrounding signaling proteins in 
mast cells.  
  Non-destructive methods for visualizing and understanding the nature of 
membrane heterogeneity are being developed [4, 5]. In particular, recent advances in 
sub-optical resolution light microscopy [6], will prove useful for the visualization of 
membrane heterogeneities, which are estimated to exist on sub-micron length scales 
under physiological conditions. Nearly all methods suffer from experimental or 
interpretational limitations, so a combination of methods will be necessary to fully reveal 
the mechanisms that regulate membrane heterogeneity as it relates to immunoreceptor 
signaling. 
 The signaling that emanates from IgE-FcεRI crosslinking has been extensively 
studied for many years, but it is only recently appreciated that this signaling alters RE 
trafficking.  Naal et al. first established that IgE-mediated signaling results in the 
stimulated outward trafficking of RE [7].  Furthermore, this trafficking is extremely robust 
and refractory to many modes of inhibition, but it is sensitive to inhibition of Ca2+ 
moblization [7]. Chapter 3 demonstrated that sphingosine derivatives, D-sphingosine 
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and DMS, are potent inhibitors of antigen and ionophore-stimulated RE trafficking.  
These derivatives also inhibit degranulation.  Ca2+ mobilization is a shared signal for 
both RE trafficking and granule exocytosis, and is also inhibited by sphingosine 
derivatives. The use of a genetically encoded PM-associated phosphoinositide sensor, 
mRFP-MARCKS EDSA3, indicated that these derivatives function by neutralizing 
negatively charged phosphoinositides at the plasma membrane and thereby causing 
inhibition of Ca2+ mobilization, a central player in multiple signaling pathways. 
 Revealing the mechanism by which sphingosine derivatives inhibit mast cell 
signaling has several important ramifications. It demonstrates a role for plasma 
membrane phosphoinositdes in Ca2+ signaling. It provides a likely mechanism for earlier 
work showing that sphingosine derivatives inhibit SOCE [8] and the more recent finding 
that sphingosine derivatives reduce coupling of Orai1 and Stim1 necessary for SOCE 
[9]. Additionally, D-sphingosine and DMS also block Ca2+ signaling upstream of store 
release, indicating that these derivatives act at multiple steps of Ca2+ mobilization. At the 
same time, it makes less likely that the inhibitory effects of DMS are a result of blocking 
sphingosine-1-kinase production of sphingosine-1-phosphate as previously proposed 
[10, 11].  
 In part, the initial motivation for our study of sphingosine-mediated inhibition was 
to develop tools to probe the function and regulation of RE trafficking in mast cells. The 
initial work by Naal et al. suggested that the rapid outward trafficking of RE in stimulated 
RBL cells provided membrane necessary for processes such as plasma membrane 
remodeling and ruffling [7]. Interestingly, when antigen was restricted to specific regions 
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of a patterned surface, RE trafficked to the site of antigen ligation [12]. Such directed 
trafficking is an extremely interesting phenomenon, and suggests a specific function.  In 
other immune cells types, RE are known to transport cytokines [13, 14], and even more 
interestingly they are involved in directed trafficking of certain cytokines [15].  
Collectively, these results were the motivation for assessing the involvement of RE in 
the trafficking of cytokines in mast cells.   
Preliminary experiments demonstrated partial colocalization of newly synthesized 
IL-4 with RE.   Surprisingly, siRNA knockdown of Rab11A, which is known to regulate 
RE trafficking, does not inhibit cytokine release. Further studies reveal that Rab11A 
knockdown does not negatively impact antigen-mediated outward trafficking of CTxB-
labeled RE.  These results suggest, in agreement with Balasubramanian et al., that RE 
do not exist as a homogeneous organelle, but instead are comprised of differentially 
regulated pools of membrane [16].  The inability to precisely target and inhibit RE 
trafficking in RBL cells continues to be a limitation, and, as a result, this limits the 
conclusions that can be made concerning the involvement of RE in cytokine trafficking. 
Future studies will need new methods to more directly address this problem. Making 
use of chemical inactivation [17] or genetically encoded markers (e.g. TNFα) in 
conjunction with dominant negative or constitutively active GTPases, such as Rab11A 
and Arf6, may prove useful.   
 RE have diverse functions in multiple cell types, often in processes that require 
directional trafficking of large quantities of membrane [18].  One such example is the 
demonstration that RE traffic to the site of phagocytosis [13]. Additionally, RE are 
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implicated in interactions with several bacterial vacuoles [19, 20]. The obligate 
intracellular parasite Toxoplasma gondii enters host cells through a process of active 
invasion distinct from phagocytosis [21], but, similar to phagocytosis, the parasite 
resides inside a host-derived membrane following invasion.  The precise sources of this 
membrane have been unclear.  Utilizing a differential CTxB labeling protocol to 
distinguish between RE and PM membrane pools in RBL mast cells, the results in 
Chapter 5 strongly suggest that RE of host cells contribute to the nascent PV of 
Toxoplasma. Evidence from experiments using additional RE markers support this 
result. 
 The importance of RE trafficking to the T. gondii vacuole is currently being 
addressed. One hypothesis is that RE contributions to the PV provide membrane 
necessary for PV expansion during parasite replication.  The use of mutant RBL cells 
with defects in RE trafficking (J. Wilson, unpublished results) will be useful for these 
studies.  Additionally, over-expression or siRNA-mediated knockdown of RE regulators 
may be illuminating. Uncovering the details of RE-Toxoplasma interactions will provide 
important information concerning both the unique intracellular environment of 
Toxoplasma and, more generally, the regulation of RE trafficking. 
 Like many pathogens, T. gondii has developed multiple mechanisms to 
subvert the immune function of its host [22].  Chapter 6 documents a previously 
unknown mechanism of immunomodulation, Toxoplasma-mediated inhibition of PLCγ1 
that results in the reduction of antigen-stimulated Ca2+ mobilization and degranulation in 
RBL mast cells. Future work should aim to determine the parasite-derived factor 
211
necessary for PLCγ1 inhibition. The demonstration that inhibition can occur in the 
presence of cytochalasin D, suggests that proteins secreted at the time of invasion are 
promising candidates. A good example of possible effectors is the ROP family of 
proteins secreted by parasite rhoptries concurrently with invasion. PLCγ-mediated 
cleavage of PIP2 into DAG and IP3 plays an essential role in FcεRI receptor signaling, 
but is also extremely important in other immune signaling pathways. As such, these 
results may extend to modulation of PLCγ-mediated signaling in macrophages and 
dendritic cells, as both are preferentially infected by T. gondii. Furthermore, it will be 
important to investigate how this inhibitory mechanism interacts with other known 
mechanisms of immunomodulation to affect the course of infection.  
Additionally, there is the possibility that down regulation of immune responses in 
mast cells is important in in vivo infections, particularly co-infection situations. 
Laboratory conditions are tightly controlled to ensure that experimental hosts only 
encounter a single pathogen. However, in nature that probably not the case, in fact, it is 
more likely hosts are routinely dealing with concurrent exposure to multiple pathogens.   
Thus, while infection of mast cells by T. gondii is not thought to be common, there are 
situations in which mast cell infection could be highly relevant. For example, individuals 
infected with the parasitic worm Trichinella spiralis experience mastocytosis in the gut 
that is accompanied by increased intestinal permeability and parasite-induced intestinal 
damage [23]. If a Trichinella-infected host was concurrently infected with T. gondii, this 
altered intestinal environment might contribute to dramatic increases in the number of 
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Toxoplasma-infected mast cells. In this situation, Toxoplasma could very well need a 
mechanism to control normal mast cell function.   
Collectively, this body of work demonstrates how detailed research on the well-
documented IgE-FcεRI signaling pathways continues to reveal important discoveries on 
aspects of mast cell biology and function. Furthermore, these efforts do much more than 
just further our understanding of the allergic response; this work contributes to our 
understanding of many topics important in immune function, including the basis of 
membrane heterogeneity, regulation and function of membrane trafficking, and how 
pathogens and their hosts interact.  
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